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 Though many HPLC methods have been developed and reported in literature for 
vitamin analysis for the past two decades, applying certain methods directly from 
literature more than often fails to reproduce the results reported due to many variables of 
liquid chromatography. This issue was targeted in this project through the examination of 
chromatographic behaviors of water-soluble vitamins in order to help the analysts better 
modify methods from literature or even develop new methods from scratch to fit their 
analytical need with the resources available (e.g., columns, detectors, etc.) in their lab. 
 The first part of the project investigated the chromatographic behaviors of five 
vitamins: thiamine (B1), riboflavin (B2), pyridoxine (B6), cyanocobalamin (B12) and 
ascorbic acid (C) using different reversed-phase columns. Type-B-silica columns with 
novel reverse bonded phase compatible with 100% aqueous phase were found to be best 
suited for the analysis of water-soluble vitamins. With a simple mobile phase system 
using 0.1% formic acid (A) and acetonitrile (B), the five analytes mentioned above could 
be conveniently separated in 2 groups. Group 1 with vitamin B1, B6 and C can be eluted 
under 100% phase A, while group 2 with vitamin B2 and B12 can be eluted under 85% 
phase A, 15% phase B. Approaches to enhance the retention of the three fast-eluting 
vitamins (B1, B6 and C) were investigated. Perfluorinated acids such as TFA or HFBA 
proved to be efficient in improving the retention of B1 and B6 in reversed-phase 
columns. An alternative is to use buffered mobile phase with pH from 5.0 to 7.0. 
Ammonium acetate buffer pH 5.8, which is compatible with LCMS, was found to be able 
 iii 
to improve B1 and B6 retention significantly. HILIC column was another alternative to 
enhance the retention of not only B1 and B6 but also C. 
 The second part of the project was expanded to include the other four water-
soluble vitamins (niacinamide B3, pantothenic acid B5, biotin B7 and folic acid B9). The 
goal was to develop HPLC methods for the analysis of all nine water-soluble vitamins 
using DAD-ELSD and LCMS. ELSD is a universal detector that responds more or less 
similar to all vitamins. However, its sensitivity is too low to even allow the analysis of 
samples with high concentration of target analytes such as dietary supplements. DAD is 
more sensitive but subject to possible background interferences and noisy baseline at low 
wavelengths (e.g., 210 nm) that were needed to obtain response from non-chromophoric 
vitamins like pantothenic and biotin. Therefore, the use of DAD for simultaneous multi-
vitamin analysis was limited to simple samples like dietary supplements. LCMS has the 
highest sensitivity and specificity among the three detectors. It was proven to be effective 
for the simultaneous analysis of all nine analytes in fortified food products with more 
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 Vitamins are essential nutrients that must be provided to the body in small 
amounts on a regular basis to perform various chemical and physiological functions in 
the human body (1). They are widely distributed in natural food sources and can be easily 
introduced into the diets to satisfy daily needs. Though vitamins are a group of organic 
compounds that have different structural and chemical properties, they can be 
conveniently categorized into two groups based on their solubility: fat-soluble vitamins 
and water-soluble vitamins (2). While the former includes vitamins A, D, E, and K and 
other carotenoids with varying degrees of vitamin A activity, the latter is composed of 
vitamin C and 8 B-vitamins, namely thiamin (vitamin B1), riboflavin (vitamin B2), niacin 
(vitamin B3), pyridoxine (vitamin B6), pantothenic acid (vitamin B5), biotin (vitamin 
B7), folate (vitamin B9) and cyanocobalamin (vitamin B12). Vitamin solubility not only 
decides their distribution in various food groups, but also is an important factor to be 
considered for their analysis and quantification.  
 Vitamins have a variety of uses in foods as colorants, antioxidants and especially 
nutritive additives (3). Although the vitamin requirement of the human body can be easily 
satisfied by a balanced diet, certain subpopulations in the US are more susceptible to low 
micronutrient intakes and hence a higher risk of vitamin deficiency. Enrichment and 
fortification of vitamins in foods such as infant foods, fruit juices, milk, cereal, etc. have 
helped address this issue in the US. Accurate information on vitamin content in food 
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sources consumed frequently is critical to assessing dietary adequacy and planning a 
healthy and balanced diet for optimal nutrient intakes (1). That is where the significance 
of vitamin analysis comes into play. As many vitamins are unstable and easily degraded, 
monitoring their loss during processing is important in the development of appropriate 
processing and storage schemes for optimal nutrient content in the final food products 
(4). Moreover, addition of vitamins into food needs to be properly controlled to satisfy 
the guidelines set by the governmental authorities (3). Therefore, rapid and reliable 
analysis of vitamins in foods is in high demand by food manufacturers.  
 Measurement of vitamins in foods is complicated by many factors (5), which 
include: (1) diverse chemical structures and properties of vitamins render it difficult to 
develop a single universal method for their simultaneous determination. Moreover, each 
vitamin can occur in different forms called vitamers that possess the same biological 
activity upon ingestion; (2) Vitamins often occur in food at relatively low levels; (3) 
Foods are complex matrices, from which the vitamin extraction presents many 
challenges; (4) Vitamins are susceptible to degradation by exposure to light, air, heat and 
high pH.  
 This research project aims to develop fast, reliable and sensitive HPLC methods 
for the analysis of five water-soluble vitamins in the B-vitamin group: thiamine, 





1.1 Vitamin B1 (Thiamine) 
1.1.1 Nomenclature, structure and physiochemical properties 
 First isolated in 1926 and characterized later on in the 1930s, thiamine was the 
first water-soluble vitamin structurally characterized and was formally assigned the name 
vitamin B1 by the British Medical Research Council in 1927 (6-9). The chemical 
structure of the free base thiamine molecule and other related compounds are shown in 
Figure 1.1. It is comprised of a pyrimidine ring (4′-amino-2′-methylpyrimidinyl-5′-
ylmethyl) connected to the 3-nitrogen atom in a substituted thiazole moiety (5-(2-
hydroxyethyl)-4-methylthiazole) by a methylene bridge (10). In nature, thiamine 
normally occurs in three phosphorylated forms, among which thiamine pyrophosphate 
(TPP) is the most dominant form contributing up to 90% of the total thiamine in cells 
(11).  
 TPP acts as a coenzyme in the conversion of pyruvate to acetyl CoA, an essential 
step in TCA cycle (11). Besides the metabolically active TPP, thiamine can be found in 
the organism’s tissues as other phosphorylated forms (thiamine monophosphate or 
thiamine triphosphate) or dephosphorylated forms (12). Inter-conversion of thiamine to 
other phosphorylated forms in tissues is catalyzed by different phosphokinase and 
phosphatase enzymes (13).  
 Two commercially available forms of thiamine are thiamine hydrochloride and 
thiamine mononitrate (2). Thiamine hydrochloride is a colorless, crystalline powder with 
a yeasty odor and a salty nut-like taste. It melts at about 207oC, with decomposition. 
While the hydrochloride form is more soluble in water (1 g/ml) and therefore used in 
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injectable and parenteral pharmaceuticals and food for food fortification, the mononitrate 
form is much less soluble (0.027 g/ml) and finds its use in dry blends, multivitamins, and 
dry products such as enriched flour (9). As thiamine hydrochloride is often used as the 
standard reagent in vitamin B1 analysis, it is worth noting that this form is sparingly 
soluble in methanol, ethanol and glycerol and insoluble in fat solvents (ether, acetone, 























   
Thiamine pyrophosphate (TPP)
 
   
Thiamine triphosphate (TTP) 
   
 Thiamine hydrochloride Thiamine mononitrate  
 
Figure 1.1 Structures of thiamine and related compounds. 
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1.1.2 Stability and degradation 
 Thiamine is generally stable in the dry state and can sustain high temperatures up 
to 100oC (15). Aqueous solutions of thiamine itself are acidic, and at pH below 5.0, they 
are even stable to autoclaving at 120oC-130oC and not susceptible to oxidation (2). Being 
most stable at pH 2.0 to 4.0, thiamine gradually loses its stability as the matrix pH 
approaches neutrality and alkaline (16). When it reaches pH 8 and above, thiamine 
solution rapidly turns yellow and various complex degradation products are formed (17). 
Free thiamine bases are very unstable and very easily oxidized. Mild oxidation results in 
the formation of thiamine disulfide without loss of thiamine activity. Under more 
vigorous conditions, thiamine is oxidized to other biologically inactive derivatives, 
among which thiochrome is an important compound utilized in analytical chemistry for 
thiamine analysis (9). In the presence of sulfite ions at pH 6.0 and above, thiamine is 
rapidly cleaved at the methylene bridge, splitting apart thiazole and pyrimidine moieties.  
A similar reaction happens in thermal degradation with thiazole being further 
decomposed to hydrogen sulfide (3).  
 
1.1.3 Nutritional and physiological functions 
 Thiamine, in the form of TPP, acts as a coenzyme in the three closely related 
dehydrogenase enzyme complexes that catalyze the oxidative decarboxylation essential 
for carbohydrate metabolism: pyruvate dehydrogenase complex, alpha-ketoglutarate 
dehydrogenase complex, and branched-chain ketoacid dehydrogenase complex (8, 10, 
13). Another complex, transketolase, plays a role in the transfer of glycoaldehyde moiety 
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between sugars and together with ketoaldose, connecting the pentose phosphate pathway 
with glycolysis (18). Recent research has reported that peroxisomal enzyme also requires 
TPP in the alpha-oxidation of 3-methyl branched-chain or straight chain fatty acids (19, 
20). In addition to its vital roles in energy metabolism, thiamine has also been known to 
occupy a special site on nerve cell membranes and function in neurotransmission; 
however, the exact mechanism is not yet elucidated (21, 22). 
 The RDA of thiamine is 1.2mg/day for men and 1.1mg/day for women (12). This 
recommended intake is easily met if one consumes a sufficient amount of nutritious food 
to meet energy needs. However, as thiamine is not stored in the body for long-term use, 
failing to provide adequate intake leads to thiamine deficiency. A mild form of this 
deficiency can occur within 10 days after thiamine intake is stopped, accompanied by 
symptoms such as poor sleep, malaise, weight loss and confusion (11). Severe thiamine 
deficiency results in two classical conditions known as beriberi and Wernicke-Korsakoff 
syndrome (18). The former condition is further categorized into dry, wet and infantile 
beriberi (23). Another acute pernicious form was recorded in the 1980s and named 
shoshin beriberi (24, 25). Dry beriberi is characterized by damage to the nervous system 
with symptoms such as poor appetite, fatigue and peripheral neuritis (23) while wet 
beriberi patients may develop cardiac failure and edema (8). Alcohol abusers are 
susceptible to another severe thiamine deficiency condition called Wernicke-Korsakoff 
due to the poor diet and the impairment of thiamine absorption by alcohol (21). Mental 
disorders characteristic of Wernickle-Korsakoff includes confusion, hallucinosis, 
psychosis, and even coma (13) . No upper limit (UL) has been determined due to the lack 
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of supporting evidence of toxicity for excess thiamine intake (12). This is a common 
occurrence with water-soluble vitamins that are readily excreted in the urine.  
   
1.1.4 Occurrence and distribution in food 
 Yeast and yeast extract, whole grain cereals and cereal products, beans, nuts, egg 
yolk, poultry, fish, meat (especially liver and lean pork) are among the richest dietary 
sources of thiamine (26) while refined and processed foods without fortification are poor 
sources (18). 
 Prolonged thermal processing may lead to a significant loss of thiamine due to 
thermal breakdown (12). Moreover, as a water-soluble compound, thiamine leaches into 
water during boiling or blanching. Cooking may cause a substantial loss of up to 90% of 
thiamine content following the boiling of rice and green vegetables (18, 27). Therefore, 
cooking methods with little or no water such as steaming are recommended to conserve 
thiamine content in food.  
  
1.1.5 Analytical methods 
1.1.5.1 Extraction 
The extraction protocols are dependent upon the goals of the analyst to quantify total 
thiamine in the free forms or thiamine phosphate native forms. Regardless of the form 
being analyzed, the first step of the extraction involves the liberation of thiamine and 
thiamine phosphate esters from their association with proteins though acid hydrolysis 
under high temperature (2, 8). If the free form is of interest to the investigator, the sample 
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is then subjected to enzyme hydrolysis to convert the phosphorylated thiamine forms into 
the free forms (28, 29). The optimal extraction procedure outlined in The AOAC 
International Method 942.23 (30) is similar to the method published by The European 
Union Measurement and Testing Program (28) and includes the following steps: (1) 
autoclaving 0.2-5 g sample in 0.1N HCl for 30min at 121°C, (2) adjusting the solution to 
pH 4.0 with 4.0 M sodium acetate buffer (pH 6.1), (3) incubating the mixture with 
takadiastase at 37-45°C for 4hrs. This autoclaving temperature is not high enough to 
degrade the phosphorylated thiamine, the predominant forms in samples of animal origin 
(28). However, for cereal products, the temperature is recommended to be lowered to 
108°C to protect the non-phosphorylated forms which are more susceptible to 
degradation (2). Another common alternative condition is to digest the sample at 95°–
100°C in a steam bath, or in boiling water, with frequent mixing for 30 minutes (30). If 
the analysis targets a native phosphorylated thiamine species then these thermal treatment 
in acidic conditions is sufficient without the enzymatic digestion (31). The main purpose 
of the enzymatic step is to dephosphorylate thiamine, which can be performed by 
commercial diastases such as Takadiastase, Claradiastase or Mylase (28, 32). Besides α-
amylase and phosphatase activity, these enzymes also possess some protease activity 
which is useful for digesting proteinaceous samples such as meat. For milk and dairy 
product samples, the extraction procedures can be simplified to include only the 




1.1.5.2 Non-HPLC methods:  
 One of the earliest methods used to determine vitamin B1 in biological samples is 
microbiological assays (9). The most commonly used microorganism species for this 
method are Lactobacillus fermenti (ATCC 9338) and Lactobacillus viridescens (ATCC 
12706) (2). The former, though originally used, is subject to inhibitory and stimulatory 
substances (33). Therefore, L.viridescens, which requires intact thiamine for growth, is 
favored due to its higher specificity for the assay (34). The extraction protocol in AOAC 
Official Method 942.23 (Thiochrome analysis procedures) can be followed in preparation 
for microbiological assays. In order to ensure the complete utilization of total vitamin B1 
by L. viridescens, both acid and enzyme hydrolysis are required to liberate and 
dephosphorylate all the bound forms in order to prevent differential growth response to 
TMP, TPP and TTP (2, 34). Another alternative method utilizing the protozoan 
Ochromonas danica was developed by Baker for thiamine assessment in blood-based 
samples (35).  
 Official standard procedures by AOAC, AACC (American Association of Cereal 
Chemists) and European Committee for Standardization all involve the conversion of 
thiamine into a highly fluorescent product named thiochrome through alkaline oxidation 
with cyanogen bromide or potassium ferricyanide (9). This reaction (Figure 1.2) was first 
described by Barger et al. in 1935 and has been widely used in a variety of procedures 
reported throughout the literature (36). Phosphorylated thiamine can also be converted 
into thiochrome phosphate esters with the intact phosphate moieties and share the same 
fluorescent properties with thiochrome (37). They all have similar excitation and 
 11
fluorescence maxima at 375nm and 435nm, respectively (10). Without the interference of 
other fluorescent components, the fluorescence intensity of thiochrome is correlated to 
total thiamine content in a sample (9). This reaction when combined with HPLC 
fluorescence either pre or post-column can enhance the selectivity and sensitivity of 
thiamine analysis significantly (10).   
Figure 1.2 Thiochrome reaction 
 
 Paper partition chromatography (PPC) was the first chromatographic technique 
used for the analysis of thiamine phosphates in biological materials. Elution of the 
targeted compounds by several different solvent systems followed by photometry at 270 
nm of the eluted spots was used to quantitate each thiamine compound down to the 10-µg 
level (10). Separation of thiamine phosphates by PPC was also reported to be followed by 
a microbiological assay, which allowed a detection limit of about 0.02 µg (60 pmol) of 
thiamine (10). It is worth mentioning that this limit is at least three orders of magnitude 
higher than that of HPLC with a fluorescence detector. Another similar technique, thin 
layer chromatography (TLC), allowed the separation of more complex mixtures of 
thiamine and its metabolites and precursors when used on two dimensional with two 
different solvents. These TLC procedures have been used to analyze thiamine in 
pharmaceutical samples at levels of 20 µg to 10 mg (38). 
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 Ion exchange chromatography has also been a common technique used to separate 
thiamine and its phosphates in both pharmaceuticals and biological samples. AOAC 
official method 953.17 uses Bio-Rex 70 cation exchange resin to clean up the sample 
extract after acid and enzyme hydrolysis (39). A sephadex cation exchange column was 
also reportedly used in thiamine analysis as well (40).  
 In comparison to spectroscopic and especially liquid chromatographic methods, 
other approaches are less popular. Electrochemical (41, 42) and capillary electrophoretic 
(43, 44) methods have not been extensively used for routine analysis of thiamine though 
their feasibility has been proven. Another less popular technique is flow injection 
analysis (FIA) which has emerged as a promising technique applicable to 
pharmaceuticals and biologicals. When coupled with fluorimetric or chemiluminescent 
detection, the method exhibits high sensitivity and selectivity as well as provides high 
sample throughput. Fluoresence-based methods requires thiamine be converted to either 
thiochrome or other closely related fluorescent derivatives (45-47). Chemiluminescence-
based methods make use of thiamine’s ability to decrease chemiluminescense produced 
by luminol-ferricyanide or luminol-potassium periodate reaction (48, 49). 
 
1.2 Vitamin B2 (Riboflavin) 
1.2.1 Nomenclature, structure and physiochemical properties 
 First isolated, though not purified, as yellow fluorescent compounds from whey 
and different biological matrices more than 100 years ago, riboflavin was originally 
known as lactochrome or lactoflavin (50, 51). It was not until the 1930s that the structure 
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and synthesis of riboflavin were determined by Kuhl (52) and Karrer (53). In the same 
decade, the coenzyme forms of riboflavin, namely flavin mononucleotide (FMN) and 
flavin adenine dinucleotide (FAD) were isolated and structurally identified (54). In fact, 
these terms are misnomers because FMN and FAD are basically not mono and 
dinucleotide respectively (50). However, the names are still accepted and widely used. In 
the scientific context, the term “riboflavin” is used to refer to the parent riboflavin 
molecule and in many cases can be used synonymously with vitamin B2 (2). 
 The official IUPAC name of riboflavin is 7, 8-dimethyl-10-(1′-d-ribityl) 
isoalloxazine (3). The name "riboflavin" originates from the sugar moiety (ribitol) which 
is the reduced form of the pentose sugar ribose and the isoalloxazine ring moiety 
(commonly referred to as flavin ring) which imparts the yellow color to the oxidized 
molecule (9). The reduced form, which occurs in metabolism along with the oxidized 
form, is colorless. The addition of a phosphate group or adenosine-5′-diphosphate at the 
5′ position of the ribityl side yields FMN and FAD respectively (9). These groups can be 
removed through acid hydrolysis, which is utilized in analytical procedures to liberate the 
free form for the quantitation of the total riboflavin. The structure of riboflavin and other 






Figure 3 Structure of riboflavin 
 
Riboflavin 5’-phosphate (FMN) 
Flavin Adenine Dinucleotide (FAD) 
 
Figure 1.3 Structures of flavin coenzymes 
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 Riboflavin is an odorless orange crystalline powder with an unpleasant bitter taste 
and a melting point of about 280oC (14). In neutral aqueous solution, riboflavin exhibits a 
strong yellow-green fluorescence (15). Though classified as a water-soluble vitamin, 
riboflavin has a low solubility in water (10–13 mg/100 ml at 25–27.5oC; 19 mg/100 ml at 
40oC; 230 mg/100 ml at 100oC) (14, 54). It is sparingly soluble in absolute ethanol (4.5 
mg/100 ml at 27oC) and not at all in acetone, diethyl ether, or chloroform (2). Riboflavin 
solubility can be enhanced in dilute acid or alkali though it is not very stable in alkali (2). 
The presence of aromatic compounds is known to make riboflavin more soluble in 
aqueous solution, which is utilized in pharmaceutical preparations (2). In contrast, FMN 
and FAD are much more soluble than riboflavin (2, 14).    
 The well-studied characteristic spectral properties of flavins in different oxidized 
and reduced states have laid a foundation for their chemical analysis (55). In the oxidized 
state, flavins are yellow pigments that have two characteristic absorption bands at 370 
and 450 nm (51). Affected by solvent properties, the maxima around 370nm tend to shift 
to lower wavelengths as the solvent polarity decreases (56). The reduced forms of flavins, 
on the other hand, show untypical and variable absorption spectra above 300nm (57).   
 Analytical procedures employing these UV-Vis spectral properties have been 
adapted for vitamin B2 analysis. However, their popularity pales in comparison to 
fluorimetric methods considering riboflavin possess a strong native fluorescence without 
the need of derivatization (Ex λ = 440–500, Em λ = 520–530) (55). Among the three 
forms, riboflavin and FMN have similar fluorescence capacity, which is much stronger 
than FAD’s (58). It is due to the fluorescence quenching of the adenine and the 
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isoalloxanzine ring. It is worth mentioning that the reduced forms of flavins do not 
fluoresce (57).  
 
1.2.2 Stability and degradation 
 In crystal form, riboflavin is stable when stored in dry conditions (2). Stability 
becomes a concern when riboflavin occurs in solution as it is easily degraded by exposure 
to both UV and visible light (9). The rate of this photodegradation process is sped up with 
elevated temperature and pH with the wavelength range of 350–520 nm exerting the 
greatest destructive effects (59). As shown in Figure 1.4, the nature of this degradation is 
the reduction of the isoalloxanzine ring by the ribityl side chain, resulting in the 
formation of lumichrome and lumiflavin under alkaline and acidic conditions, 
respectively (58, 60). Both of these degraded products do not exhibit vitamin B2 activity. 
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Figure 1.4 Photodegradation of riboflavin under basic and acidic conditions 
 
 Except for being light sensitive, riboflavin is generally stable to heat and 
oxidation (2). If light is excluded, most food processing operations or normal cooking 
have little effect on riboflavin content. Its stability increases as  acidity  increases with 
optimal  stability  to  heat  degradation  being  between  pH  2.0  and  5.0 (2).  
 Low stability of flavins upon exposure to light is taken into consideration in food 
packaging (9). Containers made of glass or other translucent materials are subjected to 
sunlight, which induces significant loss of riboflavin in the food products such as milk 
and juices (12). The same phenomenon even occurs in dry products such as enriched 
pasta over a prolonged exposure to light during storage (9, 26). The use of blow molded 
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polyethylene containers can provide a sufficient barrier against photodegradation of 
riboflavins in food products (61).  
 
1.2.3 Nutritional and physiological functions 
 The three major biologically active forms of vitamin B2 found in nature including   
riboflavin, riboflavin-50-phosphate (FMN) and riboflavin-5’-adenosyldiphosphate (FAD) 
have equal vitamin activity in human (21, 26). With the ability to participate in either 
one- or two-electron redox reactions, FMN and FAD can either act as cofactors for 
several flavoprotein enzymes that catalyze redox reactions in cells or serve as electron 
carriers in the mitochondrial electron transport system (23, 51). Some typical reactions in 
intermediary metabolism that require riboflavin include dehydrogenation, hydroxylations, 
oxidative decarboxylations, dioxygenations, and reductions of oxygen to hydrogen 
peroxide (62, 63). Acting as coenzymes of dehydrogenases, FMN and FAD are essential 
to both glucose and fatty acid metabolism (21). Besides their role in energy metabolism, 
they contribute to drug and steroid metabolism in conjunction with cytochrome P450 
enzymes (64). Other important functions of riboflavin also include the activation of 
pyridoxine (vitamin B6) and the conversion of tryptophan to niacin (26).  
 Riboflavin does not have much, if any, antioxidant activity by itself. However, its 
reduced form as a precursor to FMN and FAD exhibits protective effects against 
oxidative damage to cells (54).  Together with NADPH, riboflavin coenzymes help 
recycle glutathione peroxidase, an enzyme that breaks down reactive lipid peroxides (64, 
51). Riboflavin has been found to be related to a number of disease states (51). Some 
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studies suggest that there is an association between cataract and riboflavin deficiency and 
nutritional supplements (including riboflavin) may help to improve cataracts (65). 
Riboflavin deficiency may also increase plasma homocysteine concentration, which is 
thought to be linked to an increased risk of cardiovascular disease (66). Moreover, 
impaired iron absorption and even night blindness have been found to be associated with 
riboflavin deficiency (51).  
 Like other water soluble vitamins, urinary riboflavin excretion occurs on a daily 
basis, therefore deficiency can happen when the dietary intake is low (64). Symptoms of 
riboflavin deficiency (ariboflavinosis) may include glossitis, angular stomatitis, angular 
cheilitis and dermatitis (26). However, these classical symptoms are not characteristic of 
riboflavin deficiency but closely associated with other vitamin deficiencies as well. 
Actually, when ariboflavinosis does occur, it does not do so in isolation but rather 
accompanies other nutrient deficits (54). RDA of vitamin B2 for men and women are 
1.3mg/day and 1.1mg/day respectively (12). No toxicity symptoms have been reported 
therefore no UL has been established (12). 
  
1.2.4 Occurrence and distribution in food 
 As FMN and FAD are essential for the enzymatic activity in living cells, flavins 
are prevalent in all natural unprocessed foods (15). Yeast extract, liver and kidney are 
exceptional sources of vitamin B2 (2). However, the primary contribution to the dietary 
intake is from milk and dairy products, which contains mainly free riboflavin with a 
small amount of protein-bound flavins (about 14%) (67, 68). Due to a significant loss of 
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up to 60% during milling, cereal products are enriched with the vitamin (2). Together 
with whole grain, enriched cereal products are important sources in regions where they 
are a part of the staple diet (9). In terms of nutrient density, dark green leafy vegetables 
such as spinach, broccoli, asparagus, etc. top the list (12). They are an excellent source 
for vegans who avoid consumption of milk products. 
 Riboflavin is generally heat stable, therefore cooking does not destroy it. 
However, it is susceptible to degradation upon exposure to UV light and irradiation (9). 
Milk is therefore packaged in cardboard or opaque polyethylene containers, instead of 
translucent glass bottles to provide protective barriers for vitamin B2 (26). 
 
1.2.5 Analytical methods 
1.2.5.1 Extraction 
 Riboflavin extraction from foods is similar to that of thiamine in that it requires 
both an acid and enzymatic treatment. The acid hydrolysis step is normally performed by 
autoclaving samples with 0.1 M HCl at 121oC for 30 minutes to liberate the flavins from 
the protein complex. In this process, FAD is converted into FMN which is partially 
hydrolyzed to riboflavin or goes through isomerization to form 2’-, 3’-, and 4’-
phosphates (69). For food samples with high-starch content, this step also helps to 
convert the polysaccharide into soluble sugars (28). Subsequent dephosphorylation to 
produce free riboflavins can only be accomplished by enzymatic hydrolysis using the 
same diastatic enzymes commonly used for thiamine extraction procedures (e.g., 
Takadiastase, Takadiastase and Mylase) (28). Due to variable phosphatase activity, 
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parameters of incubation condition such as time, temperature and pH should be 
empirically adjusted for the optimal conversion (70). If the goal of the study is to analyze 
the native forms of riboflavin or if the predominant forms in the samples are free or 
loosely bound riboflavins, then mild extraction protocol with simple precipitation of 
protein suffices (2). That is normally the case for the analysis of milk, eggs, and dairy 
products. Detailed extraction procedures can be found in AOAC Official Method 970.65 
and 981.15 (71, 72). 
 
1.2.5.2 Non HPLC methods 
 AOAC Official method 970.65 is based on the native fluorescence ability of 
riboflavin (71). It has been widely used to determine the riboflavin content of food 
products for routine nutritional label compliance analysis. The basic procedure of the 
methods involves the acid hydrolysis of FMN and FAD to release free riboflavin and 
oxidation to remove the interfering fluorescent components with potassium 
permanganate. The oxidation step does not affect riboflavin and is essential to increase 
the analysis specificity. Fluorescence measurements are made at Em λ=565nm and Ex 
λ=440nm. Sodium hydrosulfite is used to reduce riboflavin to nonfluorescent leuco form 
and the sample is measured again as a blank to correct for the non-riboflavin fluorescence 
left over after the sample preparation. This manual method was modified for 
semiautomated flow-injection analysis procedure outlined in AOAC Method 981.15 
which was originally published by Egberg and Potter (73, 74).  
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 Another fluorometry method is approached indirectly by converting riboflavin 
into lumiflavin through photolysis under alkaline condition (75). The sensitivity and 
specificity of the method is greatly enhanced by strong fluorescence capacity of 
lumiflavin and an extra step of lumiflavin extraction with chloroform. This method is not 
as popular as the indirect fluorometry analysis by AOAC; however, this sample 
preparation protocol can be applied to LC methodology (76). 
 Lactobacillus rhamnosus (ATCC 7469) has been extensively used for the 
determination of vitamin B2 (2). Since this organism cannot use FAD and responds to 
FMN and riboflavin differently, microbiological methods utilizing L. rhamnosus is 
recommended for total riboflavin analysis (77). The procedures therefore require the 
hydrolysis step to release free riboflavin from FMN and FAD. L. rhamnosus growth is 
affected by common components in food including starch and protein degradation 
products (2). Fatty acids, on the other hands, show contradictory effects with either 
stimulatory or inhibitory activity. Therefore, it is recommended that fat extraction be 
done before the acid hydrolysis step. Some other microorganisms that have been 
proposed to use over the time include Leuconostoc mesenteroides, Tetrahymena 
pyriformis and Enterococcus faecalis (9). Among them, E. faecalis and was found to be 
less affected by matrix effects and offer much higher sensitivity than L. rhamnosus (9). 
However, it is not used as extensively due to the lack of commercial media needed for its 
growth. 
 Identification of flavins can be done by TLC or its advanced form HPTLC (78-
81). Quantitative analysis of the separated flavins is then followed by the use of 
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densitometry. Commercial availability of  high-quality precoated plates with various 
stationary phases and particle sizes allows the separation of different flavin compounds 
from each other. This technique was even applied to the simultaneous determination of 
riboflavin with other water soluble vitamins as well. One advantage worth mentioning is 
that TLC can be utilized for multidimensional separation.    
 Conventional column chromatography with Silica gel C18 or Florisil used to be 
utilized for sample clean-up in LC methods in previous decades before SPE gained its 
popularity (82, 83). Ion exchange chromatographic methods with DEAE-Sephacel 
(acetate form) and DEAE-cellulose (chloride form) were reported to separate FMN 
efficiently from riboflavin and FAD, which is useful for the preparation of substantial 
amounts of purified FMN and FAD (69).  
 Flow injection analysis (FIA) when coupled with fluorescence provides a highly 
sensitive and selective analytical approach (84, 85). Due to the strong fluorescence of 
riboflavin and its metabolites, the derivatization step can be skipped, making the method 
simple and feasible enough for routine analysis. In addition, FIA can also be combined 
with chemiluminesence (86, 87).  Capillary electrophoresis is another technique that 
takes advantage of riboflavin spectral properties. The procedures are applicable to 
pharmaceutical samples with high vitamin levels and adaptable to multianalyte analysis 





1.3 Vitamin B6 
1.3.1 Nomenclature, structure and physiochemical properties 
 Vitamin B6 was first identified as a curative factor distinct from riboflavin and 
niacin for a characteristic dermatitis in rats by Gyorgy in 1934 (90, 91). He referred to the 
compound as pyridoxine, which was isolated and structurally characterized by several 
researchers in the late 1930s (92). Later research found other derivatives of pyridoxine 
including pyridoxal and pyridoxamine that also demonstrated vitamin B6 activity in 1944 
(93). The commonly used term ‘vitamin B6’ is a generic descriptor for all derivatives of 
3-hydroxy-2methylpyridine that are referred to as vitamin B6 vitamers and show the 
same biological activity of pyridoxine (PN) in rats (94). Generally used synonymously 
with vitamin B6, PN is one of the three forms occurring naturally besides pyridoxal (PL) 
and pyridoxamine (PM). They can exist in free or phosphorylated forms and be bound to 
proteins. Enzymatically phosphorylated and converted to the metabolically active 
pyridoxal-5′-phosphate (PLP), these three forms are interconvertible and considered to be 
biologically active equivalents (12). The end product of vitamin B6 metabolism, 4-
pyridoxic acid (4-PA) is also a common form occurring naturally in biological samples 
(9). Another important form is the glucosidically bound form of PN (PN glucoside), 
which has a low bioavailability and only occur in plant sources (95). All the above 
structures are demonstrated in Figure1.5  
 Free vitamers of B6 are commercially available as crystalline hydrochlorides 
including pyridoxine hydrochloride (PN.HCL), pyridoxal hydrochloride (PL.HCL) and 
pyridoxamine dihydrochloride (PM.2HCL) (96). Among them, PN.HCl is the UPS 
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reference standard and the only form used in food fortification and pharmaceutical 
preparations due to its higher stability than PL and PM. PN.HCl is a white, odorless, 
crystalline powder with a slightly salty taste and a melting point of 204–206oC (with 
decomposition) (9). It is readily soluble in water (22g/100ml), sparingly soluble in 
ethanol (1g/100ml) and practically insoluble in diethyl ether and chloroform. PN.HCl has 
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1.3.2 Stability and degradation  
 When protected from light, aqueous solution of PN.HCl shows no significant loss 
even at elevated temperature (40 and 60oC) for up to 140 days at pH 4 to 7 (97).  PN.HCl 
and PM.2HCl were reported to be the most and least stable forms of the three free B6 
vitamers (98).  In general, all forms of vitamin B6 are quite stable at acidic pH when light 
is excluded, but exposure to light and especially UV or near UV irradiation results in 
significant degradation, the degree of which increases as the pH approaches alkalinity 
(97, 99). In order to avoid photodegradation during sample preparation for an accurate 
analytical determination, low-actinic amber glassware and gold fluorescent light should 
be used in the analytical laboratory (9). Heat also causes vitamin B6 degradation, the rate 
of which increases with elevated pH levels (26, 100). Phosphorylated vitamers even when 
stored in the dark are still susceptible to hydrolysis to free counterparts (101). Their 
stability can be greatly enhanced in acidic solution and low temperature (-20oC or lower) 
storage before the analysis.   
 
1.3.3 Nutritional and physiological functions 
 PLP has been reported to have functions in more than 100 enzymatic reactions in 
the body, many of which are majorly involved in protein and urea metabolisms (2, 102). 
The class of vitamin B6 dependent enzymes includes those for trans-aminations, α 
decarboxylations, α,β eliminations, β,γ eliminations, aldolizations, and racemizations 
(100). Decarboxylases play a role in synthesizing important neurotransmitters (converting 
the amino acid tryptophan to niacin or to the neurotransmitter serotonin); therefore 
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vitamin B6 intake is necessary for healthy brain function (103). Aminotransferases play 
an important role in anabolism and catabolism of amino acids. PLP is also critical to the 
activity of glycogen phosphorylase (104) and lipid metabolism (105). The conversions of 
tryptophan to niacin or to the neurotransmitter serotonin are also dependent on PLP (26). 
Moreover, PLP functions in the synthesis of heme, nuleic acids and phospholipid in the 
body as well (12). Several studies conducted in the last decade have suggested that 
vitamin B6 may play important roles in cognitive performance, immune function, and 
steroid hormone activity (21). Recent reports have shown yet another role of vitamin B6 
as an effective antioxidant (106).  
 Due to the role of PLP in amino acid metabolism, vitamin B6 requirement 
increases with increased protein intake. RDA of vitamin B6 for adults (19-50yrs) is 
1.3mg (12). As vitamin B6 naturally occurs in foods high in protein, adequate protein 
intake can easily achieve the recommended vitamin B6. Inadequate vitamin B6 intake 
leads to interrupted synthesis of key neurotransmitters in the nervous systems (92, 107). 
Tryptophan metabolism is upset with undesirable compounds being formed and 
accumulated in the brain. Early symptoms of depression and confusion may progressively 
advance to more severe conditions including abnormal brain wave patterns and 
convulsions if deficiency prolongs. Alcoholics have a higher risk of vitamin B6 
deficiency as alcohol can antagonize the vitamin (12, 21). Acetaldehyde produced during 
alcohol metabolism can remove PLP coenzymes from the enzyme complex, which are 
then catabolized and excreted. 
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 Unlike other water soluble vitamins discussed here, overconsumption of vitamin 
B6 can lead to toxicity (12). It was reported that neurological damage was experienced by 
those studied subjects having the daily intake of 2 grams of vitamin B6 (20 times higher 
than the Upper Limit (UL) of 100mg) for 2 months or longer (12). Symptoms of vitamin 
B6 toxicity may include fatigue, headaches, irritability, skin lesions, convulsions, muscle 
weakness and even irreversible nerve degeneration (107). 
 
1.3.4 Occurrence and distribution in foods 
 Vitamin B6 occurs in a wide variety of natural unprocessed foods with yeast 
extract, liver and wheat bran being excellent sources (15). Other important sources 
include whole-grain cereals, meats, fish, poultry, potatoes and other starchy vegetables, 
legumes, noncitrus fruits, fortified cereals and soy products (2, 12). Over 90% of vitamin 
B6 content is found in the germ and bran of cereal grains (108). However, a significant 
loss (up to 90%) can occur during the milling process to produce flour, which results in a 
much lower vitamin B content in white bread compared to whole wheat bread (109). The 
major form of vitamin B6 in plant-derived foods is β-glucoside of PN, which has a low 
bioavailability (95). PN glucoside was found to be poorly metabolized and converted into 
the active PN form in rats, leading to its incomplete utilization and low bioavailability 
(only 20-30% efficiency of pyridoxine).  
 Besides loss through leaching, vitamin B6 is also susceptible to heat degradation 
in cooking and processing (9). This is more of a concern in animal-derived foods as the 
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main forms of vitamin B6 in these products are PL and PM which are less stable than PN, 
the prevalent form in plants.  
 
1.3.5 Analytical methods 
1.3.5.1 Extraction 
 Extraction approaches for vitamin B6 for liquid chromatographic (LC) analysis 
can involve (1) hydrolysis of phosphorylated forms to liberate the free vitamers PL, PM,  
and  PN; (2) release of all the vitamers native forms including the phosphorylated and 
glycosylated forms (PN-glucoside), and metabolites such as 4-PA or (3) conversion of all 
forms into PN. Therefore, depending on the ultimate goal of the study, extraction 
conditions may vary (9). Common extraction process involves acid hydrolysis under 
heating condition (either in a boiling water bath or in an autoclave) followed by enzyme 
hydrolysis (28). The purpose of the acid hydrolysis step is to partially release free 
vitamers from phosphorylated and glycosylated forms and convert polysaccharide in high 
starch-content food into soluble sugars (92). Mineral acids are normally used in this 
vigorous treatment step with hydrochloric acid being the most common. Specifically, in 
AOAC official method 961.15, animal-derived foods are autoclaved with 0.055N HCl for 
5h at 121oC to dephosphorylate vitamin B6 as well as release PL from its bound forms 
while plant-derived samples are treated with a stronger acid concentration (0.44 N HCl) 
to liberate PN from its glycosylated form (110). Coupled with enzymatic hydrolysis of 
phosphate ester bonds, the release of free vitamers satisfies the requirement of the 
approach (1) mentioned above. The conversion of free vitamers into PN for approach (3) 
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can be performed right after the hydrolysis steps. PM, via the reaction with glyoxylic 
acid, is first converted to PL, which in turn is reduced to PN by sodium borohydride in 
alkaline medium (111). The extraction of vitamin B6 in the native forms for approach (2) 
requires a milder treatment. Organic acids without heat and enzymatic treatment are often 
employed to denature proteins and release protein-bound vitamers in their phosphorylated 
and glucosylated forms (9, 28). 
 
1.3.5.2 Non-HPLC methods 
 Common subjects for vitamin B6 analysis are foods (natural or supplemented), 
pharmaceutical and biologicals (blood, plasma and urine). Vitamin B6 determination is 
challenging because vitamin B6 (1) occurs naturally in six different forms at relatively 
low levels in most biological samples; (2) has low solubility in organic solvents, making 
their use irrelevant in extraction and purification/enrichment procedures; (3) is highly 
photosensitive, which requires the analysis to be performed in a subdued light condition 
and (4) is tightly bound to the protein matrix in the samples (9, 100). Numerous methods 
developed over the years satisfy different requirements of vitamin B6 analysis, but have 
their own disadvantages. Enzymatic and immunological assays are ideal for biological 
samples, they also have certain limits in application. Enzymatic assays can only detect 
PLP (112). As to immunoassays, different forms of vitamin B6 require different 
antibodies and even then the chance of cross reactivity is likely to happen, thereby 
compromising the selectivity of the methods (113). Microbiological assays are sensitive 
and specific but they are time consuming and require strictly followed protocols to obtain 
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accurate results. Moreover, they are not suitable for biological fluids such as blood and 
plasma as complicated substances in those samples can either promote or inhibit the 
growth of micro-organisms, thereby invalidating the results (114).The ideal organism for 
the microbiological assay of vitamin B6 should produce equal growth response to PN, PL 
and PM (2). However, there are no single strains that satisfy this requirement as they all 
show differential response to the three vitamers. Commonly used microorganisms include 
yeast (Saccharomyces uvarum, Saccharomyces cerevisiae), bacteria (Streptococcus 
faecalis, Lactobacillus helviticus, Lactobacillus casei) and protozoan (Tetrahymenia 
pyriformis). The most commonly used microorganism is S. uvarum (ATCC 9080) 
introduced in 1943 (115). S. uvarum responds similarly to PN and PL but less to PM. 
Therefore, a chromatographic procedure is employed to separate PN, Pl and PM before 
the microbiological assay, which forms the basis for AOAC Method 961.15 (110). 
Another strain, Kloeckera apiculata (ATCC 9774), was suggested by Barton-Wright and 
later by Guilarte (116, 117). Both studies showed equal response to PN PL and PM by K. 
apiculata. However, this is not conclusive among other research groups.   
 Spectrophotometric and fluorometric methods are mainly developed for the 
analysis of pharmaceuticals. Spectrophotometric methods are based on the UV 
absorbance of the analytes. Absorption spectra of all B6 vitamers in 0.1M HCl are similar 
and they show maximum absorption at around 290nm (92, 118). At different pH values, 
the spectra vary and may have maximum absorption at more than one wavelength. This 
fact can be used to increase selectivity not only in spectrophotometric methods but also in 
HPLC-UV. Derivatization is also helpful in enhancing the sensitivity and selectivity of 
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the spectrophotometric methods (9). Fluorimetric methods utilizing the fluorescence 
capacity of vitamin B6 compounds are more sensitive and selective. PL, PN, PM and 
their phosphorylated counterparts PNP and PMP exhibit significant fluorescence while 
only PLP is weakly fluorescent (100). Fluorimetric methods are ideal for 
pharmaceuticals, but can be limited when used for others due to the complex sample 
matrix.  Application of the fluorimetric methods to quantitate PLP and PL has been 
reported but these methods are considered unreliable due to interference from other 
fluorescent compounds in the samples (119, 120). Rigid sample cleanup procedures are 
therefore required (100). Spectrophotometric and spectrofluorometric procedures have 
been coupled with flow injection or sequential injection analysis to automate the 
determination of vitamin B6 in pharmaceuticals (121, 122). 
 Early electrochemical assays for the analysis of vitamin B6 were based on the 
oxidation of PN at a carbon paste electrode (9). Modifications made to these assays such 
as combining with flow injection and sequential injection techniques or using 
potentiometric membrane sensors and modified glassy carbon electrodes have made these 
assays more selective and efficient (123, 124).  
 
1.4 Vitamin B12 
1.4.1 Nomenclature, structure and physiochemical properties 
 Vitamin B12 deficiency (pernicious anemia) was originally described in 1855 
(125). Not until 1925 was the treatment reported when Whipple discovered the curative 
effects of raw liver for anemic dogs (126). One year later, Minot and Murphy claimed 
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that this treatment was successfully applied to human patients (127). The identification 
and isolation of the active compound was simultaneously reported by Folkers (128) in the 
US and Smith in Britain (129). In 1956, Dorothy Hodgkin determined the structure of 
vitamin B12 by X-ray crystallography (130).    
 Belonging to the corinoid family, vitamin B12 is a collective term for cobalt-
containing compounds that have anti-pernicious anemia activity (9, 26). The structures of 
cyanocobalamin and other related compounds are shown in Figure 1.6. Cobalamin is 
composed of a corrin backbone with a six-coordination cobalt as the center (131). The 
corrin structure has four reduced pyrrole rings with three being joined by methylene 
bridges and two linking directly. It is similar to heme structure, with the central cobalt 
coordinating with the nitrogen atoms in the pyrrole rings. Two biologically active forms 
of vitamin B2 acting as coenzymes in human are methylcobalamin and 5’-
deoxyadenosylcobalamin (or adenosylcobalamin) in which the methyl and adenosyl 
ligands bind to cobalt at the X position, respectively. Other forms shown in Figure 1.6 
include aquocobalamin, hydroxycobalamin and cyanocobalamin. The latter two are 
available for use in medical fields and food fortification respectively (9). Among them, 







-R Name Abbreviation 
-CN Cyanocobalamin CN-Cbl 
-OH Hydroxycobalamin OH-Cbl 




-CH3 Methylcobalamin MeCBl 
-SO3 Sulfitocobalamin SO3Cbl 
 
Figure 1.6 Structure of vitamin B12  
 
 CNCbl is an odorless, dark red crystalline hygroscopic powder which can take up 
more than 12% by weight of moisture (3, 9). It is quite soluble in water (1.25g/100 mL at 
25°C), lower alcohols, phenols and other hydroxylated polar solvents while insoluble in 
acetone, ether, chloroform and benzene (2, 14). Crystals of cyanocobalamin decompose 
above 200°C without melting (9).  
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1.4.2 Stability and degradation 
 Cyanocobalamin is stable in crystalline forms and aqueous solution in air at room 
temperature when protected from light (2). On exposure to light, the cyano group is 
cleaved to produce OHCbl, which occurs as aquocobalamin in neutral or acidic solution 
(9, 131). Because these two forms are equally biologically active, this photolytic reaction 
does not result in a loss of vitamin B12 activity. Other cobalamins such as sulfito-, 
chloro-, cyanato-, nitrito-, bromo-, thiocyanato-, and azido- can result from the binding of 
corresponding ions or groups to the central cobalt.  
 CNCbl exhibits optimal stability at pH 4.5-5.0 and can sustain autoclaving at 
120oC for 20 min in solution of pH 4.0-7.0 (2). Hydrolysis under heating in acidic and 
alkaline conditions results in biologically inactive degraded products. Vitamin B12 is also 
susceptible to deactivation in the presence of strong oxidizing agents or reducing agents, 
such as ascorbic acid, sulfite, and iron (II) salts (132).  
 
1.4.3 Nutritional and physiological functions 
 Vitamin B12 and folate are interdependent as they activate each other through the 
transfer of the methyl group from the latter to the former (12, 133). Acting in 
conjunction, they both play important roles in the regeneration of methionine and the 
synthesis of DNA and RNA (134). Moreover, vitamin B12 also helps maintain the sheath 
surrounding nerve fibers and participate in bone cell activity and metabolism (12). The 
two biologically active forms of vitamin B12, adenosylcobalamin and methylcobalamin, 
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function as coenzymes for methylmalonyl-CoA mutase and methionine synthase which 
play key roles in the metabolism of propionate and amino acids (21). 
 The RDA for vitamin B12 is the lowest among all the vitamins listed with only 
2.4 micrograms per day for adults (132). Unlike other water soluble vitamins, vitamin 
B12 can be reserved in the body up to 2-5mg, about 50% of which is stored in the liver 
(2, 133). Approximately 0.1%-0.2% of this amount is excreted via renal and biliary 
routes per day. As most of the vitamin B12 secreted in the bile is recycled via 
enterohepatic circulation, the liver can efficiently store a sufficient amount during long 
periods of deprivation. Therefore, vitamin B12 deficiency is rarely seen.      
 Vitamin B12 deficiency mostly results from inadequate absorption which is due to 
the lack of either hydrochloric acid or intrinsic factor (132, 133). These conditions are 
normally observed in the elderly who are prone to atrophic gastritis causing damage to 
the stomach cells or those with a defective gene for the intrinsic factor. Subsequent 
vitamin B12 deficiency is called pernicious anemia and characterized by large, immature 
red blood cells due to the inhibition of DNA synthesis (12). The factor responsible for 
slowing down DNA synthesis is actually folate deficiency itself. Because vitamin B12 
and folate activation is closely related, folate can mask vitamin B12 deficiency anemia 
when it is given instead of the needed vitamin B12. However, in this case, other 
symptoms of vitamin B12 are not treated. As vitamin B12 is needed to protect and 
promote the normal growth of nerve fibers, its deficiency can cause severe damage to the 
nervous system. Preliminary symptoms such as fatigue, depression, impaired cognition 
and poor memory may ensue a marginal deficiency (26). However, these symptoms are 
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not specific enough to diagnose the deficiency, especially if sufficient folate is provided 
in the diet. Excess vitamin B12 consumption appears to cause no harm so no UL has been 
established (134). 
 
1.4.4 Occurrence and distribution in foods 
 Vitamin B12 is synthesized solely by bacteria and other microorganisms found in 
soil, water, sewage or the intestinal tract of animals (132). Only animal-derived food 
contains vitamin B12 though a small amount may be detected in plants due to microbial 
contamination from soil or manure (2). Meat, fish, egg, cheese and milk are good sources 
of vitamin B12 (12). Contrary to common belief, yeast is not a good source of vitamin 
B12 (135). When grown in a vitamin B12-enriched media, yeast may provide some 
amount but yeast itself does not contain active vitamin B12. Fermented soy products and 
sea algae such as spirulina do not contain active vitamin B12 either (135). As vitamin 
B12 is found exclusively in food of animal origin, vegans are likely to have suboptimal 
vitamin B12 intake. In this case, vitamin B12–fortified products or supplements are 
reliable sources. Except for possible loss through leaching, vitamin B12 is stable to most 
food processing and cooking techniques (12). However, unlike other water-soluble 
vitamins, it is susceptible to microwave heating. Degradation of up to 40% of vitamin 





1.4.5 Analytical methods 
1.4.5.1 Extraction 
 AOAC Official method 952.20 is a microbiological assay recommended for the 
determination of vitamin B12 in vitamin preparation (137). However, the extraction 
protocol in that method has been proven to be applicable to food samples as well (138). 
The procedure involves homogenizing the sample in an extraction solution containing 
disodium phosphate, citric acid and sodium metabisulfite, which is then autoclaved at 
121oC for 10 minutes. The purpose of the heat treatment is to release protein-bound 
cobalamins and catalyze the conversion of those cobalamins into more stable 
sulfitocobalamin form (2). Modifications of the AOAC procedure using various 
extraction buffers and protein denaturant acids have been reported. Alternative 
conversion of liberated cobalamins into cyanocobalamin is also commonly used.  
 Procedures may also vary depending on the nature of the samples. Simple matrix 
such as pharmaceuticals can be easily prepared by solubilization into water without 
further treatment while more complicated food matrices may require treatment with 
various buffers (139, 140) or trichloroacetic acid (141) and even enzymatic hydrolysis 
with α-amylase and pepsin to better release the protein-bound cobalamins (142, 143). 
Because vitamin B12 normally occurs only in trace amounts, its extraction often requires 
a cleanup and/or concentration step to enhance the analysis selectivity and sensitivity 




1.4.5.2 Non-HPLC methods 
 Paper chromatography and thin-layer chromatography are among the earliest 
techniques used to separate cobalamins and corrinoids (144, 145). Cellulose-based 
adsorbent materials were frequently used with complicated solvent mixtures (145). Two-
dimensional TLC was reported for cobalamin separation in blood plasma by Linnel et al 
(146). The bioautography technique first developed by Linstrand and Stalberg allowed 
the visibility of cobalamins in the chromatograms utilizing the growth response of 
cobalamin dependent E. coli (147). Areas on the agar dish inoculated with this strain of 
bacteria exhibit growth on exposure to cobalamins separated in the TLC or paper 
chromatograms.  
 Microbiological assays published by AOAC use Lactobacillus delbrueckii (ATCC 
7830) for the determination of vitamin B12 in pharmaceutical preparations and food 
matrices (137). It is sensitive enough to quantitate CNCbl at the level of 1.0pg/ml (9). 
However, L. delbrueckii has similar growth response to hydroxocobalamin, 
sulfitocobalamin, dicyanocobalamin, and nitritocobalamin while lower and greater 
response was observed with adenosylcobalamin and methylcobalamin respectively (148). 
Therefore, it is recommended that these two cobalamins be converted to 
hydroxycobalamin by exposure to fluorescent light before the microbiological assays 
(148). Specificity of the assays is compromised due to the interference of other vitamin 
B12 biologically inactive analogs to the growth response of L. delbrueckii (2). However, 
such compounds are mainly found only in fermented materials and their occurrence in 
foods is low enough not to cause significant interferences in the analysis. Another 
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microorganism used in a procedure developed by Ford is Poterioochromonas 
malhamensis (149). Having similar growth response to that of L. delbrueckii, this 
protozoan is more specific and responds only slightly to nonbiologically active 
cobalamins. However, a comparative study of the two microorganisms on the analysis of 
various food products did not show much difference in the obtained results (150). 
Considering the longer incubation time of the P. malhamensis method, L. debrueckii is 
preferable in most laboratories.    
 Radio-ligand binding assays are more often routinely used for blood and tissue 
analysis than for food analysis. The methods utilize intrinsic factor (IF) as the binding 
protein and [Co]CNCbl as the radiolabeled ligand (151, 152). Besides IF, other binding 
proteins used include transcobalamin I (TC I), transcoblamin II (TC II) and haptocorrin 
or R-binder (9). However, one disadvantage of the radio-ligand binding assay is that the 
binding proteins can bind other biologically inactive cobalamins, compromising the assay 
specificity (9). More specific procedures available for CNCbl and AdoCbl are developed 
using monospecific antisera can overcome the non-specific binding with other 
cobalamins (152). In food analysis, though radio-ligand binding and microbiological 
assays show some degree of agreement for most foods, they are not interchangeable. In 
many cases, radio-ligand procedures gave lower values than microbiological assays 
(148). 
 Aqueous solution of cobalamins has maximal absorbance in the region of 350-
370nm (2, 132), which is utilized in  reported spectrophotometric procedures. However, 
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because cobalamin absorption is not intense, these methods are only applicable to high 
concentration pharmaceutical  products (153, 154).  
 Cobalamins are relatively weak fluorescent compounds; therefore, few reported 
methods utilize their native fluorescence (155). Watanabe et al. proposed the conversion 
of vitamin B12 into a highly fluorescent derivatives using 6, 7-dimethoxy-1-methyl-
2(1H)-quinoxaline-3-propionylcarboxylic acid hydrazide (DMEQ) followed by the 
binding of the derivative with hog intrinsic factor (156).  
 Several chemiluminscence methods have been published. The method proposed 
by Liu et al. makes use of the energy transfer fluorescence quenching of Acridino 
orange-Rhodamine B and the ability of vitamin B12 to diminish the fluorescence 
intensity of the Rhodamine B (157). Another chemiluminesence-based method by Song 
and Hou relied on the enhancement of cobalt (II) on the chemiluminescence reaction 
between luminol and dissolved oxygen . When combined with flow injection analysis 
(FIA), these methods not only offer high sensitivity but also provide a high sample 
throughput. 
 
1.5 Vitamin C (Ascorbic acid) 
1.5.1 Nomenclature, structure and physiochemical properties 
 Vitamin C is the generic descriptor referring to a class of compounds that exhibit 
the same biological activity as ascorbic acid and exert the preventive effects against 
scurvy, a vitamin C deficiency disease (158). Although the curative effects of citrus fruits 
were first documented by James Lind, a British naval physician in 1747, it had not been 
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until the 1930s that the active antiscorbutic component was isolated from natural sources 
by Szent-Györgyi group and Haworth and King (159, 160). 
 Ascorbic acid occurs naturally in two stereoisomer forms, L-ascorbic and D-
isoascorbic (also known as erythorbic acid), among which, only the former shows 
vitamin C biological activity. The terms L-ascorbic acid and ascorbic acid can be used 
interchangeably as the trivial names accepted by IUPAC for vitamin C (158). Its 
systematic chemical designator is 2, 3-didehydro-l-threo-hexano-1,4-lactone (C6H8O6, 
MW =176.1) (3). Other active compounds include esters of ascorbic acid like ascorbyl 
palmitate, the synthetic form 6-deoxy-l-ascorbic acid or the oxidized form L-
dehydroascorbic acid. The structure of ascorbic acid and its related compounds are all 
provided in Figure 1.7. 
 Ascorbic acid is an odorless, white to pale yellow crystalline powder with a 
pleasant sharp taste. It has a high water solubility (33g/100ml at ambient temperature) 
and an mp of about 190oC (with decomposition) (2, 14). Ascorbic acid has two ionization 
sites at the hydroxyl groups on C3 and C2 with pKa of 4.17 and 11.79 respectively (3). 
The most prominent chemical property of ascorbic acid is its strong reducing ability of 
the carbonyl enediol group, which leads to it being used as the antioxidant agent in food 
technology (9). Other important functional roles of ascorbic acid include its application 
as a nutritional food additive, browning inhibitor and stabilizer especially in the 
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Figure 1.7 Structure of L-ascorbic acid and related compounds 
 
 The synthetic lipid-soluble form of ascorbic acid, ascorbyl palmitate exhibits 
100% relative antiascorbutic activity of ascorbic acid and can be used synergistically with 
other fat soluble antioxidants such as tocopherols (2). Another synthetic form of ascorbic 
acid is erythorbic acid that possesses similar reductive properties to ascorbic acid. 
However, erythorbic acid only exhibits about 5% of antiascorbic activity of ascorbic acid 
(161). Being commercially cheaper to manufacture, erythorbic can be used as a substitute 
for ascorbic in some countries when the antioxidant and not the nutritional properties is 
required (2).  
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 Ascorbic acid is readily oxidized to dehydroascorbic acid in a reversible reaction. 
In the human body, this oxidized form is easily reduced back to ascorbic acid; therefore 
full vitamin C activity is maintained (2). Dehydroascorbic acid is a misnomer as it is not 
an acid per se due to the lack of dissociable protons at C2 and C3. 
 
1.5.2. Stability and degradation: 
 Pure crystalline ascorbic acid and sodium ascorbate are highly stable even in the 
presence of oxygen and on the exposure to daylight at normal room temperature for long 
periods of time as long as it is kept in dry conditions (9). One study found that 
commercial form of ascorbic in vitamin C tablets can have their potency intact even after 
a storage period of 8 years at 25oC (162). 
 Ascorbic acid is much less stable in solution due to its strong reducing ability 
which results in rapid oxidation to dehydroascorbic acid. The process is slower in the pH 
range of 3.0-4.5 than 5.0-7.0 (163). At neutral and alkaline pH, ascorbic acid is highly 
unstable due to not only the much faster conversion to dehydroascorbic acid, but also 
further degradation of dehydroascorbic acid in a non-reversible reaction to the 
biologically inactive straight-chained product named 2,3-diketo-1-gulonic acid (2).  
 The stability of ascorbic acid in food is quite dependent on the pH level. At low 
pH, ascorbic exists in the fully protonated form which is less susceptible to degradation. 
Optimal pH range for ascorbic stability is between pH 4.0 and 6.0 (158). However, the 
whole oxidative degradation of ascorbic in food is a complicated process influenced by 
many factors including oxygen availability, thermal processing conditions, oxidizing 
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lipid effects, the presence of transition metal catalysts, antioxidants and ascorbic acid 
oxidase (9).  
  
1.5.3 Nutritional and physiological functions 
 With its strong reducing ability, vitamin C works as an antioxidant to protect the 
body from free radicals which are highly unstable and reactive molecules with one or 
more unpaired  
electrons (164). Figure 1.8 shows how vitamin C can readily donate its electrons to 
neutralize free radicals, preventing the chain reactions from damaging other substances; 
and then the reactive vitamin C radical itself reacts with another radical to become 
reactivated. Vitamin C is stored mostly in the adrenal glands and is released together with 
hormones into the blood stream when the body is exposed to stresses such as infections, 
burns, ingestion of toxic heavy metals, extremely high/low temperatures and cigarette 
smoking (12). It is believed that the vitamin C antioxidant property plays an important 
role especially when stress triggers the immune system into action (158). As the immune 
system relies on free radicals to attack the invasive microorganisms and remove the 
damaged cells, vitamin C comes into play as an antioxidant to keep this oxidative activity 
in control. The reducing property of vitamin C also plays an important role in enhancing 




Figure 1.8 Oxidation of ascorbate 
L-ascorbate anion AH- loses an electron to a free radical like •OH, resulting in the 
formation of ascorbyl radical A•- which then reacts with another radical to yield 
dehydroascorbic acid. Vitamin C is therefore recycled and the reservoir of antioxidants is 
maintained in the body. 
 
 Vitamin C plays an important role as a cofactor in the synthesis of collagen which 
is a fibrous structural protein of connective tissues (21). Collagen formation requires the 
conversion of proline and lysine to hydroxyproline or hydroxylysine, allowing the 
collagen molecule to take up its shape as a triple helix with a strong, ropelike structure. 
This hydroxylation process is facilitated by the activity of hydroxylase enzymes for 
which vitamin C acts as a co-factor (165).   
 Vitamin C is needed for the synthesis of other compound as well. It aids in the 
hydroxylation of carnitine which is important for the transport of long-chain fatty acids 
across mitochondrial membranes in cells (12), and the conversion of tryptophan and 
tyrosine to neurotransmitters serotonine and norepinephrine as well as the production of 
the metabolic rate regulating hormone thyroxin require vitamin C (12). 
 In human adults, classic symptoms of scurvy occur after 45 to 80 days of vitamin 
C deprivation (165). The early notable signs of deficiency include gum bleeding around 
the teeth and skin lesion (12). As the deficiency worsens, scurvy symptoms start to 
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escalate.  Malfunctioning collagen synthesis results in further hemorrhaging, muscle 
degeneration, impaired wound healing, tooth loss, edema and bone weakness (26, 158).  
Anemia, infections and psychological changes, including hysteria and depression are also 
commonly observed (134). As little as 10 milligrams daily can prevent scurvy but that 
amount is not enough to maintain the healthy reserve of vitamin C in the body (21). The 
RDA for adult women and men are 75 and 90mg/day respectively (9).  
 
1.5.4 Occurrence and distribution in foods 
 Humans are among the few species that cannot synthesize vitamin C; therefore, it 
is an essential nutrient that needs to be provided in human diets. Beside citrus fruits 
which have long been known to be an excellent source of vitamin C, other fruits and 
vegetables such as strawberry, blackcurrant, bananas, broccoli, spinach, bell pepper, etc. 
can also potentially provide a generous amount of the vitamin to the human diets (2, 12). 
Cereal grains and legumes are examples of poor sources of vitamin C (12). While human 
milk is an adequate source to prevent scurvy in infants, cow’s milk is significantly lower 
in the vitamin due to the oxidative loss during processing (2). Organ meats (liver, 
kidneys, heart) have some vitamin C but muscle meats contain literally none (165). In 
cured meats such as luncheon meats, the manufacturer may add erythorbic acid, which is 
another isomer of ascorbic acid to prevent oxidation and spoilage (12). It is worth 
mentioning that this compound has only little vitamin C activity in the human body. 
 Losses in cooking are not limited to leaching into the cooking medium and the 
degree of heating. Further degradation upon the exposure to water and oxygen in 
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combination with other factors such as pH and transition metal catalysts can result in 
significant loss of the vitamin. Baking also potentially reduces vitamin C content because 
it can participate in the Maillard browning reaction (9). Therefore, in general, cooked 




 Due to its labile nature, the key success to extraction procedures of vitamin C is to 
stabilize the compound in the sample (9). Ideally the extraction solution should provide 
an acidic medium (preferably below 4.0) to ensure the stability of both ascorbic and 
dehydroascorbic acid (166). Moreover, it is also expected that the extractant chelate 
metals, denatures and precipitates proteins (thereby  inactivating  all  enzymes including 
ascorbic acid oxidase) and limit soluble oxygen (166). Over the years, there have been 
many procedures developed to better suit different sample matrices and determinative 
analytical methods. Metaphosphoric acid at 3% concentration dissolved in 8% glacial 
acetic acid suggested in AOAC Official Method 967.21 has been the most commonly 
used extractant (167). Modification of the procedure with the addition of EDTA to 
enhance metal chelation is made in AOAC Official Method 985.33 (168). In those 
samples where starch could interfere with colorimetric titrations or fluorometric assays, 





1.5.5.2 Non-HPLC methods 
 One of the most common and simplest method of vitamin C determination is the 
AOAC titration method with 2, 6-Dichlorophenolindophenol (DCPIP) (167). The 
principle of the method is based on the reduction of DCPIP by ascorbic acid (170). In its 
oxidized form, DCPIP has a deep blue color at neutral or alkaline pH and pink in acid 
solution. Upon reacting with ascorbic acid, this dye is reduced into a colorless form. The 
endpoint is therefore signaled when excess DCPIP display the pink color in the acid 
extract of the sample. If the endpoint is difficult to be detected in colored samples, 
absorbance at 518 nm can be measured to alternatively determine the endpoint. The 
method cannot measure dehydroascorbic acid and distinguish between l-ascorbic acid and 
isoacorbic acid (9). Moreover, its specificity is open to question due to the fact that all 
reducing agents contained in the sample can react with DCPIP, leading to possible 
overestimation of ascorbic acid content (2). Interfering compounds include cuprous, 
ferrous ions, sulfite, thiosulfate, tannins, betanin, cysteine and glutathione. Many 
modifications such as adding chelating agents to suppress the interference from the metal 
ions (168) or using SPE (171) to remove significant interferences from the sample matrix 
were suggested to minimize the interfering effects on the titration.  
 Another method that utilizes the redox reaction is the metal ion reduction method, 
the principle of which is to form a stable colored complex between the reduced ion and a 
chelator (172). The complex is then spectrophotometrically measured. The most 
commonly used metal ion redox reaction is the reduction of Fe(III) to Fe(II) for which 
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2,29-dipyridine, 2,4,6-tripyridyl-5-triazine, and ferrozine are usually used as the chelating 
agents. Nobrega employed Fe (III) and hexacyanoferrate (III) as chromogenic 
complexing reagents and combined the method with flow injection technique to 
quantitate ascorbic acid (173).  
 Derivatization methods require the conversion of L-ascorbic acid to L-
dehydroascorbic acid using activated charcoal (174) or DCPIP (175) as the first step. 
AOAC International Method 967.22 developed by Deutsch and Weeks is based on the 
condensation reaction between  o-phenylenediamine (OPD) and L-dehydroascorbic acid 
to form a highly fluorescent quinoxaline product which is then determined 
fluorimetrically at Ex λ = 350, Em λ = 430 (174). Another less extensively used 
derivatization method reacts 2,4-Dinitrophenylhydrazine (DNPH) with L-
dehydroascorbic acid under acidic conditions to form a red osazone derivative, the 
absorbance of which is then determined at about 520nm (176). Developed in 1943, this 
DNPH method is suitable for the analysis of total vitamin C in samples with low sugar 
content.  
 Enzymatic treatment with ascorbate oxidase or ascorbate peroxidase can be used 
instead of chemical treatment to convert L-ascorbic acid to L-dehydroascorbic acid 
before the OPD derivatization step (177, 178). Tsumura et al. reported the efficient use of 
guaiacol peroxidase, a commercially available enzyme extracted from horseradish for the 
oxidation step. The enzymatic treatment was then combined with the direct 
spectrophotometric assay to determine ascorbic acid in various foods (179). 
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 The most noticeable modification in L-ascorbic acid analysis in recent literature is 
the coupling of flow injection analysis and sequential injection analysis with proven 
approaches such as spectrophotometric (180), fluorescence (181), chemiluminescence 
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CHROMATOGRAPHIC BEHAVIORS OF THIAMINE, RIBOFLAVIN, 
PYRIDOXINE, CYANOCOBALAMIN AND ASCORBIC ACID 
 
2.1 Introduction 
 Playing an essential role in normal growth and maintenance of the body, vitamins 
are needed only in a small amount daily that can be easily provided with proper diets (1). 
However, the human diet sometimes fails to meet the daily vitamin requirements so some 
people are more prone to vitamin deficiency than others (2). In those cases, fortification 
of food products such as infant formula, cereal, low-calorie foods, juices, etc. becomes 
important in ensuring an adequate intake of vitamins (3). Therefore, a rapid and simple 
vitamin analysis in supplemented food products would benefit the proper regulation of 
fortification. The current regulatory and standard methods for water-soluble vitamin 
analysis are mostly based on microbiological techniques developed more than 50 years 
ago (4, 5). Although they can offer high sensitivity, these methods are time-consuming 
and sometimes not sufficiently specific (6). Other proposed methods involve 
spectrophotometric or fluorimetric techniques which are sometimes time-consuming and 
not adaptable for simultaneous determination of water-soluble vitamins with different 
chemical and physical properties (4-6). 
 Another popular current method of choice is HPLC which was first utilized for 
the analysis of vitamins in the 1970s. It is favored due to the convenience, specificity, 
sensitivity and  accuracy, especially with the current improvement in the chromatography 
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technology. United States Pharmacopeia (USP) and Association of Official Analytical 
Chemists (AOAC) both have included standard chromatographic methods for vitamin 
analysis in their handbook, which are summarized in Table 2.1 and 2.2. However, most 
of these methods only focus on the analysis of a single vitamin at a time. Moreover, in 
order to improve retention and peak shape of the vitamin analytes, they require the use of 
many complicated mobile phase components, most of which are not directly transferable 
to other detectors, especially MS without significant modifications.  
 For the past two decades, there have been many HPLC methods developed and 
reported in the literature for vitamin analysis. The trend is to develop multi-vitamin 
analysis methods which are simple and easy to transfer. Thanks to the chromatography 
literatures, it is unnecessary to reinvent the wheel when it comes to developing HPLC 
methods for routine vitamin analysis. However, applying certain methods directly from 
literature more than often fails to reproduce the results reported due to many variables in 
liquid chromatography. In the present study, chromatographic behaviors of the five 
water-soluble vitamins including thiamine, riboflavin, pyridoxine, cyanocobalamin and 
ascorbic acid were studied. The ultimate goal of the project is to help the analysts better 
modify methods from literature or even develop a novel method to fit the need of their 










Method and application Approach 
Vitamin B6 
(Pyridoxine) 
50.1.26 AOAC Official 
Method 2004.07 
Vitamin B6 in baby foods 
and reconstituted infant 
formula 
Column: Phenomenex Luna 5 µm phenyl-hexyl 
column, 250x4.6 mm id or other equivalent 
reversed-phase C8 and C18 columns 
Mobile phase: Methanol-0.01M phosphoric acid 
(26:74) with 0.05% 1-heptanesulfonic acid (w/v), 
pH 2.50-2.60. 
Condition: flow rate 1.0 mL/min; fluorescence  






Vitamin B12 in baby 
foods, infant formula and 
adult nutritionals  
 
Column: Macherey-Nagel Nucleosil 100-3 C18 
HD, 125x3.0mm, or C18 ACE 3AQ, 150x3.0 mm 
Mobile phase: (A) 0.025% TFA in water, (B) 
0.025% TFA in acetonitrile. 
Conditions: flow rate 0.25ml/min; injection  
volume 100 µL; detection UV 361 nm; and 
gradient elution 
AOAC Official Method 
2011.09 
Vitamin B12 in baby 
foods, infant formula and 
adult nutritionals  
 
Column: ACE 3AQ, 150x3.0 mm or equivalent 
Mobile phase: (A) 0.025% TFA and (B) 
acetonitrile   
Conditions: flow rate 0.25ml/min; injection 
volume 100 µL; UV detector 361 nm; gradient 
  
AOAC Official Method 
2011.10 
Vitamin B12 in baby 
foods, infant formula and 
adult nutritionals  
 
HPLC system: Gradient system with switching 
valve and isocratic pump on side and a UV-Vis 
detector. Autosampler capable of injecting 2 mL 
sample. 
Column: 1/ Analytical size-exclusion column 
Zorbax  GF-250 4µm, 250x9.4mm or Shodex 
Protein KW 5µm, 300x8mm or equivalent; 2/ 
Thermo Scientific Aquasil C18 3µm, 100x4.6mm 
or equivalent 
Mobile phase: 1/Isocratic pump: 2.5% acetonitrile 
in water. Flow  rate:  1.1-1.2ml/min. 2/ Gradient   
pump: (A) 0.4% TEA in water, pH 5-7; (B) 0.4% 
TEA and 25% acetonitrile in water pH 5–7; (C) 
0.4% TEA and 75% acetonitrile in water pH  5–7 
Conditions: UV 550nm 




Table 2.2 Chromatographic methods for vitamin analysis suggested by USP 
 
Vitamin forms Approach 
Ascorbic acid 
Method 1 (pg 1670) 
Titration with standard dichlorophenol-indophenol solution  
Ascorbic 
Method 2 (pg 1738) 
Titration with 0.1N sodium thiosulfate 
Biotin 
Method 1(pg 1671) 
Column: 4.6x150mm, 3 µm packing L7 
Mobile phase: Mixture of 85 ml acetonitrile, 1 gram sodium 
perclorate and 1mL phosphoric acid diluted to 1 L with water 
Conditions: flow rate 1.2 mL/min, UV detection at 200nm 
Biotin 
Method 3 (pg 1701) 
Column: 4.6x250mm, packing L1 
Mobile phase: solution A with 100 ml triethylamine, 80ml 
phosphoric acid 85% diluted to 1L. Mix 80 ml acetonitrile and 
10 mL solution A and dilute to 1 L. 
Sample clean-up with SPE 
Conditions: flow rate 2.0 mL/min, UV detection at 200 nm 
Cyanocobalamin 
Method 1(pg 1672) 
Column: 4.6x150mm, 5µm packing L1 
Mobile phase: Methanol:Water (7:13)  
Conditions: flow rate 0.5 mL/min, UV detection at 550 nm 
Folic acid  
Method 1(pg 1675) 
Column: 3.9x300mm, packing L1 
Mobile phase: 2 gram of monobasic potassium phosphate in 650 
mL water + 12 mL of tetrabutylammonium hydroxide 25% in 
methanol +7.0 mL phosphoric acid + 240ml methanol. Adjust 
with phosphoric acid or ammonia to pH 7.0 then dilute with 
water to 1 L.  
Conditions: flow rate 1.0 mL/min, UV detection at 280 nm 
Folic acid 
Method 2 (pg 1675) 
Column: 4.6x250mm, packing L7 
Column temperature: 50oC 
Mobile phase: Mixture of 0.4 mL triethylamine, 15 mL acetic 
acid, 350ml methanol diluted with 8 mM sodium 1-
hexanesulfonate to 2 L.  
Conditions: flow rate 2.0 ml/min, UV detection at 270 nm 
Calcium pantothenate  
Method 1(pg 1677) 
Column: 3.9x150 mm, packing L1 
Mobile phase: phosphoric acid in water (1:1000) 
Conditions: flow rate 1.5 mL/min, UV detection at 210 nm 
Calcium pantothenate 
Method 3 (pg 1679) 
Column: 3.9x300mm, 5 µm packing L1 
Column temperature: 50oC 
Mobile phase: methanol and phosphate buffer (1:9) (phosphate 
buffer contains 10g monobasic potassium phosphate in 1L 
water adjusted with phosphoric acid to pH 3.5 
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Conditions: flow rate 2.0 ml/min, UV detection at 205 nm 
Niacinamide 
Method 1 (pg 1679) 
Column: 3.9x300 mm, packing L1 
Mobile phase: 1L mixture of methanol, acetic acid and water 
(27:1:73) containing 1.4 mg sodium 1-hexanesulfonate 
Conditions: flow rate 1.0ml/min, UV detection at 280 nm 
Niacinamide 
Method 2 (pg 1680) 
Column: 4.6x250mm, packing L1 
Mobile phase: 0.1M sodium acetate solution adjusted to pH 5.4 
with acetic acid. A small amount of methanol (up to 1%) may 
be used for improved resolution. 
Conditions: flow rate 1.0 mL/min, UV detection at 254 nm 
Pyridoxine 
hydrochloride  
Method 2 (pg 1680) 
Same as above (Niacinamide Method 2) 
 
Riboflavin  
Method 2 (pg 1680) 
Column: 4.6x250 mm, packing L1 
Mobile phase: Mixture of sodium acetate (6.8 g/L) and 
methanol (13:7). Add 2 mL triethylamine per L of mixture, 
adjust pH with acetic acid to 5.2.   
Conditions: flow rate 2.0 mL/min, UV detection at 254 nm 
Thiamine 
Method 2 (pg 1681) 
Column: 4.6x250mm, packing L1 
Mobile phase: Solution A (1.88 mg/mL of sodium 1-
hexanesulfonate in 0.1% phosphoric acid) : Acetonitrile (46:9) 





Method 3 (pg 1682) 
Column: 4.6x250 mm, packing L7 
Column temperature: 50oC  
Mobile phase: Mixture of 0.4 mL triethylamine, 15 mL acetic 
acid, 350ml methanol diluted with 8 mM sodium 1-
hexanesulfonate to 2 L 





Method 1 (pg 1706) 
Column: 3.9x300mm, packing L1 
Column temperature: 50oC  
Mobile phase: 1L mixture of methanol, acetic acid and water 
(27:1:73) containing 1.4 mg sodium 1-hexanesulfonate 
Conditions: flow rate 1.0 mL/min, UV detection at 280 nm 
Calcium pantothenate 
Method 1 (pg 1742) 
 
Column: 4.0x100mm, packing L1 
Mobile phase: methanol and 0.2 M monobasic sodium 
phosphate (3:97). Adjust with 1.7 M phosphoric acid to a pH of 
3.2 +/- 0.1 
Conditions: flow rate 1.0 mL/min, UV detection at 210 nm 
Niacinamide (pg 1745) Column: 4.6x250mm, packing L7 
Mobile phase: Mixture of 0.4ml triethylamine, 15ml acetic acid, 
350ml methanol diluted with 8mM sodium 1-hexanesulfonate to 
2 L 
Conditions: flow rate 2.0 mL/min, UV detection at 270 nm 
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Pyridoxine HCl (pg 
1746)  
Column: 4.6x250mm, packing L7 
Mobile phase: Mixture of 0.4 mL triethylamine, 15 mL acetic 
acid, 350ml methanol diluted with 8mM sodium 1-
hexanesulfonate to 2 L 
Conditions: flow rate 2.0 mL/min, UV detection at 270 nm 
Source: U.S. Pharmacopeia, National Formulary 2013, USP36/NF31 Dietary 
Supplements Oficial Monographs 
 
2.2 Materials and Methods 
2.2.1. Standards and reagents 
 Vitamin standards were purchased from different suppliers/manufacturers: 
thiamine hydrochloride, pyridoxine hydrochloride and cyanocobalamin from Enzo Life 
Sciences (Farmingdale, NY); riboflavin from Eastman Kodak Co. (Rochester, NY) and 
ascorbic acid from Fisher Scientific (New Jersey, USA). All reagents were of analytical 
grade.  
 HPLC grade acetonitrile, certified ACS o-phosphoric acid 85% and trace metal 
grade glacial acetic acid were purchased from Fisher Scientific (New Jersey, USA). 
Trifluoroacetic acid 99% (TFA), heptafluorobutyric acid 99% (HFBA) and formic acid 
99% were obtained from Acros Organics (New Jersey, USA). Water was purified using a 
Millipore Synergy UV system (Millipore Billerica, MA, USA). Mobile phase pH was 
measured using UB-10 pH meter from Denver Instrument (New York, USA).  
 
2.2.2. Standard preparation:  
 Individual stock solutions of thiamine, pyridoxine, cyanocobalamin and ascorbic 
acid were prepared monthly at 1000 ppm (1mg/mL) in Millipore-purified water. 
Riboflavin was prepared at 50 ppm by dissolving 25 mg of the component into 500 mL of 
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0.05 M formic acid. The solution was then sonicated in the dark for one hour for 
complete dissolution. These stock solutions were kept in 1.5 mL Eppendorf tubes and 
stored at -80oC to avoid degradation. Working solutions of vitamin standards were 
prepared daily by mixing and diluting the individual stock solutions in deionized water to 
desired concentrations. Preparation steps were performed in the subdued light condition 
using glasswares covered with foil to keep vitamins from degradation, especially vitamin 
B2, B6 and B12. 
 
2.2.3. Instrumentation: 
 The LC system consisted of Shimadzu SIL-20A HT auto-sampler, Shimadzu LC-
20AT liquid chromatograph, Shimadzu DGU-20A5 degasser and Shimadzu SPD-20A 
UV-Vis detector. All samples were filtered through Fisher Brand Nylon 25mm Syringe 
filters 0.22 µm and 0.45 µm Fisher Scientific before being loaded onto the HPLC system 
for analysis.  
 
2.2.4 Column testing: 
 The five vitamins of interest were divided into two groups based on their 
retention: group 1 includes thiamine, pyridoxine and ascorbic acid while group 2 
included riboflavin and cyanocobalamin. Working standard solutions of each group was 
prepared at 100 ppm level each (except for vitamin B2 at 5 ppm level). Both groups were 
eluted with isocratic runs programmed by adjusting the percentage of phase B coming to 
the mixing chamber. Chromatographic conditions are listed in Table 2.3. Mobile phase 
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with 0.1% formic acid (phase A) and acetonitrile (phase B) were used. Chromatographic 
separation of the analytes was performed on different columns, the characteristics of 
which are shown in the Table 2.4. 
Table 2.3 Summary on HPLC conditions for two groups of vitamin analytes 
 
Group 1 (Vitamin B1, B6 and C) Group 2 (Vitamin B2 and B12) 
Mobile phase: Isocratic with 100%A:0%B 
Flow rate: 0.8 ml/min 
Injection volume: 10µL 
Column temperature: ambient 
Mobile phase: Isocratic with 85%A:15%B 
Flow rate: 0.8 ml/min 
Injection volume: 10µL 
Column temperature: ambient 
 
2.2.5 Acid modifier testing for vitamin B1, B6 and C 
 The effects of different acid modifiers on chromatographic selectivity of thiamine, 
pyridoxine and ascorbic acid were studied. Aqueous mobile phase containing either 
formic acid, acetic acid, phosphoric acid or TFA with concentrations of 0.01%, 0.025%, 
0.05%, 0.1% and 0.25% were prepared. Analyses were performed on an Agilent Zorbax 
SB-Aq column (5µm, 250 x 4.6 mm) with isocratic condition of 100% aqueous phase at 
the flow rate of 1.0 mL/min. Detection was set at two wavelengths of 254 nm and 280 
nm. Working standard solutions of each group were prepared at 100 ppm level each for 
analysis. 
 
2.2.6 Enhancing retention of B1, B6 and C 
2.2.6.1 Heptafluorobutyric acid (HFBA) 
 Isocratic condition with 0.1% HFBA (~7.7mM) in water-acetonitrile (85:15) at 
flow rate of 0.5 mL/min was tested for the separation of a mixture of thiamine (B1), 
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riboflavin (B2), pyridoxine (B6) and ascorbic acid (C) on Agilent Zorbax Eclipse Plus 
C18 column (3.5µm, 150 x 3.0 mm).  
 
2.2.6.2 Buffer with higher pH 
 Ammonium acetate buffer at pH 5.76 and acetonitrile were used as the mobile 
phase to improve the retention of thiamine and pyridoxine. Both isocratic and gradient 
conditions were tested on Agilent Zorbax SB-Aq column (5µm, 250 x 4.6 mm) at the 
flow rate 0f 1.0 mL/min for the separation of the mixture of thiamine, riboflavin, 
pyridoxine, cyanocobalamin and ascorbic acid.  
 
2.2.6.3 HILIC column 
 The method development using HILIC (Hydrophilic Interaction Liquid 
Chromatography) column was performed on Agilent Technologies 1200 Series LC 
system consisted of G1379B Degasser, G1312A Binary pump, G1329A Autosampler, 
G1316A Thermostatted column compartment and G1314B Variable wavelength detector. 
The mobile phase included (A) 100 mM ammonium acetate buffer, pH 4.8 and (B) 
acetonitrile. Both isocratic and gradient conditions were tested on Phenomenex Luna 
HILIC column (3µm, 100 x 3.0 mm) for the separation of different mixtures of vitamin 
analytes. 
 
2.2.7 Column performance calculations 
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 Column performance was evaluated with two main factors: retention times (tR ) 
of the five vitamin analytes and tailing factor (Tf). Tailing factor describes the asymmetry 
of peak shape and is calculated as follows: 
 
with W0.5 as the width of the peak and f0.5 as the distance from the peak center line to the 
front slope, both measured at 5% of the maximum peak height. For further discussion on 
tailing factors as well as other column performance factors, please refer to the Appendix 
B. 
 
2.2.8 Testing the applicability of hydrophobic subtraction model to the prediction of 
chromatographic behaviors of the vitamins 
 Column characterization parameters obtained from “PQRI Database” on USP for 
selecting columns of equivalent selectivity are provided in Table 2.1. Detailed 
information of the hydrophobic subtraction (H-S) model behind this database is provided 
in Section 2.4. The retention times of the five vitamins obtained by protocols in section 
2.2.4 are correlated with the five column selectivity parameters including hydrophobicity 
(H), steric interaction (S*), hydrogen-bond acidity (A), hydrogen-bond basicity (B) and 
relative silanol ionization or cation-exchange capacity at pH 2.8 (C2.8). Six columns 
included in this study are Ypro, YAq, ZoAq, SyPo, SyHy and UlAq. 
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Type-A-silica columns  
 NovaPak 
(Waters) 
3.9x150 60 4 120 7.3 2.0-8.0  L01 
 Ultrasphere 
(Beckman) 
4.6x250 80 5  12 2.0-7.0  L01 
Type-B-silica columns with novel reverse bonded phase compatible with 100% aqueous phase 
YPro YMC Pro 
C18 
4.6x250 120 5  16 2.0-8.0  L01 
YAq YMC ODS-
AQ 
4.6x250 120 5  10,14 2.0-7.5  L01 
ZoAq Zorbax SB-
Aq 
4.6x250 80 5 180  1.0-8.0 No endcapped  
SyPo Synergi 
Polar-RP 









4.6x250 100 5  15 2.5-8.0 No endcapped  













3.0x150 95 3.5 160 9 2.0-9.0   
 Gemini C18 
110A 
4.6x250 110 5 375 14 1.0-12 C18 with TMS endcapping  
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2.3 Overview of chemical behaviors of the five vitamins in solution 
2.3.1 Thiamine 
 With a pKa of 9.2, the quarternary N on the thiazole ring (N-3) of the thiamine 
molecule remains cationic over a wide pH range. Another pKa (~4.8) is due to the 
protonated pyrimidine N-1’, which yield uncharged pyrimidyl moiety of thiamine free 
base as shown in Figure 2.1 (7, 8).  
  
Figure 2.1 Protonation of thiamine 
 
2.3.2 Pyridoxine 
 Vitamin B6 compounds occur in different ionic forms in aqueous solution 
depending on the pH (9, 10). They exist either as cations in acidic solutions and or as 
anions in alkaline solutions (1). Due to the opposite nature of the basic pyridinium N 
(pKa~8) and acidic hydroxyl groups (pKa~3.5–5.0), vitamin B6 mostly occurs in 
Zwitterionic form at neutral pH (9). The net charge on B6 vitamers varies as a function of 
pH (10). Shown in the figure below are the four predominant forms of pyridoxine in 





































Figure 2.3 Riboflavin structure 
 Riboflavin itself contains various potential ionic sites that are theoretically 
suggested to produce different ionic forms, including the anions formed from the 
deprotonation of hydroxyl groups attached to C-2’,3’,4’ and 5’ of the ribityl side chain or 
cations formed from the protonation at N-1,3,5 and 10 (Figure 2.3) (11). Empirical 
studies reported pKa of 10 for the protonation of riboflavin at N3 position (12). 
Therefore, riboflavin is predicted to be non-ionized and its chromatographic behavior 
does not depend on the pH of the buffer within the pH range of 2.0-7.0, the normal 
working pH range of conventional reversed-phase silica based columns.  
 
2.3.4 Cyanocobalamin 
 Though there have been many studies on the chemistry of vitamin B12 and 
related compounds in the literature for the past century (13-15), only a few sources cited 
the pKa values of cobalamins and these values lack consistency across the references 
found (16-18). According to Ladd et al., vitamin B12 is a weak base that stays 
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approximately neutral at pH from about 5 to 10 while it is positively charged in acidic 
environment and negatively charged above pH 11 (19). That seems to agree with the pKa 
of 3.3 and 9.3 reported in two sources found (17, 18).  
 
Figure 2.4 Cyanocobalamin Structure  
 
2.3.4 Ascorbic acid 
 The acidic and reducing nature of L-ascorbic acid (AA) is contributed by the 2, 3-
enediol moiety. Ionization of the C-3 hydroxyl group (pKa1= 4.04) is more favorable than 
that of the C-2 hydroxyl (pKa2 =11.4) (7). Figure 2.5 shows the two possible ionic forms 
for ascorbic acid that can occur in the solution at different pH values. It is worth 
mentioning that even though the oxidized form L-dehydroascorbic acid retains its vitamin 
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C biological activity, it behaves differently in terms of chromatography (1). This 
compound is not shown under UV-Vis detection.  
 
Figure 2.5 Ionic forms of ascorbic 
 
2.4 Hydrophobic-Subtraction (H-S) model of RP column selectivity 
2.4.1 Brief introduction 
 The theory behind the H-S model originates from the recognition that retention in 
RP chromatography is primarily attributed to the hydrophobic interaction among sample 
molecules, the mobile phase and the stationary phase, as described by solvophobic theory 
(20-22). However, as the column could contribute to retention in additional ways, other 
than by hydrophobic interaction between solute and column, it became apparent that the 
solvo-phobic model is incomplete to describe the RPC retention and selectivity (23). The 
hydrophobic-subtraction model proposed by Snyder and Dolan started with the 
assumption the major contribution of hydrophobicity to RP-LC retention is subtracted to 
better understand the remaining contributions to retention from other solute-column 
interactions (23-30).  Retention is quantitatively described as a function of solute and 
column in the following equation (26, 30): 
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 (Eq.1) 
 In this equation, k and kEB are the retention factors of a given solute and a non-
polar reference solute (ethylbenzene) obtained on the same column under the same 
condition (50%, v/v, acetonitrile/buffer; buffer is pH 2.80, 60 mM potassium phosphate) 
respectively (23). The separation factor α is related to the complementary properties of 
the solute and the column. The five terms η'H, σ'S*, β'A, α'B and κ'C in this equation 
refer to the five solute-column interactions shown in Figure 2.6 (a–e), respectively (25, 
31). The Greek letters η', σ', β', α', κ' denote complementary solute properties, where η' is 
solute hydrophobicity, σ' is molecular bulkiness or resistance to insertion of the solute 
into the stationary phase, β' is solute hydrogen-bond basicity, α' is the solute hydrogen-
bond acidity, and κ' is the effective charge on the solute molecule. The other five capital 
letters H, S*, A, B and C refer to column properties, which are of primary practical  
interest  because  they  determine  the  selectivity  and  applicability  of  most  RPC  
columns. 
 Column hydrophobicity H increases with an increase in ligand density and ligand 
length attached to the particle. Small-pore packings which result in the compression of 
the ends of the alkyl chains, also increase ligand density, hence the value of H. End-
capping of free silanols does not lead to a significant increase in total carbon, therefore it 
only affects H slightly. 
 Column steric interaction S* describes the resistance to the penetration of bulky 
solutes into the stationary phase. Behaving the same way as H, this parameter exhibits an 
increase as the bonded phase becomes more crowded (ie. longer chain length or denser 
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concentration of the bonded phase) and a decrease with an increase in particle pore 
diameter. End-capping also shows a minor effect on values of S*. However, in contrast to 
H, an increase in S* corresponds to bulky solute molecules being more difficult to 
penetrate the crowded bonded phase attached to the RP particles. This leads to less 




















Figure 2.6 Cartoon representation of five solute–column interactions of H-S model  
(Adapted and reconstructed in modified forms from references 22 and 30) 
Note: Figures in blue are analyte molecules. B, hydrogen-bond acceptor group of the 
analyte (e.g., NH2); BH
+, protonated group of the analyte (e.g., NH3
+); X, hydrogen-bond 
acceptor group of the stationary phase. 
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 Column hydrogen-bond acidity is attributed to non-ionized residual silanols on 
the stationary surface. In this case, these underivatized silanols in the non-ionized form 
acted as a proton donor responsible for the retention of hydrogen-bond acceptor 
molecules as illustrated in Figure 2.6c. This parameter is therefore expected to exert 
significant selective effects on nonionized basic molecules such as amines and amides, 
especially aliphatic derivatives.  Column hydrogen-bond basicity is believed to 
originate from various functional groups within the bonded phase. Forming a permanent 
part of the column surface, silanols and siloxane groups seem to be potential acceptor 
sites contributing to the column basicity. If that is the case, then end-capping, which 
reduces the number of free silanols on the surface and restricts the silanol accessibility of 
the solutes, is expected to cause a pronounced decrease in B. However, empirical data 
indicates instead a slightly positive effect of end-capping on the values of B, which 
negates the speculation that silanol and siloxane groups are responsible for column 
hydrogen-bond basicity. Supporting evidence has suggested that water from the mobile 
phase apparently sorbs onto the bonded phase, interacting with and binding to non-
ionized carboxylic acids. This sorbed water is believed to play an important role in 
column hydrogen-bond basicity. Columns with greater B values preferentially retain 
acidic compounds. Polar-embedded columns fall in this category. With a polar functional 
group (urea, amide, carbamate) inserted within the alkyl ligand attached to the silica 
surface, these columns preferentially bind both phenols and carboxylic acids. Some type-
A columns with high metal impurities also exhibit a larger value of B. 
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 Column cation-exchange capacity C arise from the dissociation of underivatized 
silanols -SiOH  -SiO- + H+. As the pH of the mobile phase increases, the silanol 
ionization increases, imposing more negative charges on the column, which tend to 
attract ionized (positively charged) bases and repel ionized (negatively charged) acids. 
Type B columns are less acidic than Type A columns; therefore, the C value of the 
former is expected to be lower than that of the latter. End-capping restricts the access to 
ionized silanols, resulting in a significant decrease in C. Silanol ionization results in a 
negative charge on the column, and this charge attracts ionized (positively charged) bases 
and repels ionized (negatively charged) acids. For samples that contain ionized acids or 
(especially) bases, the column parameter C is a very important contributor to column 
selectivity. For samples that do not contain acids or bases, C is unimportant. Column 
ionization and values of C increase as mobile-phase pH is increased. End-capping results 
in decreased access to ionized silanols and a large decrease in C. 
 
2.4.2 Application of the H-S model to equivalent column selection 
 HPLC columns need to be replaced from time to time for routine analysis due to 
deterioration. Also, when a method is transferred to another laboratory, a particular 
column is needed for the procedure. However, in either case, problems may be 
encountered. Although manufacturers now manage to maintain column performance 
reproducibility from batch to batch, a new column of the same designation may not result 
in the same (or acceptable) separation, especially when the chromatographers are dealing 
with samples that are difficult to be separated (23). Moreover, the same column may not 
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be supplied by the original manufacturer anymore or not be readily available at the new 
site where the method is transferred (25). These cases require the chromatographer to 
choose alternative columns that are equivalent in selectivity to the original one. That is 
when the H-S model can come into play as it allows the quantitative comparison of two 
columns and selects those of equal selectivity to the column one would like to replace. 








where H1 and H2 refer to values of H for columns 1 and 2 respectively, and similarly for 
the remaining column parameters S*, A, B and C. The equation also considers the 
differences of the relative contributions of each parameter by adding weighting factors 
(12.5, 100, etc.) which were determined empirically (24). Depending on the nature of the 
solute, C-term and B-term can be omitted for samples that do not contain ionized 
compounds (acids or bases) and carboxylic acid respectively. FS can be interpreted as the 
distance between two columns in a plot of the five parameters in a five-dimensional 
space. The smaller the value of FS, the closer in selectivity the two columns of interest is. 
In general, if FS ≤ 3 then the two columns are considered excellent matches and expected 
to have similar selectivity and band spacing for any sample or set of conditions (24, 31). 
On the other hand, Fs values above 5 indicate poor matches. 
 The Impurities Working Group of the Product Quality Research Institute (PQRI) 
Drug Substance Technical Committee applies the H-S subtraction model to the 
evaluation of several hundred RP-LC columns including from C1–C30 alkyl-silica (both 
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type-A and-B), embedded-polar group, polar-end-capped, cyano, and most other 
commonly used column types (23). Results obtained from this project have been 
collected and continually updated in a searchable database referred to as PQRI database 
by USP. The list of equivalent columns to those used in this study is put together using 
this PQRI database and included in the Appendix C.  
 
2.5 Results and discussion 
2.5.1 Mobile phase choice for column testing procedure 
 Some analytes, especially thiamine, pyridoxine and ascorbic, are ionic compounds 
that are not well retained in reversed-phase chromatography. Therefore official methods 
by USP and other reported methods in literature for these vitamins usually involve the 
use of ion pairing reagent for reversed-phase chromatography to enhance their retention 
on the column. The addition of amphiphilic ions in the mobile phase such as alkyl 
sulfonates or sulphates for basic solutes and quaternary amines for the acidic ones can 
greatly enhance the retention and separation of ionizable vitamin analytes through a dual 
mechanism: (a) the adsorption of the amphiphilic counterion on the stationary phase 
surface introduces the ionic interaction to the analytes; (b) the formation of the ion pair 
between the amphiphilic counterion and the analyte, resulting in an increased retention of 
the complex on the hydrophobic bonded phase (32, 33). However, the biggest drawback 
of this method is that the ion-pair reagents are hard to be fully washed from the column, 
which requires the dedication of a particular column to ion-pair applications (33). 
Moreover, trace levels of those reagents can change the column selectivity when it is 
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used for non-ion-pair applications, making column-to-column reproducibility a problem 
(20, 24). Therefore, the use of amphiphilic ion-pairing reagents is usually recommended 
as a last resort in chromatography practice.  
 Because these vitamins can occur in aqueous solutions in various ionized states, 
pH of the mobile phase is an important factor that can affect the reproducibility of the 
method. It is highly recommended that the pH of the mobile phase should be about 2 pH 
units away from the pKa of the analytes (32, 34). The reasoning behind this is 
conveniently explained based on the Henderson-Hasselbalch equation which states: 
pH= pKa +  (Eq.3) 
where A- and HA should be extensively understood as deprotonated and protonated 
species of the same chemical, and does not necessarily only refer to acidic compounds. 
At pH of 2 units away from the pKa, it is guaranteed that one species exists in the 
solution predominantly with the percentage of 99%. In fact, throughout literature, many 
reported methods used phosphate or acetate buffers to control the pH of the mobile phase 
(35). However, there is a tradeoff for good chromatographic separation of water-soluble 
vitamins resulted from this practice. In order to maximize the retention of some highly 
polar, ionizable vitamin analytes (especially vitamin C, vitamin B1 and vitamin B6), the 
analysis must be run at a very high aqueous percentage of mobile phase. This high salt 
content condition is detrimental to the integrity of the HPLC system, causing serious 
silting of the column and tubings (34, 36). Moreover, methods using these buffer salts are 
not transferable to mass spectrometry detectors as these salts are non-volatile (37). In 
some cases when the acidic environment is needed for separation, merely acid modifiers, 
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instead of a true buffering system with a weak acid and its conjugate base, suffice. To put 
it simply, their neutralizing capacity allows them to act as mild buffers against possible 
pH fluctuation on the introduction of the samples. Even when there is a mismatch 
between the pH of samples and mobile phase, as long as the injection volume is kept 
reasonably within the neutralizing capacity of the acid additives at certain concentration, 
a stabilized pH is maintained for chromatographic separation of the analytes. For this 
preliminary stage of method scouting, a simple aqueous mobile phase with 0.1% formic 
acid was found to work effectively. Its final pH 2.75 is not only well above the lower 
limit for most silica-based columns but also more than 2 units away from the pKa’s of 
ionizable thiamine and pyridoxine. Moreover, at this pH, the ionization of residual 
silanols, which can lead to serious peak tailing for protonated compounds, is suppressed. 
As UV-Vis detection was used, acetonitrile (ACN) with its low UV cutoff in comparison 
to methanol (190nm v.s 205nm) was more preferable as the organic phase (20, 36). This 
fact is advantageous to expanding the method detection scope to other vitamins that are 
only responsive to low UV wavelength such as pantothenic acid and biotin (35).   
 
2.5.2 Column characteristics 
 The list of columns used for the preliminary phase of method scouting is provided 
in Table 2.4. For the purpose of better evaluation, all the columns tested are classified 
into 3 groups based on their silica types and aqueous phase compatibility: type A 
columns, conventional type B columns and 100% aqueous compatible type B columns. 
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2.5.2.1 Type A columns 
 In 1986, Kirkland and others coined the terms ‘Type A’ and ‘Type B’ to refer to 
two different generations of silica supports used in HPLC column packing (36). 
Approximately more than 20 years ago, silica-based columns mostly used type A silica 
which is characterized by a high level of metal impurities causing a heterogeneous acidic 
surface (38). Together with residual silanols, metal contaminants interact strongly with 
sample components, leading to poor peak shape, especially asymmetrical and serious 
tailing for basic compounds (30). Among the columns tested, Waters Nova Pak and 
Beckman Ultrasphere belong to this category. Aqueous mobile phase containing 0.1% 
formic acid with the pH of 2.75 cannot overcome the synergistic tailing effects of both 
residual silanols and metal impurities in these columns. Serious tailing was observed in 
both columns, as shown in Figure 2.7. Peak overlapping happened to pyridoxine (B6) and 
niacinamide (B3) in the first chromatogram and to niaciniamide and thiamine (B1) in the 
second. The tailing factor Tf is 5.936 for B6 in Nova Pak and 6.032 for B1 in Beckman 
Ultrasphere. Peak shape of the vitamin C, vitamin B2 and B12, however, was not affected 
and stayed symmetrical because they are not affected by the silanol interaction. Residual 
silanols are acidic in nature and normally stay uncharged around pH3 (38). However, in 
the presence of metal impurities, the acidity of silanol surface is greatly increased. 
Therefore, a lower pH mobile phase was tried. When pH of the mobile phase pH is 
lowered to 2.3 with 1% formic acid, the tailing is improved a little but overall the peak 




Figure 2.7 Demonstration for chromatographic performance of Type A columns 
Notes: Noticeable tailing was observed in both chromatograms above: B6 (Tf= 2.863) 
and B1(Tf= 6.032) in chromatogram I and B6 (Tf=5 .936) in chromatogram II 
 
 Moreover, due to the non-uniform bonded phase coverage and active sites, 
columns with type A silica support has a high column-to-column variability (38). Putting 
aside the fact that RP columns have insufficient retention for some water-soluble 
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vitamins especially thiamine and ascorbic acid, it is their poor reproducibility and bad 
peak shape that made chromatographers resort to ion-pair reagents and other complicated 
additives back in the old days .  
 
2.5.2.2 Conventional type B columns 
 Type B refers to a newer generation of highly purified and less acidic silicas 
which offer higher reproducibility and much more improved chromatographic 
performance of ionizable compounds, especially basic analytes (29, 39). Type B silica is 
used almost exclusively these days for any new lines of columns. However, as many 
official methods were established using type A columns, they are still around and 
continue to be used without the need to revalidate. These days, unless one would like to 
use the established methods by official organizations, it is recommended that one should 
use type B columns for method development process.   
 Due to their polar and ionic nature, vitamin analytes require high aqueous mobile 
phase to achieve desired retention and separation. Conventional ODS (octadecylsilane) 
columns with octadecylsilane chemically bonded to porous silica are not compatible with 
highly aqueous phase and display stability problems without the use of ion-pair reagents 
(40, 41). It has been reported that retention times decrease gradually when some RP 
columns are used with highly aqueous mobile phases while in other studies, the loss of 
retention was only observed when the flow was stopped and then restarted (42-44). This 
phenomenon was not recorded when the mobile phase containing more than 10% (v/v) of 
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Detector A Ch2:280nm 
Detector A Ch1:254nm 
 
Column: Zorbax Eclipse Plus C18 3.5um, 3.0x150mm 
Mobile phase: isocratic with 0.025% TFA 
Flow rate: 0.5 ml/min 
Injection: 10ul of standard mixture of C, B1 and B6 at 100ppm 
Detection: UV 254nm and 280nm 
 
Figure 2.8 Dewetting issue solution 
Notes: Restoring retention of the analytes by column can be achieved by reequilibrating 
the column with high percentage of organic phase (>50%) before running the aqueous 















 Reid and Henry attributed retention losses to “phase collapse” or “hydrophobic 
collapse” (45). It is speculated that the long alkyl chains are fully stretched in high 
percentage of organic solvents while they fold onto each other and onto the silica surface 
in highly aqueous phase. As a result, the stationary surface becomes less accessible for 
the partitioning of polar analytes between the mobile and stationary phases, leading to 
reduced retention. Phase collapse is the most popular explanation for the retention loss 
effect of RP columns under highly aqueous phase. However, this explanation is 
propagated more as a speculation rather than an empirically validated theory. There have 
been many reports on the behaviors of bonded alkyl chains in different solvents, but 
convincing evidence on such a phase collapse is still elusive (44). One report even raised 
the contradictory conclusion that all bonded alkyl chains stay “collapsed” in all mobile 
phases (46). 
 An alternative explanation for the retention loss of RP columns after flow 
stoppage and restart was first proposed by Walter, et al. in 1997 (44). Due to their 
hydrophobic nature, most C18 bonded phases cannot be wetted by water (47, 48). 
Therefore, in order to push water into the pores of the stationary phase, pressure must be 
applied (42, 43). The force that keeps water in the pores is the water/solid interfacial 
tension and the external pressure. This metastable condition is maintained as long as the 
column is under sufficient pressure. However, once the pressure falls below the needed 
value or the flow is stopped, water is expelled out of the pores due to the liquid/gas 
surface tension and partial pressures of water vapor and gases formerly dissolved in 
water. The pores then are inaccessible to the mobile phase, which results in the loss of 
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retention (49, 50). However, this issue is reversible. Retention can be regained by 
rewetting the pores with a mobile phase high in organic solvent (more than 50%) before 
re-equilibrating the column with 50% ACN before the aqueous mobile phase. However, it 
is inconvenient because it requires longer time for re-equilibration. 
 Excessive cases of tailing are the most evident in the cases of Type A silica 
columns as discussed in the column choice section above. On the other hand, Type B 
columns produced with newer technology have significantly fewer iron contaminants and 
free underivatized silanol residues, hence reducing the tailing effects (39). Except for 
Waters Nova Pak and Beckman Ultrasphere columns, all others used in this section fall 
into this category. 
 
2.5.2.3 Aqueous compatible type B columns 
 The past decade has seen a dramatic increase in popularity of polar-embedded and 
polar-endcapped columns that are specifically developed for the analyses of polar 
compounds (28, 51-54). These phases involve modifications of the chemistry of classical 
alkyl phases through either an insertion of a polar functional group (amide, urea, 
carbamate and ether groups) within the alkyl chain attached to the silica surface for the 
former or the deactivation of residual silanols with polar functional groups (amino or 
hydroxyl terminated short alkyl chain) for the latter (51, 52). 
 Among the six columns designated for this part of the study, Restek Ultra 
Aqueous C18 is polar-embedded while Synergi Hydro and YMC ODS AQ are polar-
endcapped. Synergi Polar RP is a special column in the group as it is both polar-
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endcapped and polar-embedded. The bonded phase of the column is stated by the 
manufacturer as phenyl linked to the silica particle through an ether link. Another special 
case is that of YMC Pack Pro C18. Marketed as a typical type B C18 column with 
proprietary endcapping, YMC Pro was unexpectedly found to be compatible with 100% 
aqueous mobile phase. Though the exact nature of endcapping chemistry is not disclosed, 
it is thought that the column is partially polar endcapped. Last but not least is the 
unclassified Zorbax SB-Aq. According to the manufacturer, the column is non-
endcapped, which means the free residual silanols can hydrogen bond with water, 
preventing dewetting issues; therefore, the column is compatible with 100% aqueous 
phase. This compatibility may also come from the nature of the bonded phase, which can 
either be embedded with a polar group or be a polar group itself and is undisclosed by the 
manufacturer. Classification of the six tested columns in this group is illustrated by the 
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2.5.3 Chromatographic behaviors of the analytes and performance of aqueous 
compatible columns 
 The 5 analytes can be categorized into 2 groups, not necessarily based on polarity, 
but rather on their relative retention under the mobile phase used. This trend is consistent 
with all the columns tested. While vitamin B1, B6 and C are eluted at 0% organic solvent 
(100% aqueous phase of 0.1% formic acid in water), vitamin B2 and B12 require 15% of 
acetonitrile for their elution. The retention time and tailing factor of all five vitamins in 
the six aqueous-phase-compatible Type B columns are given in Table 2.5. Graphical 
illustrations of these data are shown in Figure 2.10. 
 
Table 2.5 Retention time and tailing factor of B1, B6, C, B2 and B12 
Notes: Mobile phase: (A) 0.1% formic acid and (B) Acetonitrile. Group 1 (B1, B6 and C) 
were separated under 100% A while group 2 (B2 and B12) were separated under 
85%A:15%B. Flow rate at 0.8 ml/min. 
 
Columns  B1 B6 C B2 B12 
YMC Pack 
pro 
tR (min) 2.79 5.97 6.75 13.69 10.31 
Tf 1.99 1.36 1.19 1.13 1.18 
Synergi 
Hydro 
tR (min) 3.54 11.14 6.15 14.08 10.04 
Tf 1.39 3.65 1.09 1.08 1.09 
Zorbax SB-
Aq 
tR (min) 4.30 8.98 5.19 10.52 14.70 
Tf 2.64 2.47 1.19 1.09 1.34 
Synergi Polar 
tR (min) 4.49 8.14 5.10 13.32 22.32 
Tf 1.50 1.58 1.27 1.07 1.34 
YMC ODS 
AQ 
tR (min) 7.31 7.38 5.11 23.56 39.35 
Tf 4.23 2.06 1.27 0.91 1.54 
Restek Ultra 
Aqueous 
tR (min) 8.10 14.17 6.35 19.43 19.45 






Figure 2.10 Retention time and tailing factor of B1, B6, C, B2 and B12 on different 
aqueous-phase compatible columns 
Notes: Mobile phase (A) 0.1% formic acid and (B) Acetonitrile. Group 1 (B1, B6 and C) 
were separated under 100% A while group 2 (B2 and B12) were separated under 






 Some generalization can be made about the chromatography of all the analytes in 
all columns tested from Figure 2.10A. Thiamine is the first to be eluted and pyridoxine in 
most cases comes out later than thiamine. Ascorbic acid seems to be retained equally in 
all columns as there is not much difference in the retention time across the columns. 
Apart from these trends, it is hard to generalize about the order of elution among the 
analytes in different columns. Within each group, there is no uniformity in the order of 
elution across the tested columns. The elution order depends on the nature of the packing 
materials in the columns tested.  
 Physical parameters such as particle size (µm), pore size (Å), total carbon content 
(%), surface area (m2/g), etc, are provided by the column manufacturers. While they are 
useful for the purpose of quality control (55), these parameters tell little about 
chromatographic performance of the bonded phases (56, 57). On the other hand, many 
manufacturers are not always willing to reveal the information on the bonded phases, 
endcapping groups and/or embedded groups, the nature of which is important to the 
selectivity of the columns towards the analytes of interest (55).   
 The H-S model was applied to explain chromatographic behaviors of the analytes 
in this study. For the purpose of column selectivity comparison, besides the column 
information provided by the manufacturers, column parameters obtained from H-S model 
are also conservatively used to interpret the stationary phase/analyte interactions when 
appropriate. The absolute column parameters shown in Table 2.6 were graphically 
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presented as relative measurements in Figure 2.11 for the convenience of column 
comparison.  
Table 2.6 Column parameters obtained from H-S model 
Notes: H: Hydrophobicity, S*: Steric resistance, A: Hydrogen bond acidity, B: Hydrogen 
bond basicity, C(2.8): Cation exchange at pH 2.8 
 
Columns H S* A B C(2.8) 
Ypro 1.015 0.014 -0.12 -0.007 -0.155 
SyHy 1.022 -0.006 0.169 -0.042 -0.077 
YAq 0.965 -0.036 -0.135 0.004 -0.068 
ZoAq 0.593 -0.12 -0.083 0.038 -0.136 
UlAq 0.808 -0.128 0.378 0.013 0.229 






















2.5.3.1 Thiamine and pyridoxine 
 Thiamine and pyridoxine occur predominantly in ionized forms under the mobile 
phase pH 2.8. As charged molecules can be considered as an extreme case of polar 
analytes, the role of hydrophobicity of the column on their retention is minimal. 
Therefore, it is the ionic interaction of the charges with the ionized silanol groups of the 
stationary phases that is of major importance to their retention on RP columns (31). 
Because these silanol groups are located on the silica surface, this interaction is 
dependent on steric resistance (or shape selectivity), the S* parameter in the H-S model. 
Because pyridoxine is smaller than thiamine, steric resistance has less impact on its 
retention than it does on thiamine. As a result, the interaction of pyridoxine with the 
ionized silanol groups is stronger, leading to better retention than thiamine in nearly all 
columns tested. It is noticed that for all columns tested, thiamine always comes out earlier 
than pyridoxine, even before the void volume in the case of YMC pack Pro.  
 Among the six columns tested, YMC Pro and Restek Ultra Aqueous have the 
lowest and highest retention, respectively, for all analytes, especially these two 
protonated vitamins. Further examination of their parameters revealed that the YMC Pro 
column has the lowest C and highest S* while Restek Ultra Aqueous had the highest C 
and second lowest S*. This observation agrees with the aforementioned speculation that 
the retention of these two vitamins is mainly dependent on the column cation-exchange 
capacity C and steric resistance S*. YMC is a typical type B alkyl bonded phase column 
while Restek Ultra Aqueous is a non-endcapped, polar-embedded column, which 
possibly explains their lowest and highest C values respectively. Polar-embedded groups 
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are believed to attract water to the silica surface, producing an immobilized layer that 
reduces the cationic interaction between bases and residual silanols (58). If that is the 
case, then both protonated thiamine and pyridoxine should have been weakly retained on 
Ultra Aqueous. However, the data showed they were both very well retained on Ultra 
Aqueous. Because the chemistry of the embedded groups is unknown, benefit of the 
doubt is given to their potential cationic interaction with the analytes, resulting in longer 
retention.     
  Synergi Hydro and YMC ODS-Aq columns are both polar endcapped and have 
similar H values, which are also close to that of YMC Pack Pro. It has been reported that 
polar-endcapped columns have similar hydrophobicity to non-endcapped or traditionally 
endcapped columns (type B alkyl phases) (59). In a study by Dolan and co-workers, it 
was found that these columns also behave similarly to and do not offer more enhanced 
selectivity than type B alkyl phases (28). However, that does not seem to be the case 
concerning the retention of thiamine and pyridoxine in this study. These two columns 
retained the two vitamins better than YMC Pack Pro, a typical type B alkyl phase 
column, even though their selectivity towards the two vitamins is very different. Synergi 
Hydro is more selective towards pyridoxine and less towards thiamine than YMC ODS-
Aq even though both C and S* values of the column are approximately equal to those of 
Synergi Hydro. It is interesting to note that both compounds elute nearly at the same time 
on the YMC-ODS AQ column. Retention of the thiamine increases while that of the 
pyridoxine decreases in comparison to their retention on Synergi Hydro. Just like the 
other two previous columns, endcapping means that the free silanol groups on the surface 
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of YMC ODS AQ are significantly decreased. There are only limited ionized silanol sites 
to bind with and retain certain number of positively charged species at one time. When 
the steric resistance is low enough to allow both compounds to have secondary 
interaction with ionized silanols, thiamine with more positive charges have better chance 
to bind the limited number of cationic-exchange site. Moreover, the different chemistry 
of the the polar end-capping group used, which is not specified by the manufacturer, may 
also be the reason for the differential selectivity in this case.  
 Zorbax SB-Aq and Synergi Polar RP have similar elution order of the three 
vitamins in group I. The two columns have approximately equal H and S* but very 
different C values. It appears that they have different mechanisms of reducing the 
cationic interaction between bases and residual silanols, leading to the difference in C. 
Among the six columns tested for this section, Zorbax SB-Aq is neither classified as 
polar-endcapped nor polar-embedded. According to the supplier, the siloxane bond to the 
silica surface is protected from acid hydrolysis by silanes with bulky diisopropyl side 
groups. This column is non-endacapped but these bulky side groups are believed to 
sterically shield silanols and diminish ionic interactions between protonated bases and 
residual silanols. The bonded phase of Synergi Polar RP, on the other hand, is phenyl 
embedded with a polar ether link which can form an aqueous layer masking silanols and 
reducing the ionic interactions. Somehow, the difference in C values does not result in 
significant difference in retention of the two compounds. In fact they have nearly the 
same retention in the two columns, even including vitamin C. This result may come from 
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the interactions with the bonded phase of the former and the polar groups of the latter, the 
nature of which is undisclosed by the manufacturers.  
 
2.5.3.2 Ascorbic acid 
 Existing predominantly in the undissociated form under the mobile phase pH, 
ascorbic acid (pKa 4.3) is mainly retained due to the interaction with the hydrophobic 
ligand of the column. It either elutes before, in between or after thiamine and pyridoxine 
depending on column characteristic. In general, there is no significant difference in the 
retention of ascorbic among the columns tested. It is speculated that the minor difference 
in selectivity may come from the potential hydrogen bonding between the four hydroxyl 
groups of ascorbic acid with the water sorbed onto the bonded phase according to H-S 
model. Kiridena and Poole found that the hydrogen-bond basicity of polar-endcapped 
columns was lower than that of classical C18 counterparts and much lower than that of a 
polar-embedded phase suggesting the incorporation of less water into the polar-
endcapped phase (60). However, the random distribution of B values by H-S model and 
the arbitrary analyte retention ranking regardless of column types does not seem to 
confirm Kiridena’s finding. Besides column hydrophobicity and hydrogen-bond basicity, 
it is thought that the unspecified chemistry of the polar-embedded or polar-endcapped 
groups of the columns may complicate the retention of ascorbic, contributing the 




2.5.3.3 Riboflavin and cyanocobalamin 
 Cyanocobalamin is a weak base that occurs as a positively charged species 
charged in acidic environment. Considering its structure, the positive charge is possibly 
due to the deprotonation of various nitrogenous moieties in the molecule. Partly-ionized 
bases are believed to be retained mainly as neutral species (23). That seems to coincide 
with the symmetrical peak shape of cyanocobalamin, indicating little to no trace of 
secondary interaction with residual silanols on the stationary surface. Its bulky molecular 
structure may be held responsible for limiting this ionic interaction. 
 Riboflavin is predicted to be non-ionized and its chromatographic behavior does 
not depend on the pH of the buffer within the pH range of 2.0-7.0. Riboflavin is retained 
quite well on C18 column and it elutes together with cyanocobalamin within the same 
range of organic mobile phase (15% ACN in this study). Because there is no positive 
charge involved in the residual silanol intractions, riboflavin peak shows no tailing like 
cyanocabalamin. 
 Both of these analytes, as discussed above, are mainly retained as neutral species, 
which explains why they are retained longer on RP columns than the other three vitamin 
analytes. Besides hydrophobicity, steric resistance (or shape selectivity) is the second 
most important factor that affects a compound’s retention. Vitamin B12 eluted before 
vitamin B2 on both YMC Pro and Synergi Hydro column. The other way around 
occurred to the remaining columns. The H-S model can be satisfactorily applied to 
explain the retention of riboflavin and cyanocobalamin. Their elution order in a way can 
be explained using an analogy of retention by size-exclusion chromatography (SEC) (23). 
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In SEC, the solute retention is dependent on the accessibility of the solutes to the particle 
pores. Bigger, longer molecules have a larger hydrodynamic or Stokes diameter that 
challenges their entering the particle pores, leading to reduced retention in comparison to 
other molecules of smaller sized (20). The same thing may have happened to the case of 
riboflavin and cyanocobalamin. The steric resistance of YMC Pro and Synergi Hydro are 
the highest among the columns tested, indicating the highest level of difficulty against 
penetration towards the analytes. Cyanocobalamin is much bulkier than riboflavin, 
therefore its chance of interaction with the alkyl ligands bonded phase is also much more 
reduced than that of riboflavin, leading to its earlier elution. On the other hand, when the 
steric resistance is the same towards the two molecules then stronger retention favors 
bulkier one. This explains the trend of elution of these two vitamin analytes in the case of 
YMC-ODS Aq, Zorbax SB-Aq and Ultra Aqueous C18. Synergi Polar RP is a special 
case in that it has the same selectivity towards both riboflavin and cyanocobalamin even 
though its S* value is the lowest. The difference in its bonded phase (ether linked phenyl) 
is possibly the cause of this chromatographic behavior.  
 
2.5.3.4 Peak tailing 
 Taking a look at Figure 2.10C gives us an idea about the asymmetry of the peak 
shapes of all five analytes. While ascorbic, riboflavin and cyanocobalamin have quite 
stable tailing factors and all stay within the range of 0.9 to 1.6, the other two vitamins 
have much more random tailing patterns. As explained from above, the main retention 
force for these two compounds is ionic interaction between the protonated amine groups 
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with the ionized silanol residues on the silica surface. It is this interaction that gives rise 
to the tailing issues (28).  
  According to Giddings and others, tailing may result from slow adsorption-
desorption kinetics of retained solute between the few strong sites of high adsorption 
energy and a large number of sites of low adsorption energy (61, 62). The strong sites in 
the case of RP-LC involve the interactions between the protonated bases and the small 
number of ionized silanol residues on the silica surface that can be easily saturated by 
small amount of solutes while the weaker sites refer to the hydrophobic interactions 
between solute and alkyl ligands. The initial adsorption of positively charged molecules 
onto the hydrophobic surface of the stationary phase hampers further sorption of 
molecules with the same charge. This mutual ionic repulsion effect may also contribute to 
overloading (besides merely the saturation of rather than of small number of cation-
exchange sites on columns) (63). Buckenmaier proposed this ionic repulsion as the major 
factor contributing to peak tailing mechanism of protonated bases on type-B alkyl-silica 
columns at low-pH conditions without ion-pairing mobile phases (63). In comparison to 
Type A columns, these aqueous compatible columns cause much less tailing. Higher 
purity of silica and endcapping which were discussed above in section 2.5.2.2 are the two 
reasons for their enhanced performance of these columns (39). Moreover, when further 
examining each column in this section on an individual basis, each seems to have 
different mechanism towards reduced silanol interaction, leading to less tailing. These 
mechanisms are the same as the ones discussed earlier in section 2.5.3.1 that affects the 
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retention of the two protonated basic compounds. In general, as the protonated analyte is 
retained longer, the tailing is increased. 
 
2.5.4 H-S model fitting to predict the chromatographic behavior of analytes 
 The theory behind the H-S model was quite useful for explaining the general 
retention mechanism of the five analytes. However, when it comes to making relative 
comparison of column performance, only conservative interpretation of the column 
parameters should be made when appropriate as the correlation between column 
parameters and analyte retention is not clear and consistent. At least this observation is 
true for the linear relationship that was tested in this study (Table 2.7). In general, the 
correlation was found to be quite random. Statistically significant correlation coefficient 
was found between tR and S for cyanocobalamin, tR and A for pyridoxine and tR and C2.8 
(Column cation exchange parameters at pH 2.8) for all except ascorbic acid. Among 
these, the correlation between tR and S makes sense for the case of cyanocobalamin. As 
this vitamin is quite bulky, shape selectivity plays an important role in its retention. The 
slope is negative (-116.65) indicating that as the steric resistance of the stationary phase 








Table 2.7 Values of r2 and slope (a) for correlation between analyte retention and column 












Thiamine 0.010 0.170 0.183 0.135 0.496 
-1.12 -12.59 3.87 29.63 10.35 
Pyridoxine 0.016 0.155 0.820 4 x 10-5 0.561 
-1.98 -16.63 11.33 -0.73 15.22 
Ascorbic 0.357 0.271 0.307 0.135 0.005 
2.32 5.46 1.72 -10.15 0.36 
Riboflavin 0.135 0.416 0.261 0.006 0.815 
-9.40 -44.37 10.40 13.51 29.84 
Cyanocobalamin 0.261 0.551 0.333 0.312 0.697 
-29.83 -116.65 26.85 231.35 63.02 
  
 Satisfactory correlation between tR and C2.8 for thiamine and pyridoxine is 
reasonable due to their positively charged condition. The cation exchange interaction 
with the residual silanols is confirmed. It is unexpected that the correlation coefficient for 
tR=f(C2.8) for riboflavin and cyanocobalamin are that high (0.815 and 0.697 
respectively). This result is quite random as mentioned above, as under the mobile phase 
condition, these two compounds stay undissociated. The highest correlation coefficient is 
obtained for tR= f(A) for pyridoxine (0.820). Theoretically, the only basic group on 
pyridoxine is protonated and favors cationic exchange interaction with inonized residual 
silanols instead.  
 The original purpose of this relationship study is to learn if linear modeling can 
explain some of the trends in the retention process and can be used to predict the 
retention of the same analytes on other columns if the H-S parameters of the new 
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columns are known. However, considering the correlation coefficients, it is not possible 
to use this to predict their chromatographic behaviors using linear model for single 
parameters. The retention mechanism is not a straight-forward simple process that 
involves a single interaction. Instead, it is the result of a more complicated combination 
of other secondary interactions besides the primary hydrophobic one. Multilinear model 
or different correlation model may work in this case but it is worth mentioning that the 
contribution from different interactions is not equal depending on the nature of the 
analyes in the conditions tested. These contribution cofactors can only be determined 
empirically from a bigger data set.   
 
2.5.5 Improving the retention of weakly retained vitamins (thiamine, ascorbic and 
pyridoxine) 
2.5.5.1 Acid modifiers and pH adjustment 
 The effects of different acid modifiers on the retention and tailing of the three 
vitamins are demonstrated in Table 2.8 and Figure 2.12. Thiamine occurs in equilibrium 
between the singly-charged and double-charged species under acidic condition. As the 
mobile phase pH gets close to the first pKa of thiamine (4.8), there is a significant shift in 
the equilibrium towards doubly-charged thiamine molecules, leading to a decrease in 
thiamine retention. This trend is observed for phosphoric, formic and acetic acid when 
their concentrations in the mobile phase increase. Substantial changes in both retention 
and tailing factor are noticed for acetic acid. As a weak acid, the pH range induced by 
acetic acid in the study (pH 3.06-3.73) falls close to the first pKa of thiamine in 
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comparison to the other two acid modifiers. As a result, every change in pH of the mobile 
phase by acetic acid causes a significant shift in the equilibrium between the two ionized 
species of thiamine. When ionized thiamine is retained longer on the column, its 
interaction with residual silanol is also increased, which consequently leads to serious 
tailing. Another reason for significant tailing issues is that at pH higher than 3, residual 
silanol activity is enhanced. The Zorbax-SB Aq column is not endcapped, which means 
there is a high number of residual silanol groups on the surface available for interaction 
with basic compounds, leading to tailing. This explains the wide range of tailing factors 
(2.4-8.2) when acetic acid is used.  
 Pyridoxine has two possible ionizable sites, one at the pyridinium N and the other 
at 3-hydroxyl group with pKa=8 and 5.0, respectively. There is an equilibrium of 3-OH 
dissociation, which regulates the concentration of zwiterrionic pyridoxine and cationic 
pyridoxine. Because the mobile phase induced by the acid modifiers in this section has 
pH close to the lower pka of pyridoxine, the relative concentration of the two species of 
pyridoxine in the mobile phase may cause the difference in the interaction with the 
column, which in turn leads to the difference in the retention when different acid 
concentration is used. Retention is inversely related to the total charges on the analyte. 
When the pH of the mobile phase decreases with higher acid concentration, there is an 
increase in the amount of singly positively charged species, which are better retained on 
RP column than its zwitterionic counterpart. As to tailing, it is noticed that the tailing 
factor increases up to around pH 3.0-3.5 and then decreases. It is possibly due to the 
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repulsion effects of zwitterionic pyridoxine against the ionized silanols at increased pH, 
leading to less peak tailing.  
 The retention time and tailing factor of ascorbic acid stays consistent across the 
pH gradient and does not depend on the kind of acid modifiers. Though it is an ionizable 
compound with a pKa of 4.04, no significant changes in these two chromatographic 


















Table 2.8 Retention time (tR)  and tailing factor (Tf) of B1, B6 and C on Zorbax SB-Aq 
column under different acid modifiers 
Notes: 100% aqueous mobile phase containing various acid modifiers at five 
concentration levels (0.01%, 0.025%, 0.05%, 0.1%, 0.25%). Flow rate 1.0 ml/min. 
 
Modifiers pH 
B1 B6 C 
tR (min) Tf tR (min) Tf tR (min) Tf 
Acetic acid 
0.01% acetic 3.73 5.286 8.165 5.095 2.01 4.274 1.585 
0.025% acetic 3.58 4.329 5.879 4.86 2.111 4.108 1.216 
0.05% acetic 3.43 4.25 5.244 5.289 2.472 4.134 1.18 
0.1% acetic 3.28 3.928 3.046 5.557 2.501 4.111 1.185 
0.25% acetic 3.06 3.681 2.402 5.844 2.368 4.067 1.15 
Formic acid 
0.01% formic 3.24 3.824 2.812 5.755 2.584 4.127 1.17 
0.025% formic 3.04 3.558 2.227 6.196 2.435 4.141 1.168 
0.05% formic 2.87 3.527 2.356 6.832 2.466 4.172 1.175 
0.1% formic 2.72 3.443 2.19 7.179 2.349 4.158 1.176 




3.05 3.275 2.244 6.09 2.446 4.558 1.181 
0.025% 
phosphoric 
2.75 3.118 1.955 6.918 2.292 4.23 1.179 
0.05% 
phosphoric 
2.5 2.985 1.485 6.644 1.834 4.187 1.181 
0.1% phosphoric 2.3 3.07 1.536 7.536 1.959 4.251 1.181 
0.25% 
phosphoric 
2.05 3.104 1.411 7.694 1.768 4.256 1.181 
Trifluoroacetic acid (TFA) 
0.01% TFA 2.94 4.278 3.034 8.335 2.802 4.193 1.178 
0.025% TFA 2.61 4.312 2.398 9.807 2.439 4.243 1.175 
0.05% TFA 2.3 4.638 1.754 10.949 2.145 4.239 1.174 
0.1% TFA 2.05 5.371 1.649 12.185 1.912 4.241 1.182 













Figure 2.12 Retention time and tailing factors for thiamine, pyridoxine and ascorbic with 
different acid modifiers on Zorbax SB-Aq column  
Notes: 100% aqueous mobile phase containing various acid modifiers at five 
concentration levels (0.01%, 0.025%, 0.05%, 0.1%, 0.25%). Flow rate 1.0 ml/min. 
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2.5.5.2 Perfluorinated carboxylic acid and ion-pairing effects 
 The overall discussion on the effects of acid modifiers on the chromatographic 
behaviors of the analytes above can be better summarized in another graph that focuses 
only on the final pH of the mobile phase instead of the modifiers added. Examination of 
Figure 2.13 reveals that it is the pH, not the modifiers themselves that cause changes in 
both analyte retention and peak tailing. However, TFA is a special case as it exerts a 
substantial effect on the retention of protonated vitamins (i.e., thiamine and pyridoxine) 











Figure 2.13 Retention and tailing factors of thiamine, pyridoxine and ascorbic v.s final 
pH of mobile phase (regardless of modifiers used) 
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 TFA belongs to the group of perfluorinated acid modifiers that are believed to 
enhance protonated analytes through a process of dualistic nature: (a) ion pairing and (b) 
chaotropic effects. The latter phenomenon occurs when the counterions introduce chaos 
to the ionic solvated analyte, disrupting the structured solvation shell which causes an 
increase in its apparent hydrophobicity and retention. These ions are hence named 
chaotropic ions (64, 65). They are arranged into the Hofmeister series based on their 










The increased chaotropicity related to the ions’ charge delocalization and polarizability is 
ranked from left to right, with a simultaneous increase in the symmetry. According to this 
series, TFA ions have a stronger chaotropic effects than phosphate, formate and acetate 
counterparts.  Moreover, the ion-pairing capacity of TFA was found to be stronger than 
that of acetate, formate and phosphate. The ion-pairing of chaotropic ions is also similar 
in mechanism to classical amphiphilic ions discussed above with dualistic nature (72): (a) 
the formation of the neutral ion pairs that are then retained on the hydrophobic bonded 
phase; (b) the adsorption of the counterions on the stationary phase surface introduces the 
ionic interaction to the analytes. Trifluoromethyl CF3- has a significant electronegativity, 
making it a strong electron withdrawing group. Electron density from a conjugated π 
system of the carboxylate ion is removed via resonance or inductive electron withdrawal, 
thus making the π system less nucleophilic. The formation of ion pairs with protonated 
basic analytes may be slower than in the case of other counterions. However, CF3
- is 
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more hydrophobic, which seems to be a determinant factor for the enhanced retention of 
thiamine and pyridoxine observed in this study. 
 Other perfluorinated carboxylic acids include pentafluoropropionic acid (PFPA), 
heptafluorobutanoic acid (HFBA), nonafluoropentanoic acid (NFPA), 
tridecafluoroheptanoic acid (TDFHA) and pentadecafluorooctanoic acid (PDFOA). 
Elongation of the carbon chain of these modifiers results in an increasing retention of 
protonated analytes (67). Moreover, the influence of these additives on the column is 
reversible and equilibration only requires minimal time (33). It should be noted that 
besides all of the mentioned effects, perfluorinated carboxylic acids also adjust the pH of 
the mobile phase, affecting the analyte chromatographic behaviors as well. The most 
prominent consequence of the low pH induced by TFA in the study is the suppression of 
silanol ionization, thereby reducing peak tailing.  
 Within the scope of this study, HFBA was also tested under the same 
chromatographic conditions used for this section (0% aqueous phase on Zorbax-SB Aq, 
250x4.6mm). Figure 2.14 shows the chromatogram obtained with isocratic run using 
HFBA as an additive. Mobile phase containing 0.1% HFBA (~7.7mM) was found to 
significantly increase the retention of both thiamine and pyridoxine in comparison to 
TFA. Higher percentage of organic solvent (15% acetonitrile) was used to elute these two 
compounds. Moreover, the order of elution was even inversed with pyridoxine eluting 
earlier than thiamine. With two positive sites available for the binding of ion-pairing 
reagent, thiamine–ion complex is more hydrophobic, hence retained more strongly. 
Ascorbic acid is not a basic compound; therefore its retention was not affected by the 
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addition of HFBA and remained the same even when the organic phase percentage 
(acetonitrile) increased to 2%, 5% and 10%. The adjustment of phase B percentage was 
made to obtain the optimal condition for the separation of thiamine, pyridoxine and 
ascorbic acid which is shown in chapter 3.  
 
Figure 2.14 HPLC method using HFBA as an additive in the mobile phase 
 
2.5.5.3 Buffered mobile phases 
 Low retention of thiamine and pyridoxine under acidic condition are due to the 
positive charges they carry. It is logical to think that removing these positive charges 
helps enhance their retention on RP columns. This goal can be achieved by raising the 
mobile phase pH with buffers. As these two compounds are all ionizable, the choice of 
which pH to use is of major importance. As discussed in section 2.4.1 on mobile phase 









Detector A Ch2:280nm 
Detector A Ch1:254nm 
Column: Zorbax Eclipse Plus C18 
3.5um, 3.0x150mm 
Mobile phase: (A) 0.1% (7.7 mM) 
HFBA and (B) acetonitrile. 
Isocratic run with 15% B  
Flow rate: 0.5ml/min 
Detection: UV 254nm and 280nm 
Injection: 10µl of standard mixture 






choice, it is recommended that the final pH should be about 2 pH units away from the 
pKa of the analytes to ensure reproducibility for the chromatographic method.  
 Thiamine and pyridoxine have the highest pKa at ~9.0; therefore, the positive 
charge can be removed if the mobile phase is raised to a pH higher than 9.0, which falls 
out of the normal working pH range of most columns. There are some manufacturers 
nowadays offering columns with special design (either silica-based or polymer-based) 
that can withstand such a high pH condition. However, such a high pH buffer may not be 
necessary as buffers with pH lower than 8.0, which are within the recommended 
operating range of normal silica-based columns, appears to have a sufficient effect on the 
retention time of these two compounds. There have been many methods developed using 
phosphate buffer pH 5.0-7.0 as the aqueous mobile phase for the HPLC analysis of 
thiamine and pyridoxine. Within this range, phosphoric acid and phosphate salt with low 
UV cutoffs (below 200 nm) are favorable additives used in UV-Vis detection. However, 
HPLC methods using phosphate buffers are not transferable to LCMS system due to 
these salts’ non-volatility. Ammonium acetate (pka~4.8) is the most versatile buffer 
between pH 5.0 and 7.0 for LCMS that can be used in this case. Figure 2.15 shows two 
chromatograms obtained by using the mobile phase buffered with this volatile salt. At pH 
higher than its first pKa (4.8), thiamine loses one positive charge. Thought it is still a 
cation, the effect of removing one charge from the molecule is quite significant to its 
retention on RP columns. As to pyridoxine, within the pH range of 5.0 to 7.0, it occurs in 
zwiterrionic form (or there is an equilibrium shift towards zwitterions). With one more 
negative charge, it was predicted that the retention of pyridoxine would decrease. 
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However, it happened the other way around, which is unexpected. It came out of the 
column at 8% of the organic phase (acetonitrile). The zwitterionic form somehow had a 
higher apparent hydrophobicity, hence a stronger interaction with the non-polar 
stationary phase. Or possibly, the zwitterions interacted more strongly with each other, 














Figure 2.15 HPLC methods using buffered mobile phase to enhance retention of 













Detector A Ch2:280nm 
Detector A Ch1:254nm 
Column: Zorbax SB-Aq 250x4.6mm, 
5µm 
Mobile phase: (A) ammonium acetate 
buffer pH 5.76 and (B) acetonitrile  
Flow rate: 1.0ml/min 
Detection: UV 254nm and 280nm 
Injection: 10µl of standard mixture of 
B1, B6 and C  
Gradient: 0min 8%B, 5min 18%B, 
10min 18%B, 12min 8%B, 15min 
 
C 
B6 B1 B2 
B12 



















Detector A Ch2:280nm 
Detector A Ch1:254nm 
Column: Zorbax 250x4.6mm, 5µm 
Mobile phase: isocratic with 92% 
ammonium acetate buffer pH 5.76 
and 8%ACN  
Flow rate: 1.0ml/min 
Injection: 10µl of standard mixture 
of B1, B6 and C 





2.5.5.4 HILIC column 
 As a variation of normal phase chromatography, the combination of polar 
stationary phases with aqueous mobile phases has been around since the 1970s (73, 74). 
However, the popular term HILIC (Hydrophilic interaction liquid chromatography) 
referring to this technique was not coined until 1990 by Alpert (75, 76). Attracting great 
attention in the last decade, HILIC has been widely recognized as a distinct 
chromatographic mode useful for the retention and separation of polar compounds. 
HILIC utilizes a polar stationary phase such as bare silica, cyano, amino, phenyl, 
pentafluorophenyl (PFPP) or diol and a relatively non-polar mobile phase to facilitate 
resolution of polar anlaytes (77). Typical components of HILIC mobile phase include a 
high percentage of organic solvent with water and buffer as the modifier. Offering 
selectivity complementary to reversed-phase chromatography, HILIC can also be referred 
to as “reverse reversed-phase” or “aqueous normal phase”.  
 Even though HILIC has garnered extensive attention from HPLC application 
chemists and theoreticians for the past decade, its retention mechanism is still in 
controversy today (77, 78). The most common explanation for HILIC mechanism is 
based on partitioning theory (79). It is proposed that the aqueous portion in the mobile 
phase is preferentially adsorbed onto the polar stationary phase, establishing a water-
enriched layer. This semi-immobilized polar layer is sandwiched between the stationary 
phase surface and the organic-solvent rich mobile phase (80). It is the partitioning of the 
analytes between these two layers that result in the retention and separation in HILIC. 
More polar solutes tend to be distributed more in the aqueous layer, thus be retained 
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longer than their less polar counterparts. However, the partitioning mechanism is not the 
sole component responsible for the analyte retention in HILIC. Several studies suggest 
that HILIC retention mechanism is more of a multimodal process involving hydrogen 
bonding, dipole-dipole interaction and ion-exchange between the analytes with the water 
layer and the stationary phase surface (79). 
 HILIC provides many advantages over traditional reversed-phase 
chromatography, especially when being coupled with LCMS. Not only does it offer 
enhanced retention to highly polar compounds that would otherwise be unretained on RP 
columns, HILIC also gives good peak shape to basic analytes. Due to the high volatility 
of the mobile phase, this technique potentially improves the sensitivity in MS and ELSD 
detection. Moreover, the high organic solvent content in the mobile phase has low 
viscosity, which allows higher flow rates for reduced analysis run time. In terms of 
sample preparation procedures, high organic solid phase extraction (SPE) eluents can be 
directly injected into the HPLC without further evaporation and re-constitution. 
 Demonstration for the performance of HILIC column is given in Figure 2.16. In 
the first chromatogram, isocratic condition with 98% acetonitrile was used to elute 
thiamine. It was retained longer than pyridoxine and even riboflavin, which is an 
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Column: Phenomenex Luna HILIC 100x3.00mm, 3µm 
Mobile phase: (A) Ammonium acetate 100mM, pH 4.8 
and (B) Acetonitrile. Isocratic with 98% B  
Flow rate: 0.4ml/min 
Injection: 10µl of standard mixture of B1, B2, B3 and 
B6 at 100ppm 
Detection: UV 254 nm 
Column: Phenomenex Luna HILIC 100x3.00mm, 3µm 
Mobile phase: (A) Ammonium acetate 100mM, pH 4.8 
and (B) Acetonitrile at flow rate 0.4ml/min 
Injection: 10µl of standard mixture at 100ppm level  
Detection: UV 254nm 
Gradient: 0min 95%B, 15min 50%B, 15,1 95%B 
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2.5.6 Consideration for method transferring 
2.5.6.1. Mobile phase 
 Among all the HPLC detectors used in this study, ELSD and MS require mobile 
phases devoid of nonvolatile salts and modifiers. When used with ELSD, such additives 
may collect inside the drift tube, damage the nebulizer, foul the optical cell and cause an 
excessively noisy baseline (81, 82). In the case of MS, they can pollute the mass 
spectrometer, resulting in source blockages (37). The common consequence for the use of 
nonvolatile components in both detectors is the downgrade of the system integrity and a 
decrease in detection sensitivity, compromising the analysis accuracy. Commonly used 
volatile additives for MS and ELSD are formic acid, acetic acid, triethyl amine, 
ammonium hydroxide, ammonium formate and ammonium acetate (37). Perfulorinated 
acids are also acceptable for both detectors but their use in MS may lead to significant ion 
suppression in positive ion mode (83, 84). Moreover, these acid modifiers have high 
surface tension which can potentially prevent efficient spray formation. Detection 
sensitivity may significantly decrease as a consequence.  
 UV-Vis detector, on the other hand, has no strict requirements about mobile phase 
additives. The choice of mobile phase components is dependent on the detection 
wavelength of the method. UV cutoffs for acetonitrile and methanol, the two most 
commonly used organic solvents in HPLC are 190nm and 205 nm, respectively (72, 82). 
Considering the low wavelength of absorbance (below 210nm) by pantothenic (vitamin 
B5) and biotin (vitamin B7), if the target of multi-vitamin analysis with UV-Vis detector 
includes these two compounds, acetonitrile is a better choice than methanol. As to acid 
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modifiers, TFA, formic and acetic all have UV cutoffs at 210nm (72). Depending on the 
final concentration of these acids in mobile phase, excessive baseline drift and noisy 
background interference can be observed at wavelengths below 240nm, which 
dramatically affects the detection sensitivity (72, 82). The same behavior is expected for 
volatile buffer salts commonly used in ELSD and MS such as ammonium acetate, 
ammonium formate and ammonium bicarbonate. Phosphate buffers with low UV cutoffs 
(below 200nm) are more suitable for the UV-Vis analysis of non-chromphoric 
compounds. Table 2.9 displays the properties of commonly used additives for RP 
chromatography. 
Table 2.9 UV cutoffs of common additives 
Additives UV cutoffs 
TFA 210 nm (0.05% v/v) 
Phosphates <200 nm (10nM) 
Formic 210 nm (10mM) 
Acetic 210 nm (10mM) 
Phosphoric <200 nm 
Ammonium acetate 210 nm (10 mM) 








2.5.7.2. Dwell volume (gradient delay volume) 
 Dwell volume is defined as the volume between the solvent mixing point and the 
beginning of the columns (85). While this volume is of no significance to isocratic runs, 
it plays an important role in gradient separations. The difference in dwell volume 
between different HPLC systems explains why gradient conditions developed in one 
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chromatography method do not necessarily transfer to another. Dwell volume in this case 
can be thought of as a de facto isocratic hold time at the beginning of the gradient (85). 
This gradient delay time, or dwell time is equal to the dwell volume divided by the flow 
rate. If the dwell volume of a system is too large, it is not feasible for the use of narrow-
bore columns. Demonstration of the dwell volume/dwell time concept is displayed in 
Figure 2.17. The gradient was scheduled to start right after sample injection. However, 
based on the baseline drift in chromatogram, the gradient actually did not start until after 
6 minutes into the run. This delay in signal response includes the dwell time and column 
void time. Empirical determination of dwell volume can be found in the Appendix B.  
 
Column: YMC Pack pro C18 5um, 250x4.6mm 
Mobile phase: (A) 0.025% TFA and (B) acetonitrile at flow rate of 1.0 ml/min 
Injection: 10ul of nine water-soluble vitamin mixture at 100ppm 
Gradient: 0min 0%B, 6min, 18%B, 12min 18%B, 20min 0%B 
 
Figure 2.17 Demonstration of dwell volume/dwell time 
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2.5.7.3. Time efficiency 
 Refer to the following equation in Appendix B  
 
 When the values of k and α are optimized to achieve the desirable resolution (at 
least more than 1.5) for the critical band pair (the pair with the smallest Rs in the 
chromatogram), then if the separation has more resolution than required (Rs>>1.5), this 
excess resolution can be traded for a shorter run time, which is done by reducing the 
column length and/or increasing flow rate (32). Demonstration of this adjustment is 
shown in Figure 2.18. Further reduction in run time can be achieved by using column 
with smaller particle size.  
 Columns with sub-3µm particles require very small pore frits (0.5 µm) to hold the 
particles in place; therefore they are easy to get plugged, which potentially reduces the 
column lifetime. On the contrary, the use of 3.5 µm packings seems to be a good 
compromise between the high performance of smaller particles and column life time (86). 
In comparison to the common 5 µm particles, these 3.5 µm packings reduce the run time 
by one-half for the same column length while providing equivalent resolution (87). The 
pressure for columns of 3.5um particles size also conveniently falls within the operating 
pressure range for normal HPLC system (max 400bar or ~6000psi). However, for 
narrow-bore columns or those with sub 3um particle size, in order to take advantage of 
their high efficiency with high flow rate, many factors need to be considered, including 
the back pressure. In those cases, UHPLC is needed.  
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 Nowadays, in light of improvement in modern technology, new generations of 
columns offer more solutions to the rising demand of fast HPLC analysis. Superficially 
porous particle columns which were first developed in the 1970s have reemerged for the 
past few years (88). These particles contain a solid core and an external porous silica 
layer. In comparison to fully porous particles, they have more uniform particle size 
distribution which allows them to be packed with large porosity frits. Therefore they are 
more resistant against clogging. Moreover, the narrower particle size distribution creates 
a more consistent packed bed, which greatly reduces analyte diffusion through the 
column. This is the A term in the Van Deemter equation. Moreover, the short diffusion 
paths of the analytes between the mobile phase and the thin porous crust minimize 
resistance to mass transfer, which is the C term in the Van Deemter equation. 
Superficially porous particle columns have a greatly reduced back pressure, allowing the 
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2.6 Summary on the optimization for the analysis of thiamine, riboflavin, 
pyridoxine, cyanocobalamin and ascorbic acid 
2.6.1 Objective 
 The ultimate goal of the analytical methods in this study was to quantify the 
vitamin content in a variety of pharmaceuticals and fortified food products. In order to 
ensure accuracy for quantification and reproducibility for the methods, it is recommended 
that  
• Resolution R between the peak of interest and the closest potential interfering 
peak (impurity,  excipient,  degradation product,  internal standard,  etc.) 
should be more than 2.0 
• Tailing factor (Tf) which characterizes peak shape and peak symmetry should 
be less than 2.0 
• Retention factor (k) should be more than 2.0 
 These requirements are stated in the Reviewer Guidance on Validation of 
Chromatographic Methods by FDA and should be considered during the method 
development and optimization phase (89). However, they are not necessarily hard-and-
fast rules that must be met for the analysis purpose. In reality, it is sometimes challenging 
to accomplish all of these requirements, especially when the analysis involves different 
compounds with diverse chromatographic behaviors. A more lenient requirement 
allowing resolution of at least 1.5 and retention factor k of more than 1.0 is acceptable for 
practice (32). Further details on the concepts of resolution, tailing factor and retention 
factor are included in the Appendix B.   
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2.6.2 Column consideration 
 Due to high level of metal impurities and residual silanols, Type A columns cause 
serious peak tailing for basic analytes and therefore should be avoided. On the other 
hand, Type B columns with conventional bonded reversed-phase have dewetting issues 
when used under highly aqueous mobile phase. In order to avoid this inconvenience, 
Type B columns with novel stationary phase that is compatible with 100% aqueous 
mobile phase are recommended. The column classification can be looked up on the USP 
Column Equivalency Application Database, the website address of which was previously 
provided in chapter 2. Moreover, this database can serve as a useful reference source for 
column replacement if a specific column cited for a to-be-used method is not available. 
The list of equivalent columns to those used in this study is provided in the Appendix C.  
 
2.6.2 Mobile phase consideration 
 Acidic mobile phase with pH of 2.0-3.0 is favored as it is easily prepared with 
only one single component of acid modifier. At such a low pH, the ionization of the 
residual silanol groups are mostly suppressed, resulting in minimal cation-exchange 
interactions between, hence minimizing peak tailing for basic analytes. Another 
advantage of acidic mobile phase is that it is consistent in preparation, at least more than 
pH-based salt buffers at higher pH levels. Other considerations about buffered mobile 
phase are discussed in section 2.5.6.3 and “Method transferring” section above.  
 Thiamine, pyridoxine and ascorbic acid are all ionizable compounds; therefore, 
pH of the mobile phase is of major importance for optimal separation. With pKa of 4.3, 
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ascorbic acid stays unionized at low pH, which gives its maximum retention in RP 
columns. Pyridoxine, on the other hand, is positively charged under acidic conditions. 
These two compounds have quite adequate retention in RP columns under 100% aqueous 
acidic mobile phase, with retention factor k bigger than 1.0 at least in all Type B columns 
tested in this study. Thiamine is the least retained among the three ionizable vitamins. In 
many tested columns, the retention was between 0 and 1. In conventional RP columns, it 
even elutes before the void time. Thiamine and pyridoxine are basic compounds; 
therefore a simple way to enhance their retention is to increase the pH of the mobile 
phase using buffer salts with pH of 5.0-7.0. Another way is to use perfluorinated acid 
modifiers. TFA enhances the retention of the two compounds a little bit, but not as 
significantly as HFBA and possibly other higher-chain acids in the series. HILIC 
columns, which provide complementary retention to RP columns, can also be used as 
another alternative for better retention of all these three analytes. A chromatographic 
method using HILIC column for the analysis of vitamin B1 in dry-cured sausages was 
reported (90). 
 For riboflavin and cyanocobalamin, there are no issues with early elution or peak 
tailing at least within the working pH range of silica-based columns and for all the 
columns tested in this study. They are both well-retained in RP columns and can be 
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SIMULTANEOUS ANALYSIS OF WATER-SOLUBLE VITAMINS IN 
PHARMACEUTICALS AND FORTIFIED FOOD PRODUCTS  
 
3.1 Introduction 
 Ever since liquid chromatography was first utilized for the analysis of vitamins, 
chromatographers have made efforts to develop methods targeting at simultaneous 
determination of more than one vitamin. Implementation of such multi-analyte analysis 
for routine analysis results in time and cost efficiency. Due to their diverse chemical 
properties, it is challenging to resolve all water-soluble vitamins in one chromatographic 
run without compromising the analytical sensitivity, accuracy and precision when 
compared to single-analyte methods. Selected analytical methods for multi- and single-
vitamin analysis that are available in chromatography literature are presented in Table 3.1 
below and Tables A10 to A14 in the Appendix D. Based on the review of these reported 
procedures and the chromatographic behavior study of the five water-soluble vitamins 
presented in chapter 2, two methods for the simultaneous analysis of nine water-soluble 
vitamins in pharmaceuticals and fortified food products using 1) DAD-ELSD and 2) 
















sample with 35 mL 
0.1N H2SO4 in 
boiling water bath 
for 30min. Add 
clara amylase, 
incubate at 55oC for 
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and filter. 
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250 x 4.6mm) 
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and autoclave for 15 








Mobile phase: acetonitrile 
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rate of 1.2 ml/min 
Fluorescense 
B2: Ex λ= 436 
nm and Em λ= 
535 nm; 
Thiochrome: Ex 
λ= 364 nm and 






sample in 0.01M 
HCl at 121oC for 30 
min. Cool, adjust 
pH to 4.5, add 
takadiastase and 
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16-18hr. Filter, 
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then dilute.  
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Lichrosorb RP-18 (5µm, 
250 x 4.0 mm) 
Mobile phase: gradient 
with methanol and 0.05M 
ammonium acetate at the 
flow rate of 1 ml/min 
UV 270 nm and 
290 nm 
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(85:15) containing 0.5% 
triethylamine, 2.4% glacial 
acetic acid and 5mM 
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3.6) at flow rate—1 
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sample in 0.1M HCl 
in boiling water 
bath for 1hr. Cool, 
adjust to pH 4.3-4.7, 
add claradiastase 
and incubate at 
37oC for 16-17hr. 
Add TCA 50% and 
heat in water bath 




For B1: Spherisorb NH2 
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at 2ml/min flow rate with 
chloroform-methanol 
(90:10) 
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Acid and enzyme 
hydrolysis with 
various modifying 
changes to test the 
efficiency of the 
extraction procedure 
Lichrospher 100RP 18 












of sample and SPE 
clean-up with C18 
AR 
Nova-Pack C18, (4µm, 150 
x 3.9mm) 
Mobile phase: methanol 
and 0.05M ammonium 
acetate  





Hydrolyze 2g of 
sample homogenate 
in 60ml 0.1M HCl 
in a water bath (95-
100oC) for 30 min. 
Cool, adjust pH to 
Spherisorb ODS-2 C18, 
(5µm, 250 x 4.6mm) 
Mobile phase: 0.04M 
H2SO4 in water; 0.2M 
acetate buffer containing 
0.005 M octanosulfonic 
Fluorescense 
B2: Ex λ= 422 
nm and Em λ= 
515 nm; 
Thiochrome: Ex 
λ= 360 nm and 
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4-4.5 then add 
takadiastase. 
Incubate for 3hr at 
45-50oC. Add 2ml 
TCA 50% (w/v) 
then heat at 100oC 




acid in water, with 
acetonitrile at different 
ratios; methanol/water 
(50:50, v/v) and 
acetonitrile/ 
water (50:50, v/v). Flow 
rate of 1mL/min 






Dissolve tablets in 
50 ml of 0.1M 
phosphate buffer 




µBondapak C18 (10µm, 
300 x 3.9 mm) 
Mobile phase: gradient 
with methanol and 0.1M 
KH2PO4 buffer (pH 7.0) at 




B1, B2,B3, B6 
(11) 
Mix 6g milk 
powder with 30ml 
warm water. Add 
30ml 0.6M TCA to 
the solution, shake 
for 15min and filter 
Luna Prodigy ODS 3, 
(5µm, 150 x 4.6mm) 
Mobile phase: isocratic 
with methanol:water:formic 
acid (25:74:1) containing 
0.1% sodium 
dioctylsulfosuccinate, pH 
2.8 at flow rate of 2 
mL/min 
Fluorescence 
  Ex λ = 290nm 
  Em λ = 390nm 
for B6 
  Ex λ = 450nm 
  Em λ = 510nm 
for B2 




and baby foods/ 
vitamins B1, B2, 
B3, B6, B9 and 
B12 (12) 
Acid hydrolysis: 
10g sample in 25ml 
0.1M HCl, stand in 
water bath at 90°C 
for 30 min. Cool, 
adjust pH to 4.  
Enzyme hydrolysis: 
Add 0.1 g 
Takadiastase, 
incubate for 2 h. 
Add  
1ml 50% TCA, heat 
at 90°C (in water-
bath) for10 min. 
Cool, adjust pH to 
6, dilute to 50 mL 
with 10mM 
KH2PO4 (pH 6), 
Supelco RP-Amide C16, 
(5µm, 150 x 4.6mm) 
Mobile phase: gradient 
with 10mM KH2PO4 (pH 
6) and acetonitrile at flow 










Dissolve samples in 
water, dilute at 
different levels 
C18  Microsorb (5µm, 250 
x 4.6mm) 
Mobile phase: gradient 
with 0.01 M ammonium 
Acetate (A) and methanol 
(B) 
FTIR; UV 210 








sample with 100ml 
water, mix and 
stand in dark for 10 
min. Filter. 
Supelco C18 (5µm, 250 x 
4.6mm) 
Mobile phase: isocratic 
with 0.05M sodium 
phosphate dibasic, 
heptahydrate, 10% 
methanol (v/v) and 0.018M 
trimethylamine adjusted to 
pH 3.55 with 85% 






Italian pasta/ B1, 
B2, B3, B5, B6, 
B9 (15) 
Three extraction 
procedures for three 
groups (group 1 
with B1, B2, B3 and 
B6), group 2 with 
B5 and group 3 with 
B9). 
Discovery RP-Amide C16 
5µm, 150x4.6 mm, 
Mobile phase: gradient 
with ammonium formate 




Turkish food/ C, 
B1, B2, B3, B5, 
B6, B9 (16) 
Mix 5g sample with 
20ml water,  
homogenize and 
centrifuge. Clean-up 
with Sep-Pak C18 
(500 mg) 
Discovery C18, (5µm, 150 
x 4.6mm) 
Mobile phase: isocratic 
with methanol:0.1M 
KH2PO4 (pH 7.0) (10:90) at 
flow rate of 0.7ml/min  
UV 290 nm and 
Visible 550 nm 
Polyvitaminated  
premixes/ B1, 
B2, B3, B6, B9, 
B12, C (17) 
Mix 2g sample with 
40ml water then add 
4ml NaOH 2M. 
Add 50ml 
phosphate buffer 
1M, pH 5.5, dilute 
to 100 ml with 
water. Sonicate for 
10 min and filter 
YMC-Pack Pro C18, (5µm, 
250 x 4.6 mm) 
Mobile phase: gradient 
with 0.025% TFA (pH 2.6) 
and acetonitrile at flow rate 
of 0.8ml/min 






Mix 0.5g sample 
with 4.5 mL warm 
water (40°C), 
homogenize for 1 
Spherisorb ODS-2, (3µm, 
250 x 4.6 mm) 







min, sonicate for 5 
min. Let stand in 
the dark for 60 min. 
Centrifuge and filter 
the supernatant. 
buffer (pH 2.95) at flow 
rate of 1ml/min 
Multivitamin 
tab- 
lets/ B1, B2, B3, 
B5, B6, B7, B9, 
C (19) 
Mix ground sample 
with water 
containing 0.024% 
ammonia, shake for 
1 min. Sonicate for 
30 min at 60°C. 
Cool down and 
adjust pH to 7 with 
formic acid. Filter 
supernatant 
Spherigel C18, 5µm, 
250x4.6 mm 
Mobile phase—gradient 
with 5mM HFBA and 
methanol at flow rate of 1 












slightly more than 
1/10th of an average 
tablet (0.1527 g) 
into red-colored 50-
ml volumetric 
flasks, and bring to 
volume with 10 mM 
phosphate buffer 
(pH 2.5). 
Hydro-RP C18, (4µm, 250 
x 2.0mm) 
Mobile phase: (A) 0.1% 
formic acid in water and 
(B) 0.1% formic acid  in  
acetonitrile 
MS ESI+ with 
MRM 





B2, B3, B6 (21) 
Weigh 5-8g sample 
in a 100 mL flask, 
add 45 mL 0.1N 
H2SO4. Sonicate for 
1hr. Transfer the 
solution to a 100ml 
volumetric flask, fill 
with methanol and 
store at -18°C for 
one hour. Mix and 
filter. 
Spherisorb ODS-2 C18, 
(5µm, 150 x 4.6 mm) 
Mobile phase: acetonitrile, 
aqueous phase (5 mmol/L 
hexanesulfonic acid, 0.15% 
TEA, adjusted with 10% 
H2SO4 to pH 2.8) and 
methanol 










samples in 50-mL 
graded polyethylene 
centrifuge tubes, 
add 25 mL with 2% 
(m/v) 
metaphosphoric 
Waters XTerra MS C18, 
(5µm, 250 x 4.6 mm) 
Mobile phase: gradient 
with (A) 0.02% (m/v) TFA  
in water and (B) 0.02% 
TFA 90:10 methanol/water 
(v/v%) 
UV 266 nm 
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acid, shake for 
10min. Centrifuge 
and filter. Add 5 ml 
of 1% (m/v) L-
cysteine solution 
and asjust pH to 7.0 










Dilute 5ml syrup in 
a 25-ml flask with 
0.1% (m/v) o-
phosphoric acid 
Zorbax SB-Aq C18, 5µm, 
250x4.6 mm 
Mobile phase: gradient 
with (A) 0.0125 M hexane-
1-sulfonic acid sodium salt 
in 0.1% (m/v) o-phosphoric 
acid, pH 2.4–2.5 and (B) 
acetonitrile at the flow rate 
of 1 mL/min . 
UV 210 nm for 
vitamins C, B6 
and B5; 254 nm 
for vitamins C, 





Add BHT to 2g 
homogenized 
sample. Clean-up 
with C18 sorbent.  
Alltima C18, (5µm, 250 x 
4.6mm) 
Mobile phase: 5 mM 






B1, B2, B3, B5, 
B6 (25)  
Mix sample with 
5mM HCl 20% 
methanol extraction 
solvent. Sonicate, 
adjust pH to 4.5-5.5. 
Filter 
Zorbax XDB C18, 3.5µm, 
100x2.1mm 
Mobile phase: 0.1% acetic 









slightly more than 
1/10th of an average 
tablet (0.1527 g) 
into red-colored 50-
ml volumetric 
flasks, and bring to 
volume with 10 mM 
phosphate buffer 
(pH 2.0). 
Hydro-RP C18, (4µm, 250 
x 2.0 mm) 
Mobile phase: gradient 
with (A) 0.1% formic acid 
in water and (B) 0.1% 
formic acid  in  acetonitrile 
MS ESI+ with 
MRM 







N/A Hydro-RP C18, (4 µm, 250 
x 2.0mm). Mobile phase: 
(A) 0.1% formic acid in 
water and (B) 0.1% formic 
acid  in  acetonitrile 




(27)  SeQuant ZIC-HILIC 
3.5µm, 150x2.0 mm. 
Mobile phase: (A) 20mM 
pH3.7 formic 
acid/ammonium formate  
and (B) 0.1%  formic  acid 
in acetonitrile   
Fortified foods/ 
B1, B2, B3, B6, 
B9 and C (28) 
Weigh 
homogenized 
samples in 50-ml 
graded polyethylene 
centrifuge tubes, 
add 25 ml with 2% 
(m/v) 
metaphosphoric 
acid, shake for 
10min. Centrifuge 
and filter. Add 5 ml 
of 1% (m/v) L-
cysteine solution 
and asjust pH to 7.0 
with ammonia or 
metaphosphoric 
solution. 
Restek Ultra Aqueous C18 
(5µm, 150 x 3.2 mm) 
Mobile phase: (A) 0.1% 
formic acid in water and 
(B) 0.1% formic acid  in  
methanol 
 






Place 0.5 g of 
sample in a 15 mL 
plastic tube with 2.0 
mL of water. 
Homogenize for 
3min at room 
temperature, add 6.0 
ml of acetonitrile. 
Centrifuge, 
evaporate to dryness 
and reconstitute 
with water.  
Develosil RPAQUEOUS 
C30 (5µm, 250 x 4.6mm) 
Mobile phase: 20 mM 
phosphate buffer (pH 3.0) 
and acetonitrile 







3.2 Materials and methods 
3.2.1. Standards and reagents 
 Vitamin standards were purchased from different suppliers/manufacturers: 
thiamine hydrochloride, pyridoxine hydrochloride and cyanocobalamin from Enzo Life 
Sciences (Farmingdale, NY); riboflavin from Eastman Kodak Co. (Rochester, NY), 
ascorbic acid from Fisher Scientific (New Jersey, USA), pantothenic from Sigma-Aldrich 
(St. Louis, MO, USA) , niacinamide and biotin from Acros Organics (New Jersey, USA), 
folic acid from ICN Nutritional Biochemicals (Cleveland, O., USA). All reagents are of 
analytical grade.  
 HPLC grade acetonitrile was purchased from Fisher Scientific (New Jersey, 
USA). Trifluoroacetic acid 99% (TFA) and formic acid 99% were obtained from Acros 
Organics (New Jersey, USA). Water was purified using a Millipore Synergy UV system 
(Millipore Billerica, MA, USA). Mobile phase pH was measured using UB-10 pH meter 
from Denver Instrument (New York, USA). 
 
3.2.2. Standard preparation  
 Stock individual solutions of thiamine, pyridoxine, cyanocobalamin and ascorbic 
acid were prepared monthly at concentration of 1000 ppm (1 mg/mL) in Millipore-
purified water. Riboflavin, biotin and folic acid were also prepared at 1000 ppm by 
dissolving 10 mg of the components into 10 mL of 0.5% sodium hydroxide. These stock 
solutions were kept in 1.5 mL Eppendorf tubes and stored at -80oC to avoid degradation. 
Working solutions of vitamin standards were prepared daily by mixing and diluting 
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individual stock solutions in water to desired concentrations. Preparation steps were 
performed in the subdued light condition using glasswares covered with foil to prevent 
vitamins from degradation, especially vitamin B2, B6 and B12. 
 
3.2.3 Stability study 
 The nine analytes were divided into two groups: group 1 includes thiamine, 
pyridoxine, niacinamide and ascorbic acid; group 2 includes pantothenic acid, folic acid, 
cyanocobalamin, riboflavin and biotin. In each group, mixtures were adjusted to three 
different pH ranges (acidic 2.0-3.0, neutral 6.0-7.0 and basic 9.0-10.0) with either 0.1% 
formic acid or 0.05% NaOH. Chromatographic conditions for monitoring the stability of 
all compounds in two groups are provided in Table 3.2. Each group was tested separately 
on two different days. Stability graphs were obtained by plotting peak areas of thiamine, 
niacinamide and ascorbic acid at 254 nm, pyridoxine and riboflavin at 280 nm and 
pantothenic acid, folic acid, cyanocobalamin and biotin at 210 nm against time.   
Table 3.2 Chromatographic conditions for stability study 
LC systems Shimadzu SIL-20A HT auto-sampler, 
Shimadzu LC-20AT liquid chromatograph, 
Shimadzu DGU-20A5 degasser and 
Shimadzu SPD-20A UV-Vis detector. 
Column YMC Pack Pro C18 3.5µm, 150x4.6mm 
Column temperature Ambient 
Mobile phase A 0.1% formic acid in water  
Mobile phase B Acetonitrile 
Flow rate 1.0 ml/min  
Detection UV 254 mn and 280 nm for Group I 
UV 210 nm and 280 nm for Group II 
Run time 10 min for Group I and 15min for Group II 
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3.2.4 Vitamin analysis by DAD-ELSD and LCMS 
3.2.4.1 Sample preparation 
 Three brands of multivitamin tablets, two brands of fortified cereals and one 
brand of infant formula were purchased from the local grocery stores.  
 For multivitamin tablets, a composite of ten counts of each brand was ground into 
fine powder and a portion equivalent to one tablet was weighed into a 100 ml volumetric 
flask covered with foil. About 50 mL of NaOH 0.05% was added into the flask and the 
mixture was vigorously shaken and sonicated in the dark for 10 min. The pH of the 
mixture was then adjusted with 1% formic acid before the final solution was brought to 
the mark with deionized water. The extract was run through a 0.45 µm nylon membrane 
filter before the injection. 
 For fortified cereals, 1.0 gram of each brand was weighed into 15 mL plastic 
centrifuge tube and mixed with 10 mL deionized water. The mixture was vortexed to mix 
thoroughly, sonicated for 10 min in the dark with intermittent shaking and centrifuged at 
5000 rpm for 10 min at 4oC. The supernatant was filtered through a 0.45µm nylon 
membrane, then ready for the analysis. 
 For infant formula, about 10.0 gram of the powder was mixed with 20 mL of 
deionized water in a 50 mL plastic centrifuge tube. The mixture was vortexed and 
sonicated for 10 min then 200 µL formic acid was added to precipitate protein in the 
sample. Following vigorous shaking, the mixture was centrifuged at 5000rpm for 10min 
at 4oC. The supernatant was filtered through a 0.45 µm nylon membrane, then ready for 
the analysis. 
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3.2.4.2 Chromatographic conditions 
Table 3.3 Chromatographic conditions for DAD-ELSD 
LC systems Shimadzu LC-20AT Liquid chromatograph, Shimadzu DGU-20A5 
Degasser, Shimadzu CTO-20A Column oven, Shimadzu CBM-
20A Communication bus module, Shimadzu SPD-M20A Diode 
array detector, ELSD-LTII Low-temperature evaporative light 
scattering detector 
Column YMC Pack Pro C18 (3.5µm, 150 x 4.6mm) 
Column temperature Ambient 
Mobile phase A 0.025% TFA in water  
Mobile phase B Acetonitrile 
Flow rate 1.0 mL/min  
Injection volume 20 µL 
DAD 190 to 400 nm 
ELSD Nebulizer temperature 40C, Gas pressure 350KPa, Gain 8 
Gradient Time %A %B 
0min 100 0 
1min 100 0 
4min 84 16 
9min 84 16 
9.1min 100 0 













Table 3.4 Chromatographic conditions for LCMS 
LC systems Agilent Technologies 1200 Series LC system consisted of G1379B 
Degasser, G1312A Binary pump, G1329A Autosampler, G1316A 
Thermostatted column compartment and G1314B Variable 
wavelength detector 
Column Agilent Zorbax SB-Aq, (3.5 µm, 4.6 x 100 mm) 
Column temperature Ambient 
Mobile phase A 0.1% formic acid in water  
Mobile phase B Acetonitrile 
Flow rate 0.6 mL/min 
Injection volume 10 µL 
UV Detection 254nm from 0 min to 11.5 min, 210 nm from 11.5 min to 18.5 min, 
254 nm from 118.5 min till stop 
MS Condition API-ES+, drying gas flow 12.0 L/min, drying gas temperature 
350oC, nebulizer pressure 45 psig, capillary voltage 4000V 
Gradient Time %A %B 
0min 100 0 
5min 100 0 
6min 85 15 
15min 85 15 
15.1min 20 80 
17min 20 80 
17.1min 100 0 
25min Stop  
 
 
3.3 Results and discussion 
3.3.1 Stability study 
3.3.1.1 Vitamin stability 
 Originally, this project intended to focus on the analysis of the five water-soluble 
vitamins introduced in chapter 1, including thiamine, pyridoxine, ascorbic, riboflavin and 
cyanocobalamin only. However, when optimizing the HPLC methods for the analysis of 
those five vitamins in the samples, the interferences from other vitamins in the samples 
must be resolved from them. The optimized method ended up separating all water-soluble 
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vitamins in the sample. Consequently, the project was expanded to the analysis of all nine 
water-soluble vitamins in pharmaceuticals and functional food products. This stability 
study serves as a preliminary screening for the optimization of standard storage and 
sample extraction procedures. Stability of all the water-soluble vitamins was tested in 
three different pH conditions (acidic, basic and neutral) over a 24-hour period in HPC 
vials at ambient temperature.  
 Pyridoxine and niacinamide were the most stable at all pH conditions. All the 
analytes were stored in amber HPLC vials at ambient temperature in the autosampler. It 
is the limited light exposure that protected pyridoxine from degradation. Thiamine was 
stable in acidic and neutral pH but steadily degraded over a one-day period. Ascorbic 
acid is the least stable analyte of all with degradation being observed under all three pH 
conditions. It degraded extremely fast under basic pH with only less than 0.5% left after 5 
hours. Steady degradation was observed for the neutral condition while it is the most 
stable in acidic pH.  
 It is hard to explain the unexpectedly increasing trend of pantothenic at acidic pH 
and biotin at basic pH. The former underwent a steady degradation of more than 20% by 
the end of the testing period under the basic condition while appearing stable under the 
neutral condition. The latter showed high stability at both acidic and neutral pH.  
 Cyanocobalamin and riboflavin are susceptible to degradation in basic solution 
while being more stable in the other two pH ranges. Folic acid has no sign of degradation 
under neutral and basic condition but it shows a dramatic decrease in detection response 
under acidic pH. Folic acid is notorious for its solubility dependence on solution pH; 
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therefore this behavior needs to be examined more carefully to determine if a degradation 
or solubility issue or both are to be responsible.  
  
 Thiamine Pyridoxine 
 
 Ascorbic Niacinamide 
 
 Pantothenic Folic 
Figure 3.1 Stability of nine water-soluble vitamins in neutral, acidic and basic solutions 
within one day period 
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 Cyanocobalamin Riboflavin 
 
Biotin 
Figure 3.1 (continued) 
3.3.1.2 Sample extraction procedure 
 Solubility and stability of the vitamin analytes present a real challenge for 
designing an optimal extraction procedure. Riboflavin, biotin and folic acid are the three 
compounds with the lowest solubility in the water-soluble vitamin group. Riboflavin is 
limitedly soluble in distilled water and slightly more soluble in an acidic condition. 
Literature cited the solubility of riboflavin in water as up to 0.013 g per 100 mL, equal to 
about 130 ppm (30). However, this optimal solubility can only be reached with heating 
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and agitation for a prolonged period of time (31). Considering the stability issue of 
vitamins, high temperature and long preparation time should be avoided. On the other 
hand, a basic solution is an alternative as riboflavin is dissolved much more easily at high 
pH condition. Stock solution of riboflavin was prepared in 0.05% NaOH. Though 
riboflavin is slightly unstable in such a high pH condition, the storage of its stock solution 
at -80oC managed to avoid possible degradation. When a working solution is needed, the 
adjustment of pH is maybe needed if the solution is planned to be used for an extensive 
amount of time. 
 Biotin and folic acid are also prepared and stored as riboflavin due to their higher 
solubility in basic solution (30). However, as the sample extraction may involve the 
adjustment of pH, it is questionable if the analyte may fall out of solution when brought 
from high pH to neutral or acidic pH. When evaluating the peak areas for stability, it was 
noticed that the peak area of biotin and riboflavin were about the same at all three 
different pH conditions, which means they did not fall out of the solution after being 
diluted from their basic stock solution. However, the result for folic acid showed 
otherwise when its stock was diluted with acidic solution. 
 In order to ensure that that these three low-soluble vitamins were completely 
extracted from the multivitamin tablet, basic condition was used first before the solution 
was adjusted back to the neutral pH. The extraction procedures were modified a little for 
fortified food samples. Because the three vitamins with low solubility occur in small 
amount in these samples, high pH was not required for their optimal extraction. Fortified 
cereals were only extracted in deionized water. Infant formula, on the other hand, 
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requires acidic treatment with 0.1% formic acid (pH~2.7) for the removal of its protein 
content. However, the amount of folic acid added in infant formula is so small that it is 
within the solubility limit of this compound at pH 2.7 of the extractant (32).  
 
3.3.2 Multivitamin analysis using DAD-ELSD 
3.3.2.1 Chromatographic conditions 
 The chromatography of all nine water-soluble vitamins was performed on YMC 
Pack Pro C18 column (150 x 4.6mm, 3.5 µm). TFA was used in the aqueous mobile 
phase at the concentration of 0.025%. This small amount of TFA is sufficient to maintain 
the low pH of 2.6 for the mobile phase while significantly enhancing the retention of 
thiamine and does not cause much of baseline shift at low wavelength, where pantothenic 
and biotin are detected. Moreover, this volatile acid modifier is suitable for ELS detector 
which is run in tandem with DAD.  
 DAD detector was set to collect signals within the range of 190-400 nm. Due to 
their diverse molecular structures and different spectroscopic properties, it is impossible 
to choose a single wavelength for the detection of all nine water-soluble vitamins. The 
maximum absorbance is normally chosen. However, the interference of impurities at 
certain wavelengths around the maxima is also an important factor to be considered. The 
selected wavelengths should produce a high absorbance signals for the analytes of 
interest without much background interference. In the case of biotin and pantothenic, due 
to their lack of chromophores, the wavelength choice is quite limited. For the purpose of 
quantification, three following single wavelengths were used: 210 nm for pantothenic 
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acid, cyanocobalamin and biotin; 254 nm for thiamine, ascorbic acid, niacinamide and 
riboflavin; 280 nm for pyridoxine and folic acid. Chromatograms at these wavelengths 
were displayed in Figure 3.2. 
 UV-Vis detector is moderately selective because their response to analytes is 
dependent on the analytes’ light absorbing property at certain wavelengths (33). 
However, the detector may partially become universal used at low wavelengths (195 nm 
to 210 nm) because most organic compounds respond more or less within this range (34). 
This characteristic is taken advantage for the detection of pantothenic acid and biotin, 
both of which lack chromophores, at 210 nm for this HPLC method. One drawback of 
detection at such a wavelength is the shifted baseline and noisy background, which may 
significantly reduce the detection sensitivity (35). 
 ELSD measures the amount of light scattered by particles in the eluent after the 
mobile phase has evaporated. In that sense, ELSD responds to all compounds that do not 
evaporate or decompose, hence being considered as a nearly universal detector (36-38). 
The chromatogram in Figure 3.3 shows the separation of all nine water-soluble vitamins, 
including the two non-chromaphoric pantothenic and biotin. The peak size of the analytes 
(except for niancinamide) at the same concentration in ELSD is more uniform than that in 
DAD. This uniformity in response factor is due to the fact that the output given by ELSD 
reflects the quantity of total analyte in the sample that causes light scattering (33).   
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Figure 3.3 HPLC-ELSD chromatograms of nine water-soluble vitamin standards 
3.3.2.2 Calibration range, reproducibility, LOD-LOQ 
 Before the sample analysis, method precision was evaluated with RSDs of 
retention time and peak area calculated for 7 replicate injections. Calibration range varies 
depending on the amount of vitamins contained in the multivitamin tablet samples. Three 
replicates of the standard mixtures at five or six concentration levels were obtained for 
the standard curve. LOD and LOQ were determined by the analyte concentration which 






B12 B2 B7 
C 
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respectively (S/N=3 for LOD and S/N=10 for LOQ). RSDs, linearity range, LOD, LOQ 
and correlation coefficient are reported in Table 3.5 for DAD and Table 3.6 for ELSD.   
 Because DAD and ELSD were run in tandem, their retention repeatability was 
similar and quite high, which is demonstrated by the low RSDs. However, the same does 
not go for the signal produced by the two detectors. As noticed from the comparison of 
the two detectors, the area repeatability of ELSD is lower than DAD, shown through its 
high RSDs for all analytes. In general, DAD has a LOQ about 100 times lower than 
ELSD, which means the former has a much higher sensitivity than the latter. Though this 
result is expected, it is open to question if ELSD sensitivity level can be improved. For 
ELSD detection in this method, the gain number was empirically determined to give the 
highest possible S/N ratio for the analytes tested. However, signal optimization was not 
performed for the nebulizer temperature, which may have been the culprit for the low 
sensitivity of the detection. It is worth mentioning that the mobile phase containing a 
significantly high percentage of water may have required a higher nebulizer temperature 
to completely vaporize. At the temperature set up for this method (40oC), it is possible 
that the eluent did not evaporate completely, leading to signal suppression of the analyte 
and a noise baseline (39, 40). In order to ensure adequate eluent evaporation, either a 
lower mobile phase flow rate or a higher nebulizer temperature is needed. However, 
when the nebulizer temperature adjustment approach is taken, possible thermal 




Table 3.5  Linear dynamic range, correlation coefficients (r2), limits of detection (LOD), 
limits of quantitation (LOQ) and precision of the DAD detector for the determination of 





























B1 254 2.02 0.9998 0.39-100 4.86 16.20 0.26 0.21 
C 254 3.35 0.9998 0.39-100 10.25 34.17 0.44 1.41 
B3 254 4.07 0.9999 0.39-100 6.86 22.85 0.40 0.27 
B6 280 5.03 0.9995 0.39-250 1.51 5.04 0.43 0.68 
B5 210 6.36 0.9998 0.39-250 7.71 25.70 0.07 0.77 
B9 280 7.14 0.9959 0.19-12.5 2.65 8.85 0.12 0.68 
B12 210 7.77 0.9998 0.19-6.25 8.01 26.69 0.15 0.58 
B2 210 9.36 0.9996 0.39-100 2.95 9.82 0.21 0.43 
B7 210 10.12 0.9997 0.19-6.25 42.36 141.19 0.22 0.37 
 
Table 3.6  Linear dynamic range, correlation coefficients (r2), limits of detection (LOD), 
limits of quantitation (LOQ) and precision of the ELSD detector for the determination of 




















B1 2.20 0.9981 3.125-100 0.71 2.36 0.31 3.47 
C 3.54 0.9967 3.125-100 1.71 5.70 0.40 3.21 
B3 4.25 0.9956 3.125-100 0.62 2.06 0.24 4.05 
B6 5.22 0.9987 3.125-100 0.57 1.91 0.33 2.99 
B5 6.54 0.9980 3.125-100 0.84 2.78 0.08 3.01 
B9 7.33 0.9832 3.125-100 1.43 4.75 0.10 3.44 
B12 7.95 0.9975 3.125-100 1.28 4.27 0.14 2.43 
B2 9.54 0.9982 3.125-100 0.63 2.10 0.14 2.36 
B7 10.32 0.9988 3.125-100 0.71 2.36 0.16 3.77 
 
 With higher LOQs for all analytes, ELSD has a much narrower calibration range 
than DAD. The response produced by ELSD do not follow the normal linearity but rather 
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an exponential relationship y= a.mb (37, 41). According to this function, the observed 
peak area (A) and the sample mass on-column (m) are related to each other through the 
relationship described by the exponent b and the response factor a. These two coefficients 
a and b are dependent on a variety of factors including droplet size, concentration, solute 
nature, gas and liquid flow rates, nebulizer temperature, etc. The calibration curve for 
thiamine response using ELSD is given in Figure 3.4 as a demonstration.  
 








































Figure 3.5 ELSD chromatogram of Brand A tablet sample 
Minutes




























Figure 3.6 DAD chromatogram of brand A tablet sample 
 
Minutes




























































































































































B1 2.02 0.31 0.47 1.80 mg 1.5 mg 
C 3.32 0.09 8.73 38.86 mg 60 mg 
B3 4.11 0.07 0.53 22.48 mg 20 mg 
B6 5.03 0.08 0.39 2.64 mg 2 mg 
B5 6.34 0.04 0.23 13.12 mg 10 mg 
B9 7.12 0.04 2.64 105.82 µg 400 µg 
B12 7.73 0.55 4.99 ND 6 µg 
B2 9.34 0.05 0.90 2.13 mg 1.7 mg 
B7 10.09 0.03 2.21 45.19 µg 30 µg 
Brand B 
B1 1.97 0.77 0.52 11.20 mg 10 mg 
C 3.29 0.44 0.42 259.98 mg 300 mg 
B3 4.10 0.29 0.77 98.01 mg 100 mg 
B6 5.03 0.24 0.44 11.74 mg 10 mg 
B5 6.34 0.06 0.71 53.41 mg 50 mg 
B9 7.13 0.06 3.08 143.69 µg 400 µg 
B12 7.75 0.14 0.94 62.05 µg 75 µg 
B2 9.32 0.09 0.88 9.53 mg 10 mg 
B7 10.09 0.10 2.20 32.10 µg 30 µg 
Brand C 
B1 2.02 0.52 0.38 166.45 mg 125 mg 
C 3.34 0.24 0.46 94.76 mg 125 mg 
B3 4.04 0.15 0.20 126.91 mg 125 mg 
B6 5.03 0.12 0.73 159.28 mg 125 mg 
B5 6.35 0.07 0.14 145.50 mg 125 mg 
B9 7.13 0.03 1.80 383.29 µg 400 µg 
B12 7.75 0.03 1.74 159.67 µg 125 µg 
B2 9.35 0.07 0.73 136.32 mg 125 mg 






Table 3.8 Analysis results of multivitamin tablets by ELSD 




















B1 / / / ND 1.5 mg 
C 3.50 0.18 11.73 36.96 mg 60 mg 
B3 4.37 0.37 2.47 23.02 mg 20 mg 
B6 5.21 0.13 4.61 2.69 mg 2 mg 
B5 6.52 0.10 2.62 12.95 mg 10 mg 
B9 / / / ND 400 µg 
B12 / / / ND 6 µg 
B2 9.52 0.09 4.14 2.21 mg 1.7 mg 
B7 / / / ND 30 µg 
Brand B 
B1 / / / ND 10 mg 
C 3.52 0.26 2.14 226.17 mg 300 mg 
B3 4.26 0.24 1.14 99.22 mg 100 mg 
B6 5.22 0.21 7.16 12.44 mg 10 mg 
B5 6.54 0.03 1.69 52.35 mg 50 mg 
B9 / / / ND 400 µg 
B12 / / / ND 75 µg 
B2 9.51 0.08 2.07 11.68 mg 10 mg 
B7 / / / ND 30 µg 
Brand C 
B1 2.19 0.69 2.91 166.57 mg 125 mg 
C 3.52 0.33 1.77 92.32 mg 125 mg 
B3 4.22 0.30 2.00 128.40 mg 125 mg 
B6 5.22 0.07 2.94 156.99 mg 125 mg 
B5 6.53 0.06 1.62 125.57 mg 125 mg 
B9 / / / ND 400 µg 
B12 / / / ND 125 µg 
B2 9.54 0.02 1.83 132.41 mg 125 mg 



















B1 1.5 mg 1.80 mg ND NA NA 
C 60 mg 38.86 mg 36.96 mg 0.0915 - 
B3 20 mg 22.48 mg 23.02 mg 0.0899 - 
B6 2 mg 2.64 mg 2.69 mg 0.6172 - 
B5 10 mg 13.12 mg 12.95 mg 0.2572 - 
B9 400 µg 105.82 µg ND NA NA 
B12 6 µg ND ND NA NA 
B2 1.7 mg 2.13 mg 2.21 mg 0.4452 - 
B7 30 ug 45.19 µg ND NA NA 
B 
B1 10 mg 11.20 mg ND NA NA 
C 300 mg 259.98 mg 226.17 mg 0.0039 ** 
B3 100 mg 98.01 mg 99.22 mg 0.0425 * 
B6 10 mg 11.74 mg 12.44 mg 0.0951 - 
B5 50 mg 53.41 mg 52.35 mg 0.1028 - 
B9 400 µg 143.69 µg ND NA NA 
B12 75 µg 62.05 µg ND NA NA 
B2 10 mg 9.53 mg 11.68 mg 0.0017 ** 
B7 30 µg 32.10 µg ND NA NA 
C 
B1 125 mg 166.45 mg 166.57 mg 0.9613 - 
C 125 mg 94.76 mg 92.32 mg 0.0928 - 
B3 125 mg 126.91 mg 128.40 mg 0.3008 - 
B6 125 mg 159.28 mg 156.99 mg 0.1649 - 
B5 125 mg 145.50 mg 125.57 mg 0.0008 ** 
B9 400 µg 383.29 ug ND NA NA 
B12 125 µg 159.67 ug ND NA NA 
B2 125 mg 136.32 mg 132.41 mg 0.0360 * 
B7 125 µg 256.46 ug ND NA NA 







3.3.2.3 Comparing DAD and ELSD results 
 Typical ELSD and DAD chromatograms of the multivitamin tablet samples are 
displayed in Figure 3.5 and 3.6. Analytical results of vitamin content determined by both 
detectors were provided in Table 3.7 and Table 3.8. Most of the water-soluble vitamins 
added into the supplements were detectable by DAD except for the too low amount of 
cyanocobalamin in brand A tablet. In contrast, due to much lower sensitivity, the number 
of analytes detected and quantified by ELSD is lower than that by DAD. The three 
vitamins added in the smallest amount biotin, folic acid and cyanocobalamin were below 
LOD in all tested samples. Thiamine co-eluted with other interferents at the beginning of 
the chromatogram in brand A and brand B extracts; therefore it was undetectable in those 
two samples. The remaining five vitamins (B3, B5, B6, B2 and C) were all detected and 
quantified in all three brands by ELSD.  
 A paired t-test was used to compare the mean amount of water-soluble vitamins 
per tablet found by DAD and ELSD for all three brands. The statistical analysis was 
performed by SAS  9.3 (SAS Institute Inc. Cary, NC, USA). Comparison was only made 
for those vitamins that were detected by both detectors, as shown in Table 3.9. The 
results found by the two detectors for the five vitamins in brand A are not significantly 
different at the significance level of 0.05 (α=0.05). For brand B, except for pantothenic 
(B5) and pyridoxine (B6), the other three were found to differ significantly between the 
results given by the two detectors. The mean amounts of ascorbic acid (C) and riboflavin 
(B2) are different at α=0.01 while those of niacinamide (B3) are different at α=0.05. Out 
of six paired comparison made for brand C, the amounts of thiamine (B1), ascorbic (C), 
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niacinamide (B3) and pyridoxine (B6) are significantly the same between the two 
detectors. Difference was found for pantothenic (B5) at α=0.01 and riboflavin (B2) at 
α=0.05. 
 
3.3.3 Multivitamin analysis using LC-MS 
3.3.3.1 Chromatographic conditions 
 The chromatography of all nine water-soluble vitamins was performed on Agilent 
Zorbax SB-Aq column (3.5 µm, 4.6x100mm). TFA was not chosen to be used as an 
additive in the mobile phase because of a concern about its possible adverse effect on MS 
detection. This perfulorinated acid has a high surface tension that prevents efficient spray 
formation and in the gas phase, its ions can ion pair with basic analytes, leading to 
analyte ionization suppression (42, 43). As a result, formic acid 0.1% was used instead as 
the mobile phase for this method.  In order to maximize the signal, low flow rate is 
recommended for highly aqueous mobile phase. Higher flow rate is possible for a faster 
run as long as the volume of effluent going to the MS detector is maintained adequately 
low. However, due to the lack of flow splitter, the flow rate for this method was set at 0.6 
mL/min as a compromise between the analysis time and enhanced MS signal. The LC 
system was equipped with a variable wavelength UV detector connected ahead of the MS 
detector. Different wavelengths were set up for the nine analytes as stated in Table 3.4. 
However, the UV detector was not used for the purpose of identification and quantitation 
of the vitamin content in the fortified food samples due to its low specificity and 
sensitivity. 
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Thiamine 337 265.1 70 
Ascorbic 176 177.1 70 
3.50 Pyridoxine 169 170.1 70 
5.50 Niacinamide 122 123.1 100 
9.00 Pantothenic 219 220.1 80 
11.50 
Folic 441 295.1 140 
Riboflavin 376 377.1 140 
Biotin 244 227.1 140 
15.50 Cyanocobalamin 1356 678.4 140 
 
 Compounds with different structures respond differently to the fragmentor setting. 
The ideal fragmentation voltage for each vitamin analyte was determined through flow 
injection analysis which involves the injection of the standards multiple times without a 
column. The fragmentor was set up to change over time and both positive and negative 
ionization mode were tested for every single vitamin. Based on the mass signal of the 
standards under different fragmentor voltage, the optimal setting was decided as in Table 
3.10. All nine analytes respond well in positive ionization mode while only folic and 
ascorbic respond in the negative ionization mode. Because the Agilent 6100 LCMS 
model cannot alternate the two ionization modes, it was decided that the positive mode 
was to be used for the analysis. Flow injection analysis mode was also used to select the 
ionization mode, the drying gas flow and temperature and the nebulizer pressure. The last 
two parameters are dependent on LC flow rate and mobile phase composition. For LC 
flow rate higher than 0.3 mL/min, it is recommended that the flow rate of nitrogen drying 
gas be fixed at 13 L/min. Moreover, due to the high percentage of aqueous components in 
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the mobile phase, the drying gas temperature of 350oC and the nebulizer pressure of 45 
psi were used. Finally the capillary voltage was set at 4000 psi. 
 The mass spectra of almost all water-soluble vitamins display the protonated 
molecular ion [M+H]+ as the base peak. Thiamine was detected as [M]+ instead of 
[M+H]+. Cyanocobalamin mass to charge ratio (m/z=678.4) was only half the value 
suggested in its empirical formula C63H88CoN14O14P. In fact, this compound was detected 
as a double charge species [M+H]+ (24, 44). Chromatograms of LCMS method for the 
determination of all water-soluble vitamins are included in Figure 3.7 and 3.8.  
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3.3.3.2 Method validation and analysis results 
 Method precision was evaluated with %RSDs of retention time and peak area 
calculated for 7 replicate injections. Calibration range varies depending on the quantity of 
vitamins contained in the fortified food samples. Three replicates of the standard 
mixtures at three or four concentration levels were obtained for the standard curve. LOD 
and LOQ were determined by the analyte concentration which produced signals of peak 
height three times and ten times the background noise respectively (S/N=3 for LOD and 
S/N=10 for LOQ). RSDs, linearity range, LOD, LOQ and correlation coefficient are 
reported in Table 3.11. 
 The chromatograms for the three samples were shown in Figure 3.9, 3.10 and 
3.11. The results of the vitamin content determination with MS detection were presented 
in Table 3.12. Though pantothenic was not listed on the nutritional labels of the fortified 
cereals, it was actually detected at a quantifiable amount in both samples. 
Cyanocobalamin was added in fortified foods at such a small amount that it was only 
detectable in cereal brand B. Thiamine in infant formula did not show in one single peak 
but a group of non-baseline-separated peaks instead as demonstrated in Figure 3.11. 
There was a big shift in biotin retention time as it eluted much earlier than it did in the 
standard mixture solution (11.8 min in the infant formula sample v.s 14.3 min in standard 
mixture). The identity of the peak was confirmed by its mass spectrum. As a result, both 
thiamine and biotin were not quantified. These strange behaviors were possibly due to the 
matrix effects. In fact, complicated matrices of food samples may have caused a shift in 
retention time to other analytes in comparison to that of the standards, as shown in Table 
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3.13. The retention time shift of the water-soluble vitamins in fortified cereals is within 
3% range of the standard retention time. The range is higher in the infant formula sample 
with biotin being the extreme case with 17.62% deviation in retention time. Though peak 
identification in LCMS method is not entirely dependent on retention time, a tighter 
retention window is highly recommended for accurate quantification of the analytes. In 
order to factor in the effects of the complicated matrix in food samples, inter standard 
approach should be considered for future work.  
Table 3.11 Linear dynamic range, correlation coefficients (r2), limits of detection (LOD), 
limits of quantitation (LOQ) and precision of the LCMS method for the determination of 


























B1 265.1 2.14 0.9988 0.78-3.12 0.24 0.80 0.78 2.69 
C 177.1 2.80 0.9963 6.25-50 2.92 9.75 0.06 2.67 
B6 170.1 4.21 0.9981 0.39-12.5 0.77 2.56 0.36 3.36 
B3 123.1 6.13 0.9937 6.25-50 5.17 17.24 0.60 4.84 
B5 220.1 10.10 0.9938 0.048-12.5 0.59 1.97 0.06 4.73 
B9 295.1 12.89 0.9988 0.09-1.56 1.48 4.92 0.33 2.02 
B2 377.1 13.77 0.9959 0.39-6.25 0.46 1.52 0.16 1.68 
B7 227.1 14.30 0.9996 0.024-0.097 1.37 4.55 0.24 2.49 
B12 678.4 16.10 0.9997 0.012-3.12 1.63 5.44 0.44 1.84 
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Figure 3.9 LCMS chromatogram of brand A cereal sample 
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Table 3.12 Analysis results of fortified foods by LCMS 



















Cereal Brand A 
B1 2.18 0.07 2.50 2.31 mg 1.34 mg 
C 2.79 0.04 20.66 1.63 mg 21.43 mg 
B6 4.23 0.05 0.37 1.95 mg 1.79 mg 
B3 6.06 0.38 0.26 17.49 mg 17.86 mg 
B5 10.15 0.49 2.09 0.15 mg / 
B9 13.20 0.78 0.38 0.35 mg 0.71 mg 
B2 14.10 0.72 0.58 1.58 mg 1.52 mg 
B7 ND / / ND / 
B12 ND / / ND 5.36 ug 
Cereal Brand B 
B1 2.16 0.28 0.71 1.95 mg 1.69 mg 
C 2.80 0.07 2.81 17.33 mg 67.74 mg 
B6 4.19 0.24 0.57 10.53 mg 6.45 mg 
B3 6.03 0.27 0.47 18.22 mg 22.58 mg 
B5 10.14 0.06 3.04 0.14 mg / 
B9 13.07 0.32 0.79 0.86 mg 1.29 mg 
B2 13.96 0.18 1.21 4.62 mg 1.92 mg 
B7 / / / ND / 
B12 16.58 0.18 2.42 23.88 µg 19.36 µg 
Infant formula 
B1 ND / / ND 0.37 mg 
C 2.79 / / 8.86 mg 55.81 mg 
B6 4.26 0.11 1.33 0.49 mg 0.28 mg 
B3 6.07 0.19 1.77 4.65 mg 4.65 mg 
B5 10.18 0.17 1.60 1.94 mg 2.33 mg 
B9 13.45 0.17 2.35 0.035 mg 0.074 mg 
B2 14.34 0.36 1.42 0.87 mg 0.65 mg 
B7 14.78 / / / 0.014 mg 








Table 3.13 Comparison of retention time in standard solution and in samples 

























B1 2.14 2.18 1.86 2.16 0.92 ND / 
C 2.80 2.79 0.42 2.80 0.06 2.79 0.30 
B6 4.21 4.23 0.46 4.19 0.49 4.26 1.24 
B3 6.13 6.06 1.14 6.03 1.63 6.07 1.02 
B5 10.10 10.15 0.54 10.14 0.44 10.18 0.80 
B9 12.89 13.20 2.39 13.07 1.38 13.45 4.35 
B2 13.77 14.10 2.42 13.96 1.40 14.34 4.15 
B7 14.30 ND / ND / 11.78 17.62 
B12 16.10 ND / 16.58 2.96 ND / 
  
3.3.4 Sample extraction limits 
 Except for infant formula, the final pH of the extract in all samples was neutral 
(6.0-7.0), which is not the best condition to maintain optimal stability for ascorbic acid 
based on results of the stability study. Considering its high amount in the samples, it had 
been expected that ascorbic acid degradation would not be a concern as long as the 
analysis was performed right after the extraction. However, the analysis results proved 
otherwise. The peak area %RSD of this vitamin was extremely high in brand A tablet 
(8.73%) and brand B fortified cereals (20.66%). In comparison to brand B and brand C 
tablets, the amount of ascorbic acid found in brand A was much lower than the labeled 
amount (38.86 mg for DAD and 36.96 mg for ELSD v.s 60 mg labeled). It was possibly 
due to the fact that brand A tablets also contain multi minerals which potentially 
catalyzes the reduction of ascorbic acid. The same situation must have been applied to 
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fortified food samples, considering their complicated matrices. A side study on the 
degradation speed of ascorbic in brand A tablet in acidic and neutral conditions was 
conducted to gain more insight into how to improve this compound’s stability in samples 
high in metal content. According to Figure 3.12, acidic condition was once again 
confirmed to be optimal for its stability. Separate extraction of ascorbic acid under low 
pH condition should be considered for accurate analysis of this vitamin in future work. 
Another alternative is to use antioxidants or metal-chelating agents to slow down ascorbic 
acid’s degradation. 
 Folic acid was also found at a much lower amount than being labeled in all 
samples tested. Further examination may be needed to know if this compound was 
efficiently extracted under the proposed procedures. Folic acid is notorious for its low 
solubility in water, the degree of which greatly depends on the solution pH. Considering 
the low pH of the mobile phase used, it is also open to question if folic acid may have 
fallen out of solution during the separation process inside the column. 
 
Figure 3.12 Stability of ascorbic acid in Brand A tablet sample 
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3.4 Conclusion 
 Simultaneous determination of water-soluble vitamins is complicated by many 
factors. First of all, due to their diverse chemical properties, it is difficult to separate all 
of them in one chromatographic run. On the other hand, their difference in solubility and 
stability presents another challenge with the optimization of sample preparation 
procedures. Furthermore, these vitamins are added into pharmaceuticals and fortified 
food products at different amounts and respond unequally to different modes of detection. 
Among the three detectors used in this study, ELSD is the least feasible for routine 
analysis. In spite of universal response to all vitamins, its sensitivity is too low to even 
allow the detection of those vitamins occurring at high level in pharmaceuticals. DAD, on 
the other hand, provides sufficient specificity and sensitivity to the analysis of 
pharmaceuticals. However, detection at low wavelengths (e.g., 210 nm) required for non-
chromophoric vitamins like pantothenic and biotin is possibly subject to background 
interferences and noisy baseline. LCMS is both universal and highly sensitive, which is 
suitable for the analysis of complicated food matrices like fortified cereals and infant 
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VITAMIN NAMES AND PROPERTIES 
 
Table A.1 Common names and scientific names of  
all water-soluble vitamins in the study 
 
Scientific names Common names 
Thiamine Vitamin B1 
Riboflavin Vitamin B2 
Niacinamide Vitamin B3 
Pantothenic acid Vitamin B5 
Pyridoxine Vitamin B6 
Biotin Vitamin B7  
Folic acid Vitamin B9 
Cyanocobalamin Vitamin B12 



































Physical properties Absorbance 
λmax 
(nm) 







337.26 - White crystalline powder; melting point: 246oC-250oC (decomposition) 
- Solubility: Water-1.0g/ml, Ethanol (95%)-1.0g /100 ml, Glycerol-1.0 g/18 ml. 
Insoluble in ether, benzene, hexane and chloroform 

















327.37 - White to yellow crystals 
- Melting point: 374oC-392oC 
- Density: 0.35 g/cm3 















424.31 - Melting point: 240°C-244°C (decomposition) 








504.29   
a: In 0.1M phosphate buffer, pH 2.9 b: In 0.1M phosphate buffer, pH 5.5 
Sources:  The Merck Index, 13th ed., Merck and Company, Whitehouse Station, NJ, 2001; Eitenmiller, R.R.; Ye, L.; Landen, W.O. 
Vitamin analysis for the health and food sciences. CRC Press: Boca Raton, 2008; Kawasaki, T.; Egi, Y. Thiamine, In Modern 
chromatographic analysis of vitamins, Third Edition, Revised and Expanded ed.; Leenheer, A.P.d., Lambert, W.E., Van Bocxlaer, J.F. and 
NetLibrary, I., Eds.; Marcel Dekker: New York, 2000, Vol.84. pp. 375; Bates, C.J. Thiamine, In Handbook of vitamins, Fourth ed.; 
Zempleni, J., Rucker, R.B. and McCormick D.B., S.J.W., Eds.; CRC Press: Boca Raton, 2007, pp. 253; Ball, G.F.M. Vitamins in foods: 
analysis, bioavailability, and stability. Taylor & Francis: Boca Raton, FL, 2006; Vol. 156 
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Vitamin B 2   
CAS No.  
83-88-5 
C17H20N4O6 376.37 - Fine yellow-orange powder 
- Melting point : 278°C–282°C (decomposition) 
- Solubility: Slightly soluble in water (10–13 mg/100 
ml at 25–27.5oC; 19 mg/100 ml at 40oC; 230 mg/100 ml 
at 100oC) ; Slightly soluble in ethanol (4.5 mg/100 ml at 
27oC) and phenol; Insoluble in chloroform , acetone, 
benzene and ether. Solubility can be enhanced in acidic 
















CAS No.  
146-17-8 
C17H21N4O9P 456.35 - Fine, yellow-orange crystalline powder 
- Melting point: 280°C-290°C (decomposition)  
- Solubility: Soluble in water, 30 g/l (Na salt); Insoluble 












FAD CAS No.  
146-14-5 
C27H33N9O15P2 785.56 Soluble in water; Insoluble in chloroform , acetone, 










a: At pH 3.5-7.5 b: At pH 2.7-3.1 
Sources: The Merck Index, 13th ed., Merck and Company, Whitehouse Station, NJ, 2001; Eitenmiller, R.R.; Ye, L.; Landen, W.O. 
Vitamin analysis for the health and food sciences. CRC Press: Boca Raton, 2008; Ball, G.F.M. Vitamins in foods: analysis, bioavailability, 
and stability. Taylor & Francis: Boca Raton, FL, 2006, Vol. 156; Rivlin, R.S. Riboflavin (Vitamin B2), In Handbook of vitamins, Fourth 
ed.; Zempleni, J., Rucker, R.B. and McCormick D.B., S.J.W., Eds.; CRC Press: Boca Raton, 2007, pp. 233; Nielsen, P. Flavins, In 
Modern chromatographic analysis of vitamins, Third Edition, Revised and Expanded ed.; Leenheer, A.P.d., Lambert, W.E., Van Bocxlaer, 

































203.63 - Melting point: 165oC (decomposition) 

















205.64 - White, odorless crystalline powder; Melting 
point: 206oC-208oC (Sublimes); Solubility: 
Readily soluble in water (1g/5ml). Sparingly 
soluble in alcohol (1g/100ml) and  propylene 





















169.18 - Melting point: 160oC  
- Solubility: Soluble in water; Weakly soluble 























241.12 - Melting point: 226oC-227oC 
(decomposition) 





























Sources: The Merck Index, 13th ed., Merck and Company, Whitehouse Station, NJ, 2001; Eitenmiller, R.R.; Ye, L.; Landen, W.O. 
Vitamin analysis for the health and food sciences. CRC Press: Boca Raton, 2008; Ball, G.F.M. Vitamins in foods: analysis, bioavailability, 
and stability. Taylor & Francis: Boca Raton, FL, 2006, Vol. 156; Ollilainen, V. HPLC analysis of vitamin B6 in foods. Agric. Food Sci. 
Finland 1999, 8; Dakshinamurti, S.; Dakshinamurti, K. Vitamin B6, In Handbook of vitamins, Fourth ed.; Zempleni, J., Rucker, R.B. and 
McCormick D.B., S.J.W., Eds.; CRC Press: Boca Raton, 2007; pp. 315; Ubbink, J.B. Vitamin B6, In Modern chromatographic analysis of 
vitamins, Third Edition, Revised and Expanded ed.; Leenheer, A.P.d., Lambert, W.E., Van Bocxlaer, J.F. and NetLibrary, I., Eds.; Marcel 
Dekker: New York, 2000; Vol.84. pp. 443.  
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ε x 10-3 





1355.38 - Dark red hygroscopic crystalline. Anhydrous form 
can take up to 12% moisture; Darkens at 210–220° C 
- Soluble in water (1.25g/100 ml). Aqueous solution is 














1346.37 - Dark red. Darkens at 200°C 
- Moderately soluble in water. Insoluble in acetone, 




















Nitrocobalamin B 12c C62H88CoN14
O16P 



























1579.6 - Yellow-orange crystal 




























Sources: The Merck Index, 13th ed., Merck and Company, Whitehouse Station, NJ, 2001; Eitenmiller, R.R.; Ye, L.; Landen, W.O. 
Vitamin analysis for the health and food sciences. CRC Press: Boca Raton, 2008; Ball, G.F.M. Vitamins in foods: analysis, bioavailability, 
and stability. Taylor & Francis: Boca Raton, FL, 2006, Vol. 156; 
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ε x 10-3 
Ascorbic acid 
CAS No. 50-81-7 
867 
C6H8O6  176.13 - Odorless, white or very pale yellow crystalline 
powder  with  a  pleasant  sharp  taste; Melting point at 
190-192 oC with decomposition; Stable in dry form at 
room temperature for a long time 
- Readily soluble in water (33 g/100 ml  at  258C), less 
soluble in 95% ethanol (3.3 g/100 ml), absolute ethanol   
(2 g/100 ml), acetic acid (0.2 g/100 ml), and 
acetonitrile (0.05 g/100 ml); Insoluble in ether, CHCl3, 
benzene, petroleum ether, oils, and fats  












CAS No. 134- 
03-2 
8723 
C6H7O6Na 198.11 - Highly soluble in water (90g/100 g) 
- Very slightly soluble in alcohol and insoluble in 
chloroform, ether 
-  White to pale yellow crystalline powder form  
   
Ca ascorbate 
CAS No. 5743- 
27-1 1688 
(C6H7O6)2Ca 390.31 - Much less soluble in water than ascorbic acid and Na 
ascorbate (5g/100 g) 
- Slightly soluble in alcohol and insoluble in ether 
   
Ascorbyl  
palmitate 
C22H38O7 414.54 - Slightly soluble in oils and freely soluble in alcohol 
(22 g/100 ml) 
   
Sources: The Merck Index, 13th ed., Merck and Company, Whitehouse Station, NJ, 2001; Eitenmiller, R.R.; Ye, L.; Landen, W.O. 
Vitamin analysis for the health and food sciences. CRC Press: Boca Raton, 2008; Ball, G.F.M. Vitamins in foods: analysis, bioavailability, 
and stability. Taylor & Francis: Boca Raton, FL, 2006, Vol. 156; Johnston, C.S.; Steinberg, F.M.; Rucker, R.B. Ascorbic acid, In 
Handbook of vitamins, Fourth ed.; Zempleni, J., Rucker, R.B. and McCormick D.B., S.J.W., Eds.; CRC Press: Boca Raton, 2007, pp. 489; 
Nyyssonen, K.; Salonen, J.T.; Parviainen, M.T. Ascorbic acid, In Modern chromatographic analysis of vitamins, Third Edition, Revised 
and Expanded ed.; Leenheer, A.P.d., Lambert, W.E., Van Bocxlaer, J.F. and NetLibrary, I., Eds.; Marcel Dekker: New York, 2000; 





1. Retention factor 
 Formerly referred to as capacity factor, the retention factor (symbolized as k) 
measures the time that an analyte stays in a stationary phase relative to the time it resides 
in the mobile phase (1). It is independent of column geometry or mobile phase flow rate. 
To put it simply, k value measures the analyte of interest elutes with regards to the void 
volume (2). Retention factor can be calculated as follows: 
 
where tR is the retention time of the analyte peak and t0 is the void time (or dead time). 
 If tR= t0, then k is 0, which means the analyte is not retained by the stationary at 
all and elute with the first column volume of the mobile phase. For k less than 1, 
chromatographers may encounter issues of less stable separation and chromatographic 
interferences, preventing accurate and reproducible analysis of the analytes (1, 2). Many 
official agencies like USP and FDA recommend the minimal retention factor of 2 for 
HPLC methods. In fact, k values in range of 2 to 10 are favored because the analysts do 
not need to deal with issues of badly-retained compounds but enjoy a reasonable run time 
(1). However, in reality, this ideal range may be not easily achieved, especially in the 
case of too polar compounds or when the separation involves analytes of wide polarity 
window (1). In those cases, a more reasonable range for k is between 0.5 and 20 (3).  
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2. Selectivity or separation factor α 
 Selectivity measures the relative distance between the two adjacent peaks, 
expressed by the ratio of their retention factor (2).  
 
 Selectivity can be modified by the adjustment of factors like mobile phase 
constituents, stationary phase or temperature.  
 
3. Tailing factor 
 Peak tailing can be described by either tailing factor or asymmetry factor. These 
two values are typically similar for the same peak but they are not directly converted. The 
tailing factor is calculated as follows: 
 
where w0.5 is the width of the peak and f0.5 is the distance from the peak center line to the 
front slope, both measured at 5% of the maximum peak height (2). 
 Asymmetry factor, on the other hand, is expressed differently as 
 
where A and B are the distance between the center line of the peak to the back and the 
front slope respectively (1). The measurements used to calculate the asymmetry factor are 
made at 10% of the maximum peak height. 
 Peaks of interest are expected to be symmetric with Tf or Af ideally in the range of 
0.9-1.5 (1). Peaks with serious tailing are easily overlapped with adjacent peaks, leading 
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to reduced resolution (3). Moreover, tailing also reduces detection sensitivity and causes 
difficulty to accurate peak integration. FDA guidance for validation of chromatographic 
methods suggests that Tf should be less than 2 for the purpose of quantitation (4). 
 
4. Resolution 
 Resolution describes how well two adjacent chromatographic peaks are separated 
from each other and is calculated as follows: 
 
where tR1 and tR2 are the retention times of the two adjacent peaks, and w0.5,1 and w0.5,2 are 
their baseline widths at 50% maximum peak height (2). 
 Baseline resolution for peaks of the similar size is achieved with Rs of 1.5 (2). 
This minimum resolution is also recommended for quantitative analysis.  
 Resolution can also be described in three parameters N, α and k: 
 
where N is the column plate number (or column efficiency), α is the selectivity and k is 
the average retention factor of the two peaks (5). 
 The separation of any 2 peaks of interest can be optimized by modifying these 
terms experimentally.  
 
5. Void volume 
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 Void volume or dead volume (symbolized as VM) is the total volume that the 
mobile phase has access to and is not taken up by packing materials (6). In other words, 
VM includes the interstitial volume and the pore volume that are accessible to the analyte 
molecules (1, 5). The time required for this volume to pass through the column is called 
void time or dead time t0, which is also equal to the elution time of an unretained 
compound (5).  
 The determination of true void volume in LC columns is challenging and still in 
debate among scientists. This volume is usually approximated empirically by injecting a 
small and supposedly unretained species such as uracil and thiourea for reversed-phase 
columns. (5). However, it is open to question if these species are essentially unretained as 
being assumed. It has been reported that they are all more or less retained on reversed-
phase columns. 
 Another common way to estimate the void volume is to use the formula 
VM=0.5Ldc
2 with L and dc being column length and column inner diameter in cm, 
respectively (6). The estimated value is in the range of 10% error but it is acceptable for 
the method development purpose. This estimation of void volume is used in this study for 
the calculation of void time and retention factor. 
 
6. Dwell volume 
 The concept and significance of dwell volume was already mentioned in section 
2.5.7 in Chapter 2. This section presents how this volume is determined and includes the 
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dwell volume values for the HPLC systems used in the study. Procedures for measuring 
the system’s dwell volume are listed as follows (5): 
1. Remove the column and connect the tubings with a short stainless union.  
2. Prepare following mobile phase components:  A-Water (UV-transparent), B-0.2% 
acetone in water (UV-maximal absorbance at 265nm).  
3. Program the gradient profile from 0% to 100% phase B in 10 min.  
4. Record, then print out the resulted chromatogram. 
5. Locate the midpoint of the gradient and identify the time from the x-axis 
corresponding to this midpoint. 
6. Subtract half the gradient time (5min) from this time 













Detector A Ch2:265nm 
 
Figure A.1 Demonstration chromatogram for dwell volume determination 
  
 Above is the chromatograms obtained for the LC-UV/Vis system used in the 
study.  The midpoint time was found to be 8.85min and the dwell time was 8.85min-
5.00min=3.85min. As the flow rate was set up at 1.0 mL/min, the dwell volume of this 
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HPLC system was 3.85min x 1.0 mL/min=3.85 mL. Using the same method, the 
following are the dwell volume for all the HPLC systems used in this study. 
Table A.7 Dwell volume for all the HPLC systems used for this study  
 
System Components Dwell volume 
Shimadzu 
LC-UV/Vis 
Shimadzu SIL-20A HT auto-sampler, 
Shimadzu LC-20AT liquid chromatograph, 
Shimadzu DGU-20A5 degasser and Shimadzu 





Shimadzu LC-20AT Liquid chromatograph, 
Shimadzu DGU-20A5 Degasser, Shimadzu 
CTO-20A Column oven, Shimadzu CBM-20A 
Communication bus module, Shimadzu SPD-
M20A Diode array detector, ELSD-LTII Low-





Agilent Technologies 1200 Series LC system 
consisted of G1379B Degasser, G1312A Binary 
pump, G1329A Autosampler, G1316A 
Thermostatted column compartment and 

























USP COLUMN DESIGNATION AND COLUMN EQUIVALENCY 
 




USP Packing Material 
L1 Octadecyl silane chemically bonded to porous silica or ceramic micro-
particles, 1.5 to 10 µm diameter, or a monolithic silica rod 
L7 Octylsilane chemically bonded to totally porous silica particles, 1.5 to 
10 µm in diameter, or a monolithic silica rod 
L11 Phenyl groups chemically bonded to porous silica particles, 1.5 to 10 
µm in diameter 
L43 Pentafluorophenyl groups chemically bonded to silica particles by a 
propyl spacer, 5 to 10 µm in diameter 
L56 Propyl silane chemically bonded to totally porous silica particles, 3 to 
10 µm in diameter 





Table A.9 List of columns equivalent to those used in the study  
Notes: This table was generated with PQRI database at http://www.usp.org/app/USPNF/columnsDB.html 
F: Column comparison function, H: Hydrophobicity, S*: Steric resistance, A: Hydrogen bond acidity, B: Hydrogen bond 
basicity, C(2.8) and C(7.0): Cation exchange at pH 2.8 and 7.0 respectively 
 




YMC Pro C18 
0 0 YMC Pro C18 1.015 0.014 -0.12 -0.007 -0.155 -0.006 B L1 YMC 
1 0.24 SepaxGP-C18 1.014 0.014 -0.112 -0.019 0.103 0.096 B L1 Sepax Technologies 
2 0.56 ZodiacSil 120-5-C18SH 1.032 0.018 -0.109 -0.024 0.115 0.402 B L1 Zodiac Life Sciences 
3 0.56 ProntoSIL 120 C18 SH 1.031 0.018 -0.109 -0.024 0.113 0.402 B L1 Bischoff 
4 0.64 TSKgel ODS-100Z 1.032 0.018 -0.135 -0.031 -0.064 -0.161 B L1 Tosoh Bioscience 
5 0.74 ZodiacSil 120-5-C18H 1.006 0.008 -0.106 -0.004 0.127 0.156 B L1 Zodiac Life Sciences 
YMC ODS- AQ 
0 0 YMC ODS-AQ 0.965 -0.036 -0.135 0.004 -0.068 0.1 B L1 YMC 
1 0.45 Orosil C18 0.981 -0.032 -0.137 0.002 -0.048 0.155 B L1 Orochem Technologies 
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2 0.66 Genesis AQ 120A 0.96 -0.036 -0.157 0.007 0.06 0.233 B L1 Grace/Jones 
3 0.85 TSKgel ODS-80Ts QA 0.94 -0.03 -0.118 0.005 0.004 0.361 B L1 Tosoh Bioscience 
4 0.9 Develosil ODS-MG-5 0.963 -0.036 -0.165 -0.003 -0.012 0.051 B L1 Nomura 
5 1.08 Fortis UniverSil C18 0.925 -0.027 -0.124 0.048 0.233 0.254 B L1 Fortis Technologies 
Zorbax SB-AQ 
0 0 Zorbax SB-AQ 0.593 -0.12 -0.083 0.038 -0.136 0.736 EP  Agilent 
1 0.42 Zorbax StableBond 80A C3 0.601 -0.124 -0.081 0.038 -0.084 0.81 B L56 Agilent 
2 1.43 HALO PFP 0.702 -0.117 -0.073 -0.062 1.168 0.972 F L43 Advanced Materials Technology 
3 1.54 Halo 5 PFP 0.711 -0.122 -0.07 -0.052 1.159 1.847 F L43 Advanced Materials Technology 
4 1.74 Platinum EPS C8 300 0.584 -0.113 -0.136 0.089 0.481 0.961 EP  Grace/Alltech 
5 2.3 TSKgel Super-Phenyl 0.58 -0.107 -0.146 0.016 0.085 0.672 phenyl L11 Tosoh Bioscience 
Synergi Polar-RP 
0 0 Synergi Polar-RP 0.654 -0.148 -0.257 -0.007 0.057 0.778 EP L1 Phenomenex 
1 1 MicroBondapak Phenyl 0.585 -0.152 -0.247 0.021 0.359 0.976 phenyl L11 Waters 
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2 1.54 ACE 5 Phenyl 0.647 -0.138 -0.296 0.027 0.132 0.466 phenyl L11 ACT 
3 1.81 Nova-Pak Phenyl 0.704 -0.159 -0.3 0.015 0.767 0.812 phenyl L11 Waters 
4 1.83 Precision Phenyl 0.595 -0.136 -0.296 0.027 0.099 0.508 phenyl L11 Mac-Mod Analytical 
5 2.15 Microsorb 100-5 Phenyl 0.711 -0.14 -0.195 0.163 0.604 0.787 phenyl L11 Agilent/Varian 
Synergi Hydro-RP 
0 0 Synergi Hydro-RP 1.022 -0.006 0.169 -0.042 -0.077 0.26 EP L1 Phenomenex 
1 0.78 HyperClone PAH 0.98 -0.008 0.187 -0.024 1.169 1.116 other  Phenomenex 
2 1.13 Ultrasphere ODS 1.085 -0.014 0.173 0.068 0.279 0.382 B L1 Hichrom 
3 1.17 GROM-SIL 120 ODS-5 ST 1.035 -0.001 0.134 -0.005 0.135 0.121 B L1 Grace/Grom 
4 1.49 ProntoSIL 60 C8 SH 0.929 -0.015 0.161 -0.017 -0.313 1.005 B L7 Bischoff 
5 1.57 LiChrospher 100 RP-18 1.006 -0.021 0.183 -0.036 0.646 0.896 A L1 
Merck KGaA (EMD 
Millipore) 
Ultra Aqueous C18 
0 0 Ultra Aqueous C18 0.808 -0.128 0.378 0.013 0.229 1.255 B L1 Restek 
1 1.42 HSS C18 SB 0.73 -0.12 0.4 0.02 0.4 1.41 B L1 Waters 
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2 2.2 Cogent Bidentate C8 0.681 -0.113 0.369 0 0.195 1.351 B L7 MicroSolv 
3 2.38 Resolve C18 0.968 -0.127 0.335 -0.046 1.921 2.144 A L1 Waters 
4 2.41 Vision C18 B 0.689 -0.111 0.35 0.031 0.39 1.41 A L1 Grace/Alltech 
5 2.89 ProntoSIL 300 C30 0.893 -0.107 0.322 0.03 0.401 1.547 A L62 Bischoff 
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APPENDIX D 
SELECTED HPLC METHODS FROM LITERATURE FOR THE  
ANALYSIS OF VITAMIN B1, B2, B6, B12 AND C 
 











Digest with 0.1N HCl and 
takadiastase and papain. Precipitate 
proteins with TCA. Dilute and filter. 
Form and extract thiochrome with 
isobutanol 
Spherisorb silica 20µm,  500x2.1 mm  
Mobile phase: 90% chloroform/10% methanol 
Fluorescence 
367/418 nm 






None (p-hydroxybenzoic acid as IS) ODS C18 
CH3OH–water (25:75), 1% CH3COOH, 3-8 mM 
hexanesulphonate 




Enzyme hydrolysis with takadiastase 
and centrifuge.  
Nucleosil C18, 5µm, 150×4 mm  
Mobile phase-isocratic with 0.01M NaH2PO4  
and 0.15 NaClO4, pH 2.2 






    Ex λ =375nm 




TPP, TTP (10) 
Use amprolium as IS. Homogenize 
samples with 5% sulfosalicylic acid. 
Centrifuge, remove water layer. 
Clean-up: AG2-X8, anion-exchange 
Perkin Elmer C18, 10µm, 300×3 mm 
Mobile phase-gradient with 0.1M Na3PO4, pH 
5.5–0.1M Na3PO4, pH 2.6 




    Ex λ = 339nm 
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Extract three times with a total 
volume of 20 ml of methanol-water 
(8:2) 
LiChrosorb RP-18, 5µm, 250 x 4mm 
CH3OH–water-85% phosphoric acid (55:45:1) 
plus 65 mg of octane sulphonic acid 
Flow rate 1.5 ml/min 
Injection volume 5-25µl 







Mix samples with water. Adjust pH 
to 1.7–2.0 with 6N HCl then to 4.0–
4.2 with NaOH to precipitate 
proteins. Dilute and filter.  
µBondapak C18, 10µm, 300×4.6 mm. Column 
temperature 50oC. 
Mobile phase-isocratic with Water:MeOH 
(80:20) containing 0.1% EDTA, 0.15% sodium 
hexane sulfonate and 0.75% HAC 





Autoclave sample in 0.1 M HCl 
at121°C for 15 min. Adjust pH to 
4.0–4.5 and hydrolyze with 
takadiastase at 48°C for 3h 
Clean-up: Amberlite CG-50, C18 
Sep-Pak 
µBondapak C18, 10µm, 300×3.9 mm 
Mobile phase: isocratic with Water:MeOH 
(69:31) containing 5mM sodium hexane 
sulfonate/ 5mM  sodium heptanes sulfonate and 
0.5% acetic acid 




Autoclave samples in 0.25 N H2SO4 
for 30 min. Adjust pH to 4.6 with 
acetate buffer and  incubate with 
takadiastase at 40°C–45°C for 25 
min. Digest with papain, 40°C–45°C 
for 2 h. Add TCA, heat at 50–60°C 
for 5 min to precipitate proteins. 
Centrifuge. 
Mercksorb Si60, 10µm, 250×4.5 mm 
Mobile phase—isocratic with phosphate buffer 
(pH 5.6):EtOH (100:12) 




    Ex λ = 366nm 




Acid digestion with HCl 
Clean up with Sep-pak columns  
C18 µBondapak 






Autoclave 5g sample in 65ml HCl 
0.1M at 121oC for 30min. Cool, 
Waters Novapak C18, 4µm, 150x3.9mm 
Mobile phase: 50mM phosphate buffer pH 7.0 
Fluorescence  




adjust to pH 4.5, add β-amylase and 
takadiastase and incubate at 37oC 
overnight. Add TCA 50% to 
precipitate proteins, dilute and filter. 
Thiochrome derivatization. Solid-




Acid hydrolysis with 10% HCl at 
80–85°C, 30 min. Adjust pH to 4.5 
with acetate buffer. Digest with 
diatase at 45–50°C for 3h. 
Clean–up: extract with isobutanol. 
Add chloroaniline as IS. 
CAPCELL PAK C18, 6µm, 150×4.6 mm 
Mobile phase-isocratic with 
50 mM acetate buffer (pH 3.5):MeCN (85:15) 




Acid hydrolysis with 0.1N HCl (20 
ml) for 1g sample at 100°C for 30 
min. Centrifuge and adjust to pH 4.0 
with acetic acid. 
SynChropak SCD-100, 250×4.6 mm 
Mobile phase-isocratic with MeOH:Water 
(40:60) containing 50 mM pentane sulfonate 
(adjusted to pH 4.0 with acetic acid) 




    Ex λ = 370nm 
    Em λ = 430nm 
Multivitamins/ 
Thiamine (19) 
Dissolve the tablet in 0.1M NaOH, 
homogenize for 15 min and 
centrifuge. Dilute with mobile phase 
Polymeric RP Jones Chromatography, 5µm, 
250×4.6 mm 
Mobile phase-isocratic with MeCN: phosphate 
buffer 20 mM, pH 11.0 (20:80) 




Hydrolyze the samples with dilute 
HCl at100°C for 30 min. Adjust pH 
to 4–4.5, digest with takadiastase at 
47°C for 3h. 
Clean-up: weak anion exchange  
column. 
Lichrosphere 100 RP-18, 5µm, 125×4 mm 
Mobile phase-isocratic with H3PO4 –KH2PO4  
(10mM, pH 3.5):MeOH (85:15) containing 5µM 





Autoclave 10g ground sample in 60 
mL 0.1 N HCl at 120°C for 20 min. 
Adjust pH to 4.0–4.5 with 2.5M 
Spherisorb C8, 5µm, 250×4 mm 
Mobile phase—Isocratic with phosphate buffer 





sodium acetate. Incubate with 5 mL 
(6%) Clara- 
diastase at 50°C for 3 h. Add 2 mL 
50% TCA, heat at 90°C for 15 min 
to precipitate proteins. Dilute sample 
then filter. Pre-column derivatization 
to thiochrome. 
Clean-up: C 18  Sep-Pak cartridge 
Flow rate 0.65 ml/min     Ex λ = 360nm 
    Em λ = 
430nm 
Tablet, capsule,  
urine/thiamine,  
TMP, TPP (22) 
Capsule/Tablet-dissolve sample with 
water and filter. 
Urine-filter sample 
RP-Amide C16, 5µm, 150×4 mm 
Mobile phase-gradient with 
25 mM KH2PO4 (pH 7):MeCN 
Flow rate 1 ml/min 
UV 230nm 
Beers and raw  
material/ 
thiamine,  
TMP, TPP (23) 
Liquid sample-half dilute with 25 
mM  
phosphate buffer (pH 7) then filter. 
Solid sample-mix with 5mL TCA, 
sonicate for 15 min, centrifuge. 
Extract twice w/2 mL TCA. 
Combine the supernatant and dilute 
with phosphate buffer. Filter. 
RP-Amide C16, 5µm. 
Mobile phase- isocratic with 25 mM phosphate 
buffer (pH 7) 




    Ex λ = 375nm 




Autoclave 5g homogenized sample 
in 35ml HCl 0.1N at 125oC for 15 
min. Cool, adjust to pH 4.0-4.5, add 
claradiastase and incubate at 50oC 
for 3hr. Add 50% TCA, heat at 90oC 
for 15min. Cool, adjust to pH 3.5, 
dilute and filter. Thiochrome 
derivatization. 
Nucleosil 100-5 C18 AB 125x4mm column 
Mobile phase: 35%  methanol and 65% 
phosphate buffer (0.005 M, pH 7.0) at flow rate 







Mix ground sample with water in 10-
ml flask, sonicate and dilute to the 
mark. Dilute aliquots with 60% 
TiO 2 Sachtopore-NP 3µm, 250x4.6 mm 
Mobile phase: 2mM phosphate (pH 6.5) and 
acetonitrile at flow rate of 1ml/min 
UV 240nm 
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Add 9ml HCL 0.1N into 1g 
homogenized sample. Heat the 
mixture at 100°C for 30 min in a 
water-bath.  
Cool, add 6 ml of 2.5 M sodium 
acetate and takadiastase. Incubate at  
37°C 
Overnight. Centrifuge and dilute. 
SPE clean-up with Oasis WCX 
cartridge. 
 
Luna HILIC 3µm, 150x3.0 mm  
Mobile phase: gradient with (A) acetonitrile: 50 
mM ammonium acetate pH 5.8 (90:10 v/v) and 
(B) acetonitrile: 10 mM ammonium acetate pH 
































Ground sample mixed with 0.1 N 
HCl, autoclaved at 121oC for 30 min 
then cool down, centrifuge. Extract 
twice with 0.1 N HCl and dilute pooled 
supernatants to volume 
mBondapak C 18 10µm 300x3.9mm 
Mobile phase: (1) Water/MeOH/acetic acid 
(56:43:1); (2) Water/MeOH/acetic acid (50:49:1) 
Fluorescence 
(1) Ex λ=450 nm 
Em λ= 510 nm 
(filters) 
(2) Ex λ= 300- 
350 nm 





Milk- clean up with Sep-Pak C18. Elute 
riboflavin with 50% 0.02 M acetate (pH 
4.0): 50% MeOH 
Dairy products –homogenize in 0.02 M 
acetate buffer pH 4.0, cleanup Sep-Pak 
C18same as milk 
Bio-Sil ODS-5S, 250×4 mm 
Mobile phase-isocratic with 0.1% acetic:methanol 
(65:35) 
Flow rate 1 ml/min 




Hydrolyze sample in 0.1 N HCl at 
100oC for 30 min then cool. Add mylase 
and incubate at 38oC overnight. Heat at 
60oC with TCA 50% w/v for 5 min to 
remove proteins. Adjust pH to 4.0 then 
dilute and filter 
Ultrasphere-ODS 5µm 250x4.6mm 
Mobile phase: MeOH/water (40:60) containing 
5 mM sodium heptanesulfonate adjusted to pH 
4.5 with phosphoric acid 
Fluorescence 
Ex λ=450 nm, 
Em λ=530 nm 
Cheese/ 
riboflavin (30) 
Homogenize in water:MeOH (2:1). 
Acidify with HAC, mix and centrifuge. 
Extract three times with 
water:MeOH:acetic acid (65:25:10). 
Combine and dilute the extract then 
centrifuge 
LiChrosorb RP 18, 5µm,  
250×4.6 mm 
Mobile phase-isocratic with water:MeCN (80:20) 
Flow rate 1 ml/min  
UV 446 nm 





homogenized sample with 0.1 N HCl at 
121oC for 30 min. Cool, adjust pH to 
4.5.  
Enzymatic hydrolysis: Add acid 
phosphatase and incubate at 45oC 
overnight.  
Proteins precipitated by heating at 
100oC with TCA 50% w/v for 
5 min. Adjust pH to 4.5 then dilute. 
Mobile phase: Water/MeOH (3:2) adjusted to pH 4.5 
with acetic acid 
Ex λ=440 nm 
Em λ=520 nm 






Treat sample with hexane to remove fat. 
Autoclave homogenized sample with 
0.1 N HCl at 121oC for 30 min. Adjust 
pH to 6.0, dilute with water then filter 
LiChrosorb RP-8 (octyl) 10µm, 250 x4.0 mm 
Mobile phase: Water/MeOH (60:40) containing 5 
mM sodium hexane sulfonate 
Fluorescence 
Ex λ=440 nm 
(filter), 




Mix 20 ml sample with 2 ml of 10% 
lead acetate then filter 
LiChrosorb C18, 10µm, 250×4.6 mm 
Mobile phase: isocratic with water:MeOH:HAC 
(50:49:1) 












Autoclave  homogenized sample in 
0.2M H2SO4 for 20 min. Adjust pH and 
incubate with  
Claradiastase or Takadiastase at 45oC. 
Cool, dilute and filter 
Clean-up: Sep-Pak C 18 
Spherisorb S5 ODS 2, 5µm, 250×4.6 mm 
Mobile phase-isocratic with water:MeOH (65:35) 
Flow rate 1 ml/min  
Fluorescence 
  Ex λ = 445 nm 





Autoclave with 0.1N HCl for 15 min. 
Cool, sdjust pH and incubate with 
takadiastase at 48oC for 3 h. Filter and 
dilute. 
µBondapak C18, 10µm, 300×3.9 mm 
Mobile phase-isocratic with (1) Water:MeOH:HAC 
(67:32:1) containing 5 mM Sodium hexsulfonate or 
(2) Water:MeOH:HAC (68:31:0.5) containing 5 mM 
UV 254 nm 
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Clean-up: Florisil followed by Sep-Pak 
C 18 









Treat sample with 6% formic acid 
containing 2 M urea. Homogenize and 
centrifuge. Add sorboflavin as IS. 
Clean up: SPE C18. Elute with 10% 
formic/MeOH (4:1) 
Supelco LC18, 3µm, 75×4.6 mm 
Mobile phase-isocratic with 100 mM KH2PO4:MeCN  
(86:14), pH 2.9 
Flow rate 1 ml/min 
Fluorescence 
  Ex λ = 450nm 





Milk boiled to inactivate 
pyrophosphatase. Digested with 
buffered protease (pH 6.8) for 1h at 
45oC then cooled and adjusted volume 
and pH with phosphate buffer. 
Capcell Pak C18 5µm, 250x 4.6 mm, kept at 40oC 
Mobile phase: gradient with (A) 90% MeOH in water 
and (B) 0.01 M phosphate, pH 5.5.  
 
Fluorescence 
Ex λ=462 nm 
Em λ=520 nm 
Milk, nondairy  
imitation milk/ 
Riboflavin (38) 
Precipitate proteins in samples with 
10ml lead acetate (adjusted to pH 3.2) 
then filter 
Spherisorb ODS  5µm, 150 ×3.9 mm 
Mobile phase: isocratic with 
0.13% Acetic acid: MeOH (70:30) 






Mix 0.5-4.0g sample with 9.0 ml MeOH 
and 10ml CH2Cl2.  
Add 7-ethyl-8-methyl-riboflavin as IS. 
Homogenize and add 0.1M citrate-
phosphate buffer (pH 5.5) containing 
sodium azide. Mix, centrifuge, and filter 
2 PLRP-S, 5µm, 100 Ǻ, 250×4.6 mm and 150× 4.6 
mm 
Mobile phase-gradient with MeCN and 0.1% sodium 
azide in 10 mM citrate- phosphate buffer, pH 5.5 
Fluorescence 
Ex λ = 450nm 






Filtered samples directly or after 
dilution with water (with 0.22 µm);  
injected for analysis 
Hypersil C 18 5µm, 200 x2.1 mm  
Mobile phase: (A) 0.05 M phosphate buffer, pH 3.0 
and (B) MeCN 
Fluorescence 
Ex λ=265 nm 
Em λ=525 nm 
with a 500-nm 
cut-off filter 
Sausages/ Acid hydrolysis: autoclave Spherisorb ODS-2 5µm, 250x4mm kept at 35oC Fluorescence 
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Riboflavin (41) homogenized sample with 0.1 N HCl at 
120oC for 20 min. Cool, adjust pH to 
4.0-4.5.  
Enzymatic hydrolysis: Add 
Claradiastase and incubate at 50oC 
For 3 hours.  
Proteins precipitated by heating at 90oC 
with TCA 50% w/v for 
5 min. Dilute with water and filter. 
 
Mobile phase: MeCN:water with 5 mM 
heptanesulfonic acid adjusted to pH 2.7 with 
phosphoric acid (75:25) 
Ex λ=227 nm 
Em λ=520 nm 
Foods/Riboflav
in, FMN, FAD 
(42) 
Suspend sample in mixture of MeOH-
CH2Cl2 (9:10, v/v), homogenize for 
1min.  Add 0.1M ammonium hydrogen 
carbonate, pH 7.0 and mix for another 
min. Centrifuge 
Symmetry C18  5µm, 150×3.9 mm 
Mobile phase-gradient with 
MeOH and 0.05M ammonium acetate pH 6.0 
 
Fluorescence 
    Ex λ = 450nn 
    Em λ = 530nm 
Foods/Riboflav
in, FMN, FAD 
(43) 
Homogenize sample in 10 ml MeCN for 
10min. Add 10 ml 10 mM phosphate 
buffer pH 5 and mix. Centrifuge and 
dilute with phosphate buffer then filter 
 
Discovery RP-Amide C16 5µm, 150×4.6 mm 
Mobile phase-isocratic with MeCN: KH2PO4 10mM 
pH 5 (10:90) 
Flow rate 1ml/min 
Fluorescence 
    Ex λ = 270nm 
























PL, PN (44) 
Homogenize sample with 0.5 M 
potassium acetate (pH 4.5), centrifuge. 
Heating at 50oC with TCA 33.3% 
w/v to precipitate proteins, centrifuge to 
remove supernatant 
µBondapak C18 10 µm, 300x3.9mm 
Mobile phase: isocratic with 0.033 M KH2PO4 buffer, 
pH 2.2 
Fluorescence; 
Ex λ=295 nm, 




foods/PL, PM,  
PN, PLP, PMP,  
PNP, 4-PA 
(45) 
3-hydroxypyridine was used as an 
internal standard. Homogenize 1 gram 
sample with 10 mL 5% sulfosalicylic 
acid, centrifuge at 4°C then filter. 
Evaporate off ¼ the volume under N2. 
Add equivalent volume of hexane, 
vortex and remove the aqueous layer. 
Two columns connected by a switching valve: 
Column 1-Aminex A-25, 55°C, 240x6mm 
Column 2-Aminex A-25, 18°C, 240x3 mm 
Mobile phase: 0.4 M NaCl: 0.01M glycine isocratic 
or gradient with flow rate of 1.2 ml/min 
 
Fluorescence 
PM, PMP, PN, 
PNP 
    Ex λ = 310nm 
    Em λ = 380mn 
PL, PLP 
    Ex λ = 280mn 




dry milk /PMP, 
PM, PLP, PL, 
PN (46) 
Remove fat with CHCl3/petroleum ether 
(1:2). Air dry and store at -40oC 
overnight. Mix sample with water, 
adjust pH to 2.0. Incubate with pepsin at 
37oC for 3h, adjust pH to 8.0. Digest 
with pancreatin at 37oC for 12h. Add 
TCA followed by MeOH, shake and 
centrifuge. Resuspend pellet in the 
mobile phase, centrifuge. Clean-up 
pooled supernatants with SPE C18 
cartridge 
µBondapak C18 10µm, 300x3.9mm 
Mobile phase: 0.075M KH2PO4 with  





in pH 7.5 
phosphate buffer 
Fluorescence: 
Ex λ 310 nm 




PL, PN, PM 
Add 4-deoxypyridoxine as internal 
standard. Mix sample with 5% 
sulfosalicylic acid, centrifuge  
Radial-PAK C18 4µm, 100x8mm 
Mobile phase: gradient with (A) 0.033 M H3PO4 





(47) Cleanup: remove sulfosalicylic acid 
with 40x8mm 100-120 mesh AG-X8 
anion exchange column. 
 
(pH 2.2)/2-propanol (97.5:2.5); (B) 0.33 M H3PO4 
(pH 2.2)/2-propanol (82.5:17.5) 
 
in pH 7.5 
phosphate buffer 
Fluorescence 
Ex λ=338 nm 
Em λ=425 nm  
 
Chicken/PL,  
PM, PLP, PMP 
(48) 
Extract with 1M metaphosphoric acid Biosil ODS-55, 250x4 mm 
Mobile phase: isocratic with 0.066 M KH2PO4, pH 
3.0 
Fluorescence 
    Ex λ = 290nm 
    Em λ = 395nm 
Various foods/ 
PL, PM, PN,  
PLP, PMP,  
PNP, 4-PA 
(49) 
Add 4-deoxypyridoxine as an internal 
standard. Extract with 0.1-0.5M cold 
perchloric acid, centrifuge and remove 
supernatant. Adjust to pH 7.5. 
Hydrolyze with alkaline phosphate at 
25°C for 30min. Adjust to pH 4.0. 
 
Lichrosphere RP-18, 5µm, 125x4 mm 
Mobile phase: gradient with (A) methanol and (B) 






    Ex λ = 300nm 




Conversion of  all B6 forms to PN: 
Add 25ml 0.05M sodium acetate pH4.5 
+ 1ml glyoxylic acid + 400 µL ferrous 
sulfate (2g/L) + 20mg acid phosphatase 
to 2.5 g sample.  
Incubate at 37°C overnight then dilute 
with water. Add To 4.5ml 0.1M sodium  
borohydride to 5 mL aliquot, shake then  
add 0.5 mL glacial acetic acid. Fillter 
Lichrosorb 60 RP 5 µm, 250x5 mm 
Mobile phase: isocratic acetonitrile:0.05M KH2PO4 




    Ex λ = 290nm 
    Em λ = 395nm 
Various foods 
/PL, PN, PM 
(51) 
 
Add 4-deoxypyridoxine as internal 
standard. Precipitate proteins with TCA 
5% w/v TCA, centrifuge and filter. 
Dilute filtrate with 4M acetate buffer, 
pH 6.0. Add takadiastas and incubate at 
Hypersil ODS 3µm, 125x4.6mm 
Mobile phase: 3% methanol and 1.25mM 1-octane- 




addition of 1M 
K2HPO4.3H2O 
Fluorescence: 
Ex λ 333 nm 
Em λ 375 nm 
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45oC for 3h. Cool, add TCA 16.7% w/v, 
centrifuge and filter. 
 
Wheat/PL,  
PM, PN, PMP,  
PN-glucoside 
(52) 
Add 4′-deoxypyridoxine as internal 
standard. Homogenize samples in water. 
Precipitate proteins with 
metaphosphoric acid. Centrifuge and 
filter 
Ultramex C18 5 µm, 150x4.6 mm 
Mobile phase: gradient with (A) 0.033 M KH2PO4 
containing 0.008 M 1-octane sulfonic acid, pH 2.2 
(B) 0.033 M phosphoric acid:10% MeCN, pH 2.2 
Fluorescence 
    Ex λ = 311nm 
    Em λ = 360nm 
Legumes/PM, 
PL, PN (53) 
Precipitate proteins with TCA 5% w/v 
for 30 min, filter and dilute. Adjust an 
filtrate to pH 4.8, add acid phosphatase 
and incubate at 37oC for 5h. Add  
20% TCA, cool down and filter (0.22 
mm) 
Hydrolysis of glycosylated PN: adjust  
initial filtrate to pH 5.0, add b-
glucosidase, incubate at 37oC for 5h. 
Add 20% TCA, cool down and filter 
(0.22 mm) 
Spherisorb ODS-2 10µm 300x3.9 mm 
Mobile phase: 0.033 M potassium phosphate buffer, 
pH 2.2/MeOH (98:2) 
Post-column 
addition of 0.3 
M KH2PO4 pH 
7.0 
Fluorescence; 
Ex λ=328 nm 





flour/ PM, PL, 
PN (54) 
Autoclave sample with 0.1N HCl at 
120oC for 30 min. Adjust to pH 
4.8, add acid phosphatase and b-
glucosidase and incubate at 37oC for 18. 
Cool, adjust to pH 3.0 and filter 
Nucleosil 120 C18 5µm, 250x4 mm kept at 30oC 
Mobile phase: 0.04M H2SO4 and 0.005M TCA (pH 
1.0) 
Post-column 





Ex λ=333 nm 




yolk, milk / 
PMP, PM, 
Homogenize sample with 1M perchloric 
acid. Add isopyridoxal as internal 
standard. Adjust pH to 3.0-4.0 with 
KOH, refrigerate for a few hours, 
Phenosphere ODS2 5µm, 250x4.6mm 
Mobile phase: 0.15M NaH2PO4 adjusted to pH 2.5 






PLP, PNP, PL, 
iso-PL, PN, 4-
PA (55) 
centrifuge and filter (0.45 mm) Ex λ 290 nm 
Em λ 389 nm  
 
Pork products/ 
PM, PL, PN 
(56) 
4-deoxypyridoxine as internal standard. 
Acid and enzyme hydrolysis: mixsample 
in 60ml 0.1M HCl, shake and heat in 
water bath at 100°C for 30 min. Cool, 
adjust to pH 4.0-4.5 then add 
takadiastase and incubate.  
Precipitate proteins by adding 2ml 50% 
TCA, heat at 95°C for 5 min. Dilute to  
100 ml with and filter 
Spherisorb ODS C18 5µm, 250x4 mm 
Mobile phase: isocratic with 0.01M H2SO4 at flow 
rate of 1ml/min 
Fluorescence 
    Ex λ = 290nm 
    Em λ = 395nm 
Cooked  
sausages/PN,  
PL, PM, PLP,  
PMP 108, 2001 
(57) 
Extract with 20ml metaphosphoric acid 
5%, dilute to 100ml with water, 
centrifuge and filter the supernatant 
Hypersil ODS C 18 5µm, 100x4.6 mm 
Mobile phase: isocratic with 50 mM phosphate buffer 
(pH 3.2):MeCN (99:1) 
Fluorescence 
    Ex λ = 290nm 
    Em λ = 395nm 
Various foods/ 
PL, PM, PN 
109, 2003 (58) 
Autoclave sample in 50ml 0.1 M HCl at 
121°C for 30 min. Cool down, adjust to 
pH 4.5. Add acid phosphatase, incubate 
at 45°C for 18h. Add 5ml 1M HCl, 
dilute to 30 mL with 0.01 M HCl. Filter 
Phenomenex Hypersil C18, 3µm, 150x4.6mm  
Mobile phase: (A) 2.2 mM 1-octan sulfonic acid 
in 81mM KH2PO4 and 19 mM 85% phosphoric acid 
and 4.0 mM triethylamine, adjusted to pH 2.75 with 
3.5 M KOH or 85% phosphoric acid 
Isocratic with 93%A and 7% acetonitrile 
Fluorescence 
    Ex λ = 333nm 




PL, PN, 4-PA 
(59) 
Acid hydrolysis with 4ml 1M perchloric 
acid. homogenize, centrifuge and adjust 
supernatant pH to pH 7. Cool down in 
ice bath for 30 min. Centrifuge, dilute 
supernatant to 5ml with mobile phase. 
Enzymatic hydrolysis: adjust diluted 
supernatant to pH 4-4.5, add 
takadiastase and phosphatase mixture. 
Discovery RP-Amide C16 5µm, 150x4.6 mm 
Mobile phase: isocratic with 50 mM KH2PO4, pH 7 
 
Fluorescence 
    Ex λ = 335nm 
    Em λ = 389nm 
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Incubate at 50°C for 1h. Adjust 








































Mix sample with 0.05 M NaH2PO4. 
Centrifuge and filter. 
Clean up with SAX and C18 SPE 
µBondapak C18, 300x3.9 mm 
Mobile phase: gradient with 0.02M KH2PO4 







Mix ground tablets with 30ml water 
containing 0.25g ammonium 
pyrrolidinedithiocarbamate, 1g citric 
acid and 10ml dimethyl sulphoxide. 
Shake, stand in water bath at 40 °C 
for 15min. Centrifuge, and dilute 
15ml supernatant with100 ml water. 
µBondapak C18 , 10µm, 150x3.9 mm 
Mobile phase: gradient with water and methanol 






Mix 20g sample with 60ml deioinized 
water, put in the water bath set at 
50°C then add 10g NaCl. Let the 
mixture stand for 30 min. Dilute to 
100 ml with deionized water before 
removing fat with hexane.  
Sample clean up with Sep-Pak C18 
Capcellpak C18, 5µm, 250x4.6mm 
Mobile phase: isocratic with water:acetonitrile 





Mix 50g sample with Na2SO4 15% 
solution containing 1 mM sodium 
EDTA, filter.  
Sample clean up with Bond-Elut C18 
Spherisorb ODS-2, 5µm, 150x4.6 mm 
Mobile phase: isocratic with 50 mM KH2PO4 






 Brownlee Aquapore C18, 7µm, 100x1 mm & 
Vydac C8, 5µm, 150x1 mm 
Mobile phase: gradient with 25 mM acetate (pH 
4) and methanol  at flow rate of 0.04ml/min. 
MS-ESI 
positive  
ion mode w/  
SIM or MS/ 
MS-ESI 
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Extract sample with 0.1M phosphate 
buffer, pH 7.0, centrifuge and filter 
µBondapak C18, 10µm, 300x3.9 mm 
Mobile phase: isocratic with water and 
methanol (70:30) at flow rate of 0.8ml/min 
Fluorescence 
  Ex λ = 275 nm 






Extract ground tablets in 350 m 
mixture of methanol-water (50:50) for 
30 min and filter. Dilute 25ml filtrate 
with 50 ml of extractant. 
Column with phenylpropanolamine support, 
150x4.6 mm 
Mobile phase: isocratic with 0.03M phosphate 






 Kromasil C18, 5µm, 250x4.6 mm 
Mobile phase: gradient with 0.4mM TFA and 
acetonitrile at flow rate of 0.7 ml/min; or  
Zorbax Extend C18, 3.5 µm, 150x2.1 mm 
Mobile phase: gradient with water containing 
10mM 1-methylpperidine and acetonitrile at 
flow rate of 0.2 ml/min 
MS/MS-ESI+ 







Sonicate sample in 5mM KH2PO4 for 
10min, dilute with KH2PO4 and 
centrifuge. Collect middle layer, 
centrifuge. Add chloroform to remove 
lipids, centrifuge. Collect aqueous 
layer, centrifuge and filter (0.45 mm) 
Pre-separation column: 
Capcellpak MF C8 (octyl) 5µm, 150x4.6 mm. 
Focusing column: Capcellpak MG C18, 5 µm 
35x2.0mm  
Analytical column: Capcellpak UG C18, 5µm 
250x1.5 mm.  
Column temperature 40oC  
Mobile phase: gradient with (A) 5mM KH2PO4/ 







Extract with water for free vitamin 
B12. Digest with pepsin for total 
vitamin B12. 
Clean up with immunoaffinity column 
LiChrospher 100 RP18 5µm, 250x4 mm 
Mobile phase: gradient with water and methanol 
at flow rate of 1ml/min 
Fluorescence 
  Ex λ = 250 nm 






α-amylase digestion for free vitamin 
B12; α-amylase and pepsin digestion 
for total vitamin B12. 
Clean up with immunoaffinity column 
Ace 3 AQ C18, 150x3 mm 
Mobile phase: gradient with 0.025% TFA in 
water (pH 2.6) and acetonitrile at flow rate of 








α-amylase digestion for free vitamin 
B12; α-amylase and pepsin digestion 
for total vitamin B12. 
 
XTerra MS C18  5µm, 150x3.9 mm 
Mobile phase: gradient with water and 


































Extractant containing 6% HPO3, 
1mM EDTA and 0.1mM 
diethylthiocarbamate 
µBondapak C18, 10µm, 100x8mm 
 
1.5% NH 4 H 2 
PO 4 
buffer, pH 3 
Citrus juices / 
vegetables/ 
ascorbic (74) 
Mix sample with 0.3M TCA, dilute 
and filter. Add 4.5M acetate buffer 
(pH 6.2) and ascorbate oxidase. 
Incubate at 37oC for 5 min.   
Add 0.1% O-Phenylenediamine; react 
at 37oC for 30 min.  
 
Hypersil-ODS 3µm, 125x4.6mm 






Ex λ 365 nm 




Mix sample with 6% HPO3 (1:1), 
centrifuge and filter 
Brownlee RP-18, 5µm, 220x4.6 mm (or 
100x4.6 mm) 








Extract samples with 8% acetic acid 
and 3% HPO3 in water, dilute with 
the same extractant and filter 
Spherisorb ODS-2, 5µm, 250x4.6mm 
Mobile phase: Water adjusted to pH 2.2 with 
H2SO4 
UV 254nm 
Wine and beer/ 
ascorbic (77) 
Filter sample through 0.2µm 
membrane 
Nucleosil 120 C18, 7µm, 250x4 mm 
Mobile phase: 0.5% aqueous methanol 
containing 0.05M acetate buffer (pH 5.4) and 
5mM n-octylamine 
UV 266 nm 
Fruit juices/ 
ascorbic (78) 
Dilute sample with water and filter. 
For AA: add a-methyl-L-DOPA into 
sample (as an internal standard), then 
add 2% HPO3.  
For total vitamin C: add internal 
Inertsil ODS-2 5 µm, 150x4.6mm  
Mobile phase: 0.1M KH2PO4 buffer (pH 3) 
containing 1mM EDTA.2Na 
Amperometric: 
+ 0.3V vs. Ag/ 
AgCl 
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standard and L-cysteine diluted in 
0.01M phosphate buffer, pH 6.8. Let 




Homogenize sample with 4.5% HPO3 
solution for 15 min, filter, dilute with 
the same solution and filter again 
(0.22 mm) 
Spherisorb ODS-2, 5µm, 250x4.6mm 
Mobile phase: Water adjusted to pH 2.2 with 
H2SO4 
UV 254nm 
Fresh fruits and 
vegetables/ 
ascorbic (80) 
Mix macerated sample with 
2% HPO 3 , shake, filter 
Spherisorb ODS-2, 10µm, 250x4.6 mm 
Mobile phase: 0.01M KH2PO4/ 20% tetrabutyl 
ammonium hydroxide/ MeOH (970:1:30) 
adjusted to pH 2.75 using 85% phosphoric acid 
UV 244 nm 
Honey/ ascorbic 
(81) 
Dissolve in metaphosphoric 0.25% 
then filter 
Shimadzu C18- ODS 5µm, 250x4.6mm 
Mobile phase: methanol and water adjusted to 







Add 1ml of 50mM dithiothreitol 
into1ml of sample, centrifuge and 
filter (0.22 mm) 
J’sphere ODS-H80 4µm, 250x4.6mm 





Extractant contains 1g pyrogallol and 
19.21 g citric acid per liter. Extract 
sample with 100ml extractant 
solution and filter.  
 
Hypersil BDS C18, 5µm, 250x4.0mm, 
Mobile phase: isocratic with acetonitrile: ion-
pair solution (2:98) 
Ion-pair solution contains10 mM 1-hexane 
sulfonic acid, 10 mL acetic acid and 1.3 mL 






Extract 5g sample with 20ml 
metaphosphoric acid 50% and 1ml 
EDTA, dilute to 50ml, centrifuge and  
Spherisorb NH2 , 5µm, 250x4.0mm 
Mobile phase: isocratic with 0.02M 
KH2PO4:acetonitrile (40:60), pH 3.6 at flow rate 
UV 248nm 
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fi lter of 1 ml/min 
Beverages/ 
ascorbic (85) 
Dilute with water if needed  
 
Kromasil NH2, 5µm, 250x4.6mm 
Mobile phase: isocratic with 0.1M acetic at flow 
rate of 1.5ml/min  
UV 250 nm 
Foods/ ascorbic 
(86) 
Dilute sample in10ml mobile phase  
containing 20µM L-methionine. 
Intersil ODS, 5 m, 150x3mm 
Mobile phase: isocratic with 0.2% H3PO4, pH 
2.1at flow rate of 0.4ml/min 




Extract 2g sample with 5ml methanol 
and 25ml of 3% metaphosphoric acid 
and 8% acetic acid solution. Filter 
and ad 15ml 1% acetic acid to 10ml 
filtrate. 
Waters Symmetry C18 , 3.5µm, 75x4.6 mm 
coupled to an Atlantis dC18, 5µm, 150x2mm 
Mobile phase: isocratic with methanol:0.05% 





Extract with 3% metaphosphoric acid 
and 8% acetic acid solution 
Shodex RSpak KC-811, 5µm, 250x4.6mm 
Mobile phase: isocratic with 0.2% 




Extract with 4.5% metaphosphoric 
acid 
Waters Symmetry C18, 5µm, 250x4.6mm 
Mobile phase: isocratic with methanol:0.1% 






Weigh 10grams sample into 100ml 
flask, add 40ml 250ppm TCEP. HCl 
(Tris (2-carboxyethyl) phosphine 
hydrochloride), mix thoroughly and 
fill to the mark with 1% TCA. Shake 
and filter.     
LiChrospher RP-18; 5 µm; 250x4.6mm 
Mobile phase: 1.6g decylamine, 80 ml 
acetonitrile, 100 ml of sodium acetate  solution  
(0.25 M)  pH  5.4  and  820 ml  of distilled 
water. Final pH adjusted to 5.4 with phosphoric 
acid 85% and 50 mg TCEP. HCl. 






1. Harris, D.C. Quantitative chemical analysis. W.H. Freeman and Co.: New York, 2003;  
2. Snyder, L.R.; Glajch, J.L.; Kirkland, J.J. Practical HPLC method development. J. 
Wiley: New York, 1988;  
3. Kazakevich, Y.V.; LoBrutto, R. HPLC for pharmaceutical scientists. Wiley-
Interscience: 2007;  
4. Center for Drug Evaluation and Research (CDER) Reviewer Guidance-Validation of 
Chromatographic Methods. 1994,  
5. Agilent Technologies The LC Handbook-Guide to LC Columns and Method 
Development. 2011;  
6. Cunico, R.L.; Gooding, K.M.; Wehr, T. Basic HPLC and CE of biomolecules. Bay 
Bioanalytical Laboratory: Richmond, CA, 1998;  
7. Ang, C.Y.; Moseley, F.A. Determination of thiamin and riboflavin in meat and meat 
products by high-pressure liquid chromatography. J. Agric. Food Chem. 1980, 28, 
483-486.  
8. Walker, M.; Carpenter, B.; Cooper, E. Simultaneous determination of niacinamide, 
pyridoxine, riboflavin, and thiamine in multivitamin products by high‐pressure liquid 
chromatography. J. Pharm. Sci. 1981, 70, 99-101.  
9. Ohta, H.; Baba, T.; Suzuki, Y.; Okada, E. High-performance liquid chromatographic 
analysis of thiamine in rice flour with fluorimetric post-column derivatization. J. 
Chromatogr. 1984, 284, 281-284.  
10. Vanderslice, J.; Huang, M. Liquid chromatographic analysis of thiamin and its 
phosphates in food products using amprolium as an internal standard. 
J.Micronutr.Anal 1986, 2, 189-199.  
11. Amin, M.; Reusch, J. High-performance liquid chromatography of water-soluble 
vitamins. Part 3. Simultaneous determination of vitamins B1, B2, B6, B12 and C, 
nicotinamide and folic acid in capsule preparations by ion-pair reversed-phase high-
performance liquid chromatography. Analyst 1987, 112, 989-991.  
12. Nicolas, E.; Pfender, K. Fast and simple liquid chromatographic determination of 
nonphosphorylated thiamine in infant formula, milk, and other foods. Journal-
Association of Official Analytical Chemists 1990, 73, 792.  
 233
13. Vidal-Valverde, C.; Reche, A. An improved high performance liquid 
Chromatographie method for thiamin analysis in foods. Zeitschrift für Lebensmittel-
Untersuchung und Forschung 1990, 191, 313-318.  
14. Abdel-Kader, Z.M. Comparison of AOAC and high-performance liquid 
chromatographic methods for thiamin determination in foods. Food Chem. 1992, 43, 
393-397.  
15. Sims, A.; Shoemaker, D. Simultaneous liquid chromatographic determination of 
thiamine and riboflavin in selected foods. J. AOAC Int. 1993, 76, 1156-1160.  
16. Ollilainen, V.; Vahteristo, L.; Uusi-Rauva, A.; Varo, P.; Koivistoinen, P.; Huttunen, 
J. The HPLC Determination of Total Thiamin (Vitamin B< sub> 1</sub>) in Foods. 
Journal of Food Composition and Analysis 1993, 6, 152-165.  
17. Yamanaka, K.; Horimoto, S.; Matsuoka, M.; Banno, K. Analysis of thiamine in dried 
yeast by high-performance liquid chromatography and high-performance liquid 
chromatography/atmospheric pressure chemical ionization-mass spectrometry. 
Chromatographia 1994, 39, 91-96.  
18. Gehring, T.A.; Cooper, W.M.; Holder, C.L.; Thompson Jr, H.C. Liquid 
chromatographic determination of thiamine in rodent feed by postcolumn 
derivatization and fluorescence detection. J. AOAC Int. 1995, 78, 307.  
19. Hart, J.P.; Norman, M.D.; Tsang, S. Voltammetric behaviour of vitamin B1 
(thiamine) at a glassy carbon electrode and its determination in multivitamin tablets 
using anion-exchange liquid chromatography with amperometric detection under 
basic conditions. Analyst 1995, 120, 1059-1064.  
20. Blanco, D.; Llaneza, M.; Gutierrez, M. A paired ion liquid chromatographic method 
for thiamine determination in selected foods. J. Liq. Chromatogr. Rel. Technol. 1996, 
19, 2155-2164.  
21. Valls, F.; Checa, M.A.; Fernández-Muiño, M.A.; Sancho, M.T. Determination of 
thiamin in cooked sausages. J. Agric. Food Chem. 1999, 47, 170-173.  
22. Viñas, P.; López-Erroz, C.; Balsalobre, N.; Hernández-Córdoba, M. Comparison of 
ion-pair and amide-based column reversed-phase liquid chromatography for the 
separation of thiamine-related compounds. Journal of Chromatography B: 
Biomedical Sciences and Applications 2001, 757, 301-308.  
23. Viñas, P.; López-Erroz, C.; Balsalobre, N.; Hernández-Córdoba, M. Determination of 
thiamine and its esters in beers and raw materials used for their manufacture by 
 234
liquid chromatography with postcolumn derivatization. J. Agric. Food Chem. 2003, 
51, 3222-3227.  
24. Sibel Akalin, A.; Gönç, S.; Dinkçi, N. Liquid chromatographic determination of 
thiamin in dairy products. Int. J. Food Sci. Nutr. 2004, 55, 345-349.  
25. Tan, J.; Li, R.; Jiang, Z. Determination of thiamine (vitamin B1) in pharmaceutical 
tablets and human urine by titania-based ligand-exchange hydrophilic interaction 
chromatography. Analytical Methods 2011, 3, 1568-1573.  
26. Gratacos-Cubarsi, M.; Sarraga, C.; Clariana, M.; Garcia Regueiro, J.A.; Castellari, M. 
Analysis of vitamin B1 in dry-cured sausages by hydrophilic interaction liquid 
chromatography (HILIC) and diode array detection. Meat Sci. 2011, 87, 234-238.  
27. Woodcock, E.; Warthesen, J.; Labuza, T. Riboflavin photochemical degradation in 
pasta measured by high performance liquid chromatography. J. Food Sci. 1982, 47, 
545-549.  
28. Ashoor, S.H.; Knox, M.J.; Olsen, J.R.; Deger, D.A. Improved liquid chromatographic 
determination of riboflavin in milk and dairy products. J. Assoc. Off. Anal. Chem. 
1985, 68, 693-696.  
29. Watada, A.E.; Tran, T.T. A sensitive high-performance liquid chromatography 
method for analyzing riboflavin in fresh fruits and vegetables. J. Liq. Chromatogr. 
1985, 8, 1651-1662.  
30. Stancher, B.; Zonta, F. High performance liquid chromatographic analysis of 
riboflavin (vitamin B2) with visible absorbance detection in italian cheeses. J. Food 
Sci. 1986, 51, 857-858.  
31. Johnsson, H.; Branzell, C. High performance liquid chromatographic determination 
of riboflavin in food-a comparison with a microbiological method. International 
journal for vitamin and nutrition research 1987, 57, 53-58.  
32. Reyes, E.; Norris, K.; Taylor, C.; Potts, D. Comparison of paired-ion liquid 
chromatographic method with AOAC fluorometric and microbiological methods for 
riboflavin determination in selected foods. Journal-Association of official analytical 
chemists 1988, 71, 16-19.  
33. Palanuk, S.; Warthesen, J.; Smith, D. Effect of Agitation, Sampling Location and 
Protective Films on Light‐Induced Riboflavin Loss in Skim Milk. J. Food Sci. 1988, 
53, 436-438.  
 235
34. Ollilainen, V.; Mattila, P.; Varo, P.; Koivistoinen, P.; Huttunen, J. The HPLC 
determination of total riboflavin in foods. Journal of micronutrient analysis 1990, 8, 
199-207.  
35. Vidal-Valverde, C.; Recke, A. Reliable system for the analysis of riboflavin in foods 
by high performance liquid chromatography and UV detection. J. Liq. Chromatogr. 
1990, 13, 2089-2101.  
36. Bilic, N.; Sieber, R. Determination of flavins in dairy products by high-performance 
liquid chromatography using sorboflavin as internal standard. J. Chromatogr. 1990, 
511, 359-366.  
37. KANNO, C.; SHIRAHUJI, K.; HOSHI, T. Simple method for separate determination 
of three flavins in bovine milk by high performance liquid chromatography. J. Food 
Sci. 1991, 56, 678-681.  
38. Muñoz, A.; Ortiz, R.; Murcia, M. Determination by HPLC of changes in riboflavin 
levels in milk and nondairy imitation milk during refrigerated storage. Food Chem. 
1994, 49, 203-206.  
39. Russell, L.; Brooks, L.; McRae, K. Development of a robotic-HPLC determination of 
riboflavin vitamers in food. Food Chem. 1998, 63, 125-131.  
40. Andrés-Lacueva, C.; Mattivi, F.; Tonon, D. Determination of riboflavin, flavin 
mononucleotide and flavin–adenine dinucleotide in wine and other beverages by 
high-performance liquid chromatography with fluorescence detection. Journal of 
Chromatography A 1998, 823, 355-363.  
41. Valls, F.; Sancho, M.T.; Fernández-Muiño, M.A.; Checa, M.A. Determination of total 
riboflavin in cooked sausages. J. Agric. Food Chem. 1999, 47, 1067-1070.  
42. Gliszczyńska-Świgło, A.; Koziołowa, A. Chromatographic determination of 
riboflavin and its derivatives in food. Journal of Chromatography A 2000, 881, 285-
297.  
43. VINas, P.; Balsalobre, N.; López-Erroz, C.; Hernández-Córdoba, M. Liquid 
chromatographic analysis of riboflavin vitamers in foods using fluorescence 
detection. J. Agric. Food Chem. 2004, 52, 1789-1794.  
44. Gregory, J. BIOAVAILABILITY OF VITAMIN B‐6 IN NONFAT DRY MILK 
AND A FORTIFIED RICE BREAKFAST CEREAL PRODUCT. J. Food Sci. 1980, 
45, 84-86.  
 236
45. Vanderslice, J.T.; Brownlee, S.G.; Maire, C.E.; Reynolds, R.D.; Polansky, M. Forms 
of vitamin B6 in human milk. Am. J. Clin. Nutr. 1983, 37, 867-871.  
46. Ekanayake, A.; Nelson, P.E. An in vitro method for estimating biologically available 
vitamin B6 in processed foods. Br. J. Nutr. 1986, 55, 235-244.  
47. Addo, C.; AUGUSTIN, J. Changes in the Vitamin B‐6 Content in Potatoes During 
Storage. J. Food Sci. 1988, 53, 749-752.  
48. Ang, C.; Cenciarelli, M.; Eitenmiller, R. A simple liquid chromatographic method for 
determination of B6 vitamers in raw and cooked chicken. J. Food Sci. 1988, 53, 371-
375.  
49. Bitsch, R.; Moller, J. Analysis of B6 vitamers in foods using a modified high-
performance liquid chromatographic method. J. Chromatogr. 1989, 463, 207-211.  
50. Reitzer-Bergaentzle, M.; Marchioni, E.; Hasselmann, C. HPLC determination of 
vitamin B< sub> 6</sub> in foods after pre-column derivatization of free and 
phosphorylated vitamers into pyridoxol. Food Chem. 1993, 48, 321-324.  
51. van Schoonhoven, J.; Schrijver, J.; van den Berg, H.; Haenen, G.R. Reliable and 
Sensitive HPLC Method with Fluorometric Detection for the Analysis of Vitamin B6 
in Foods and Feeds. J. Agric. Food Chem. 1994, 42, 1475-1480.  
52. Sampson, D.; Eoff, L.; Yan, X.; Lorenz, K. Analysis of free and glycosylated vitamin 
B6 in wheat by high-performance liquid chromatography. Cereal Chem. 1995, 72, 
217-220.  
53. Sierra, I.; Vidal-Valverde, C. A simple method to determine free and glycosylated 
vitamin B6 in legumes. J. Liq. Chromatogr. Rel. Technol. 1997, 20, 957-969.  
54. Bognår, A.; Ollilainen, V. Influence of extraction on the determination of vitamin B6 
in food by HPLC. Zeitschrift für Lebensmitteluntersuchung und-Forschung A 1997, 
204, 327-335.  
55. Argoudelis, C.J. Simple high-performance liquid chromatographic method for the 
determination of all seven vitamin B< sub> 6</sub>-related compounds. Journal of 
Chromatography A 1997, 790, 83-91.  
56. Esteve, M.; Farre, R.; Frı ́gola, A.; Garcı ́a-Cantabella, J. Determination of vitamin B< 
sub> 6</sub>(pyridoxamine, pyridoxal and pyridoxine) in pork meat and pork meat 
products by liquid chromatography. Journal of Chromatography A 1998, 795, 383-
387.  
 237
57. Valls, F.; Sancho, M.T.; Fernández-Muiño, M.A.; Checa, M.A. Determination of 
vitamin B6 in cooked sausages. J. Agric. Food Chem. 2001, 49, 38-41.  
58. Kall, M.A. Determination of total vitamin B< sub> 6</sub> in foods by isocratic 
HPLC: a comparison with microbiological analysis. Food Chem. 2003, 82, 315-327.  
59. Vinas, P.; Balsalobre, N.; Lopez-Erroz, C.; Hernandez-Cordoba, M. Determination of 
vitamin B6 compounds in foods using liquid chromatography with post-column 
derivatization fluorescence detection. Chromatographia 2004, 59, 381-386.  
60. Jansen, C.; De Kleijn, J. The assay of cyanocobalamin in pharmaceutical preparations 
by solid-phase extraction and HPLC. J. Chromatogr. Sci. 1990, 28, 42-45.  
61. Dalbacke, J.; Dahlquist, I. Determination of vitamin B< sub> 12</sub> in 
multivitamin-multimineral tablets by high-performance liquid chromatography after 
solid-phase extraction. Journal of Chromatography A 1991, 541, 383-392.  
62. Iwase, H. Ultramicrodetermination of cyanocobalamin in elemental diet by solid-
phase extraction and high-performance liquid chromatography with visible detection. 
Journal of Chromatography A 1992, 590, 359-363.  
63. Iwase, H.; Ono, I. Determination of cyanocobalamin in foods by high-performance 
liquid chromatography with visible detection after solid-phase extraction and 
membrane filtration for the precolumn separation of lipophilic species. Journal of 
Chromatography A 1997, 771, 127-134.  
64. Chassaigne, H.; Lobinski, R. Determination of cobalamins and cobinamides by 
microbore reversed-phase HPLC with spectrophotometric, ion-spray ionization MS 
and inductively coupled plasma MS detection. Anal. Chim. Acta 1998, 359, 227-235.  
65. Chassaigne, H.; Łobiński, R. Direct species-selective determination of cobalamins by 
ionspray mass spectrometry and ionspray tandem mass spectrometry. Analyst 1998, 
123, 131-137.  
66. Li, H.; Chen, F.; Jiang, Y. Determination of vitamin B< sub> 12</sub> in 
multivitamin tablets and fermentation medium by high-performance liquid 
chromatography with fluorescence detection. Journal of Chromatography A 2000, 
891, 243-247.  
67. Wongyai, S. Determination of vitamin B< sub> 12</sub> in multivitamin tablets by 
multimode high-performance liquid chromatography. Journal of Chromatography A 
2000, 870, 217-220.  
 238
68. Alsberg, T.; Minten, J.; Haglund, J.; Törnqvist, M. Determination of hydroxyalkyl 
derivatives of cobalamin (vitamin B12) using reversed phase high performance 
liquid chromatography with electrospray tandem mass spectrometry and ultraviolet 
diode array detection. Rapid communications in mass spectrometry 2001, 15, 2438-
2445.  
69. Choi, Y.; Jang, J.; Park, H.; Koo, Y.; Hwang, I.; Kim, D. Determination of Vitamin 
B~ 1~ 2 (Cyanocobalamin) in Fortified Foods by HPLC. JOURNAL OF FOOD 
SCIENCE AND NUTRITION-NEW SERIES- 2003, 8, 301-305.  
70. Pakin, C.; Bergaentzlé, M.; Aoudé-Werner, D.; Hasselmann, C. α-Ribazole, a 
fluorescent marker for the liquid chromatographic determination of vitamin B< sub> 
12</sub> in foodstuffs. Journal of Chromatography A 2005, 1081, 182-189.  
71. Heudi, O.; Kilinc, T.; Fontannaz, P.; Marley, E. Determination of Vitamin B12 in 
food products and in premixes by reversed-phase high performance liquid 
chromatography and immunoaffinity extraction. Journal of Chromatography-A 
2006, 1101, 63-68.  
72. Luo, X.; Chen, B.; Ding, L.; Tang, F.; Yao, S. HPLC-ESI-MS analysis of Vitamin B< 
sub> 12</sub> in food products and in multivitamins-multimineral tablets. Anal. 
Chim. Acta 2006, 562, 185-189.  
73. Watada, A.E. A high-performance liquid chromatography method for determining 
ascorbic acid content of fresh fruits and vegetables. Hort.Sci 1982, 17, 334-335.  
74. Speek, A.J.; Schrijver, J.; Schreurs, W.H. Fluorometric determination of total vitamin 
C and total isovitamin C in foodstuffs and beverages by high-performance liquid 
chromatography with precolumn derivatization. J. Agric. Food Chem. 1984, 32, 352-
355.  
75. Wilson III, C.W.; Shaw, P.E. High-performance liquid chromatographic 
determination of ascorbic acid in aseptically packaged orange juice using ultraviolet 
and electrochemical detectors. J. Agric. Food Chem. 1987, 35, 329-331.  
76. Rodriguez, M.R.; Oderiz, M.V.; Hernandez, J.L.; Lozano, J.S. Determination of 
vitamin C and organic acids in various fruits by HPLC. J. Chromatogr. Sci. 1992, 30, 
433-437.  
77. Seiffert, B.; Swaczyna, H.; Schaefer, J. Simultaneous determination of l-ascorbic acid 
and d-isoascorbic acids by HPLC in wine and beer. Deutche Lebensmittel-
Rundschau 1992, 88, 38-40.  
 239
78. Iwase, H.; Ono, I. Determination of ascorbic acid and dehydroascorbic acid in juices 
by high-performance liquid chromatography with electrochemical detection using l-
cysteine as precolumn reluctant. Journal of Chromatography A 1993, 654, 215-220.  
79. Vazquez Oderiz, M.L.; Vazquez Blanco, M.E.; Lopez Hernandez, J.; Simal Lozano, 
J.; Romero Rodriguez, M.A. Simultaneous determination of organic acids and 
vitamin C in green beans by liquid chromatography. J. AOAC Int. 1994, 77, 1056-
1059.  
80. Daood, H.G.; Biacs, P.A.; Dakar, M.A.; Hajdu, F. Ion-pair chromatography and 
photodiode-array detection of vitamin C and organic acids. J. Chromatogr. Sci. 1994, 
32, 481-487.  
81. Castro, R.; Azeredo, L.; Azeredo, M.; de Sampaio, C. HPLC assay for the 
determination of ascorbic acid in honey samples. J. Liq. Chromatogr. Rel. Technol. 
2001, 24, 1015-1020.  
82. Furusawa, N. Rapid high-performance liquid chromatographic 
identification/quantification of total vitamin C in fruit drinks. Food Control 2001, 12, 
27-29.  
83. Muller, L.D. Improved extraction methods for avoiding the interference of copper in 
the LC determination of ascorbic acid in multivitamin-mineral tablets. J. Pharm. 
Biomed. Anal. 2001, 25, 985-994.  
84. Valls, F.; Sancho, M.T.; Fernandez-Muin, M.; Alonso-Torre, S.; Checa, M.A. High-
pressure liquid chromatographic determination of ascorbic acid in cooked sausages. 
Journal of Food Protection® 2002, 65, 1771-1774.  
85. Rodrıguez-Comesana, M.; Garcıa-Falcón, M.; Simal-Gándara, J. Control of 
nutritional labels in beverages with added vitamins: screening of β-carotene and 
ascorbic acid contents. Food Chem. 2002, 79, 141-144.  
86. Iwase, H. Routine high-performance liquid chromatographic determination of 
ascorbic acid in foods using L-methionine for the pre-analysis sample stabilization. 
Talanta 2003, 60, 1011-1021.  
87. Frenich, A.G.; Torres, M.H.; Vega, A.B.; Vidal, J.M.; Bolanos, P.P. Determination of 
ascorbic acid and carotenoids in food commodities by liquid chromatography with 
mass spectrometry detection. J. Agric. Food Chem. 2005, 53, 7371-7376.  
88. Hernández, Y.; Lobo, M.G.; González, M. Determination of vitamin C in tropical 
fruits: A comparative evaluation of methods. Food Chem. 2006, 96, 654-664.  
 240
89. Iglesias, J.; González, M.J.; Medina, I. Determination of ascorbic and 
dehydroascorbic acid in lean and fatty fish species by high-performance liquid 
chromatography with fluorometric detection. European Food Research and 
Technology 2006, 223, 781-786.  
90. Fontannaz, P.; Kilinç, T.; Heudi, O. HPLC-UV determination of total vitamin C in a 
wide range of fortified food products. Food Chem. 2006, 94, 626-631. 
 
